








































































































a  vast  number  of  reactions  in  our  body,  they  are  incorporated  into many  industrial 
processes.  In  the  light  of  pollution  and  decline  of  fossil  resources  it  is  essential  to 
develop new production routes to pharmaceutical and chemical target compounds. The 
exaggerated use of antibiotics and  the  resulting  increase of multi‐resistant bacteria  is 
another  threat  of  our  century.  Solving  this  problem  requires  deep  understanding  of 
antibiotic resistance mechanisms to enable rational drug‐design.  
The  main  focus  of  the  thesis  lies  on  terpene  synthases,  which  catalyse  the 
cyclisation of  linear  isoprenoid precursors  to  complex macrocycles.  These  compounds 
are  high  commercial  targets  of  the  chemical  and  pharmaceutical  industry.  Terpenes 
constitute  the  largest  group  of  natural  compounds.  Especially  in  the  class  of  the 
diterpenes  many  compounds  possess  antibacterial,  anti‐viral,  insecticidal  and  anti‐
inflammatory properties. White biotechnology opens up new routes for the production 
of  terpenes  in bacteria  in a sustainable manner.  In order  to optimise  terpene  titers  in 
bacteria,  structural  knowledge  of  the  involved  terpene  synthases  is  crucial. Here, we 
report the crystal structures of the diterpene synthases CotB2 and  IES  in complex with 
various substrate‐analogues. Furthermore, the structure of the oleate hydratase OhyRe 













Enzyme  spielen  eine  Schlüsselrolle  in  unserem  Leben.  Sie  sind  nicht  nur  an  der 
Katalyse  von  lebenswichtigen Vorgängen  in unserem Körper beteiligt,  sie  sind ebenso 
unverzichtbar  in vielen chemisch‐industriellen Prozessen.  Im Zeitalter von Klimawandel 
und zur Neige gehenden fossilen Rohstoffen ist es essentiell, neue Produktionswege für 
die  Herstellung  von  Arzneistoffen,  Verbundstoffen  und  Kosmetika,  die  bisher  primär 
über  chemische  Synthese  oder  aus  Pflanzenextraktion  gewonnen werden,  zu  finden. 
Ebenso  stellt  auch  die  übertriebene  Antibiotikagabe  und  daraus  resultierend  die 
Zunahme  von  Antibiotikaresistenzen  die  Welt  vor  ein  Problem.  Die  Aufklärung  von 
Antibiotika‐Wirkmechanismen  sowie  bakteriellen  Resistenzmechansimen  ist 
Voraussetzung  um  neue  antimikrobiell wirksame  Substanzen  zu  erforschen.  Im  Zuge 
dieser  Doktorarbeit  wurde  die  Struktur  von  AlbAS,  einem  bakteriellen  Antibiotika‐
bindenden  Protein,  bestimmt.  Die  Proteinstruktur  gibt  Aufschluss  über  das 
Bindeverhalten  vom  antibakteriellen Albicidin  auf molekularer  Ebene und hilft  so den 
Resistenzmechanismus aufzuklären. 
Der  Hauptfokus  dieser  Doktorarbeit  liegt  auf  den  Terpensynthasen,  einer 
Enzymklasse, die lineare Isoprenoide zu komplexen Makrozyklen zyklisiert. Die Produkte 
dieser  Reaktionen  sind  wichtige  Ausgangsstoffe  und Wirkstoffe  der  chemischen  und 
pharmazeutischen  Industrie.  Die  Klasse  der  Terpene  bildet  die  größte  Vielfalt  von 
Naturprodukten. Insbesondere unter den Diterpenen sind zahlreiche Vertreter mit anti‐
bakteriellen,  anti‐viralen,  insektiziden  und  entzündungshemmenden  Eigenschaften  zu 
finden. Durch die genetische Inkorporation von Terpenzyklasen  in Bakterien  lassen sich 
kosteneffektiv und umweltschonend Terpene herstellen. Genaue strukturelle Kenntnisse 
der  involvierten Enzyme  sind dabei unabdingbar, um  sie über gezielte Mutagenese  zu 








Die  Kristallstrukturen  biotechnologisch  relevanter  Enzyme,  die  im  Rahmen  dieser 
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ever,  industry  is  still  relying  primarily  on  fossil  resources.  The United Nations  aim  to 
break this paradigm and stated their Sustainable Development Goals (SDGs) in 2015. To 
implement  their  goals  of  a more  sustainable  future,  biotechnological  routes  for  the 
production of biomolecules are needed (de Lorenzo et al., 2018).        
  Many of the pharmaceutical active compounds were first discovered  in extracts of 
plants, fungi and bacteria, produced by enzymes. Isolation of the compounds from their 
native  source  can  be  difficult  and  often  does  not  provide  substances  at  an  industrial 
scale  (Chang  and  Keasling,  2006).  However,  most  of  these  biomolecules  were  then 
synthesised via organic synthesis. In the light of sustainability, this may not be the best 
approach,  since  chemical  synthesis  often  involves  toxic  waste  and  usage  of  fossil 
resources. Furthermore, some of  the sophisticated biomolecules are difficult  to access 
by  chemical  synthesis  or  are  only  obtained  in  small  yields.  In  recent  years, 
biotechnological production routes have become more attractive. Due to their capability 
of catalysing, even chemically challenging reactions, in a very elegant and effective way, 
enzymes are fascinating tools in biotechnology.                  



















are  not  only  the  source  of many  scents  ‐  they  are  also  flavours  in  food  and  active 
substances  in medicine.  Because  of  their  immense  structural  and  bioactive  diversity, 
terpenes  are  used  in  many  modern  branches  of  the  chemical,  biotechnological, 
agricultural  and  pharmaceutical  industry  (Aharoni  et  al.,  2005;  Bruck  et  al.,  2014; 
Newman and Cragg, 2016).                        




variety  of  terpene  molecules  within  the  distinct  classes  is  generated  by  terpene 
synthases (TPSs), sometimes referred to as terpene cyclases (Kirby and Keasling, 2009). 
These enzymes perform  the cyclisation of  the  linear precursor  to polycyclic  structures 
with  elaborate  stereochemistry  and  with  strict  regioselectivity  (Christianson,  2017). 











Most  of  the  sophisticated  polycyclic  terpenes  are  difficult  to  access  by  classical 
chemical  synthesis.  Instead  one  can manipulate microorganisms  to  produce  terpene 
scaffolds that can then be further modified by chemical synthesis (Chang and Keasling, 














reaction  mechanism).  The  emerging  reactive  carbocation  then  propagates 
intramolecular cyclisation. Given  the different cyclisation  strategies, class  I and class  II 
diterpene synthases differ in their tertiary fold and motifs (Fig. 2). The common fold for 
class  I TPSs  is the α‐helical bundle fold ‐ the “α‐fold”, where ten to twelve  long helices 
are connected via short loop segments, creating a claw‐like overall structure with a large 
cleft  forming  the  active  site  (Whittington  et  al.,  2002).  Class  II  TPSs  consist  of  two 
different α‐helical domains, termed β and γ (Oldfield and Lin, 2012).       
  In bacteria, diterpene synthases exclusively belong to class  I TPS, whereas  in  fungi 
and plants, they can be both class  I or class  II TPS and even mixed class  I/II.  In most of 
the known structures, bacterial TPSs form parallel (e.g. ent‐kaurene synthase (Liu et al., 
2014)) or antiparallel (e.g. CotB2 synthase (Janke et al., 2014)) dimers. However, there 
are  examples  of  higher  oligomerisation  states,  e.g.  fusicoccadiene  synthase  forms  a 
hexamer (Chen et al., 2016). In plants, TPSs can adopt a more complex fold consisting of 
several  domains.  In  the  case  of  diterpene  taxadiene  synthase  (TXS)  from  pacific  yew 
tree, a catalytically active class I α‐domain is present, as well as α‐helical domains β and 














Members  of  class  I  TPSs  usually  exhibit  a  DDXXD/E  (X=any  amino  acid)  motif, 
termed  aspartate‐rich  motif  (Ashby  and  Edwards,  1990).  The  second  catalytically 
important motif  is  the NSE/DTE  consensus‐sequence  (N,D)DXX(S,T)XXXE  (Christianson, 
2006).  Both motifs  are  crucial  in  class  I  TPSs  for  binding  three  divalent metal‐ions, 
usually  Mg2+‐ions,  that  coordinate  the  diphosphate  moiety  of  the  substrate  GGDP. 
Class II TPSs feature an aspartate‐rich motif only, often of the form DXDD.      
  Although various structures of TPSs are available to date, X‐ray crystal structures of 
TPSs  have  been  exclusively  solved  by  experimental  phasing  (Christianson,  2017).  α‐
helical  proteins  are  notoriously  challenging  to  solve  by molecular  replacement,  since 
small tilts of the helices compared to the reference model already complicate finding the 
correct solution. Furthermore, sequence identity for TPSs is often below 20 %. The two 






Terpenes  are  of  special  interest  to  the  pharmaceutical  industry  because  of  their 
broad spectrum of activities. Since total chemical synthesis of the polycyclic compounds 
with many  stereo‐centres  is  cumbersome, different production  strategies are needed. 
Using microorganisms such as Escherichia coli or yeast for the synthesis of terpenes not 












The  terpene production chassis  in bacteria  involves an upstream and downstream 









building  blocks  isopentyl  diphosphate  (IPP)  and  dimethylallyl  diphosphate  (DMAPP)  in  the  upstream 
module. In the downstream element, the linear diterpene precursor geranylgeranyl diphosphate (GGDP) is 
generated  by  GGDP‐synthase  and  cyclised  by  CotB2.  The  resulting  tricyclic  diterpene  is  then  further 
modified by the cytochromes CotB3 and CotB4 to the anti‐inflammatory drug cyclooctatin. 
 
The downstream  enzymes of  the  terpene production pipeline  in bacteria  are  the 
ideal  candidates  for  protein  engineering.  Especially  the  terpene  cyclases  are  valuable 
targets,  since  they  catalyse  the  most  challenging  reactions  of  the  chassis.  By  site‐










its precise  function  in a protein network or  its mode of binding  to  ligands/  inhibitors. 
Furthermore, mutagenesis can be informed by knowledge of a structure. In this thesis, I 
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The  bacterial  diterpene  synthase  CotB2  (derived  from  Streptomyces 
melanosporofaciens),  which  is  a  member  of  the  class  I  TPSs,  is  responsible  for  the 
cyclisation of GGDP to cyclooctat‐9‐en‐7‐ol (Fig. 4a). This fusicoccane with a 5‐8‐5 fused 
ring system is then subsequently modified by the P450 cytochromes CotB3 and CotB4 to 
the  bioactive  compound  cyclooctatin  (Fig.  4a).  Cyclooctatin  is  a  next‐generation  anti‐
inflammatory  drug  since  it  targets  a  lysophospholipase  that  is  upregulated  in 





α‐helical  bundle  fold  is  common  for  class I  TPSs.  In  the  crystal,  two  CotB2 molecules 







Fig.  4 Overall  structure  of  the  bacterial  diterpene  synthase  CotB2  and  the  role  of  its  C‐terminus.  a) 
Reaction  of  geranylgeranyl  diphosphate  (GGDP)  to  the  bioactive  compound  cyclooctatin.  b)  Cartoon‐
representation  of  CotB2,  colour  gradient  is  from  green  (N‐terminus)  to  blue  (C‐terminus).  c)  Reaction 
mechanism of 2‐fluoro geranylgeranyl diphosphate (FGGDP) to 2‐fluoro‐3, 7, 18‐dolabellatriene (F‐Dola), 
catalysed by CotB2. d) Superposition of CotB2 in its open (teal) and closed (beige) state. The C‐terminus of 








  To  get  an  idea  of  CotB2s  dynamic  transitions  during  catalysis,  we  aimed  to 
determine  its  closed  ligand‐bound  conformation.  This  task  proved  to  be  challenging 
since CotB2  is a very effective, fast enzyme. Initial soaking experiments with the native 
substrate  GGDP  or  diphosphate  failed.  We  then  soaked  CotB2  crystals  with  the 
substrate‐analogue  2‐fluoro  geranylgeranyl  diphosphate  (FGGDP),  a  GGDP  molecule 













shield  the  active  site  from  bulk  solvent.  Interestingly,  the  C‐terminus  could  not  be 
resolved by Tomita et al. who co‐crystallised CotB2 together with the substrate analogue 
geranylgeranyl  thiodiphosphate  (GGSDP)  (PDB‐ID 5GUE  (Tomita et  al., 2017)).  In  their 
structure  they captured a pre‐catalytic state of CotB2 with a single Mg2+‐ion bound  to 
the active site.                               
  In order  to prove  that  the  folded C‐terminus  is not a crystallographic artefact, we 
co‐crystallised CotB2 with alendronate (AHD), a compound that mimics the diphosphate 
group  of  GGDP.  The  AHD‐bound  structure,  although  it  crystallised  in  another  space 
group,  is  almost  identical  to  the  intermediate‐bound  one  (Fig.  5e,  PDB‐ID  6GGJ). 




(PDB‐ID  6GGK). Activity  studies performed by our  collaborators  (M.  Fuchs, C. Görner, 
T. Brück,  TU  Munich)  showed  that  the  truncation  is  catalytically  inactive  (Fig.  4f), 
underlining the importance of the C‐terminus.  
3.1.2 Active site 
Since  CotB2  belongs  to  the  class  I  synthases,  the  two  metal‐binding  motifs  are 
present.  The  aspartate‐rich motif DDXXD/E  however  is  degenerated  to  110DDPD113  in 
CotB2. In the literature, a couple of other TPSs are known to have altered aspartate‐rich 
motifs  as  well  (e.g.  Selina‐3,7(11)‐diene  synthase:  82DDGYCE  (Arigoni,  1975),  (+)‐T‐
Muurolol  synthase:  83DDEYCD  (Hu  et  al.,  2011)).  The  aspartate‐rich motif  of  CotB2  is 
located at the very end of helix D with P112 introducing a kink, so that the last aspartate 






three  aspartates  to  glutamates  and  performed  activity  assays. D110E  and D113E  still 
produce wildtype product, whereas D111E is a dead mutant. Based on the mutations it 
was  not  possible  to  distinguish which  aspartate  is  coordinating  the Mg2+‐ions.  In  the 
closed structure of CotB2, we could subsequently clearly  identify the residues that are 
responsible  for  metal  coordination.  D110  is  coordinating  two  Mg2+‐ions  (Mg2+A  and 
Mg2+C),  stabilising  the diphosphate moiety of  the  substrate  (Fig. 5a). A  third Mg2+‐ion 
(Mg2+B)  is bound by  the  residues N220, S224 and E228 of  the NSE/DTE motif  (Fig. 5a). 
Since  the mutation D110E does not affect  catalysis,  the active  site  is  large enough  to 
accommodate  a  slightly  bigger  amino  acid  residue  without  interfering  with  metal 
coordination. D111 is forming a salt‐bridge with R294 (Fig. 5a). Interestingly, Tomita and 
colleagues  also  observe  this  salt‐bridge  in  their  pre‐catalytic  state  structure  (Fig.  5c 
and d),  even  though  there  is  only  one Mg2+‐ion  bound,  instead  of  the  three  that  are 
necessary  for  catalysis  (Tomita et al., 2017). We  therefore postulate  that binding of a 
substrate  to  the enzyme  together with Mg2+B  causes  the  formation of  the  salt‐bridge, 
but  only  the  full  cluster  of  three  Mg2+‐ions  ensures  the  correct  positioning  of  the 
substrate. Nevertheless,  the  salt‐bridge  seems  to  be  essential  for  catalysis,  since  the 
mutation D111E renders the enzyme  inactive. However,  formation of the salt‐bridge  is 
not enough to start the cyclisation reaction. Instead, the full C‐terminus is necessary as 
shown by the experiments with the C‐terminal truncation of CotB2.         
  In  a  recent  review,  the  presence  of  a  “pyrophosphate  sensor”,  an  arginine  46 
residues upstream the NSE/DTE motif, was discussed as a universal feature of bacterial 
TPSs  (Dickschat,  2016).  For  CotB2,  R175 was  predicted  to  be  this  conserved  residue. 
However, having solved the closed structure of CotB2 we can now  identify R177 to be 
the pyrophosphate  sensor  that  stretches out  to  the diphosphate moiety. R175 on  the 








Fig. 5 Active  site of CotB2 with  residues of  the aspartate‐rich motif  labelled  red and  residues of  the 
NSE/DTE motif  labelled  yellow,  respectively. Hydrogen bonds are  indicated by dashed black  lines.  a) 












from  each  other.  We  therefore  considered  an  initiated  cyclisation  reaction  to  have 
happened with the cyclised reaction  intermediate being trapped  in the active site. The 
reaction presumably halts after the first ring closure, the intermediate being 2‐fluoro‐3, 
7, 18‐dolabellatriene  (F‐Dola)  (Fig. 4c). Since  the  fluorine‐atom  is very electronegative, 








It has been  shown  for a variety of TPSs,  that  single  residue exchanges within  the 
active  site  can  have  a major  impact  on  product  formation  (Hyatt  and Croteau,  2005; 
Lopez‐Gallego et al., 2010; Yoshikuni et al., 2006). Not only can an exchange to another 
amino acid residue lead to a complete loss of enzymatic function, it can even result in a 
new  product,  which  greatly  differs  from  the  native  product.  In  case  of  CotB2, 
substitution  of  a  single  residue  can  generate  scaffolds  ranging  from  monocyclic  to 
tricyclic products  (Fig. 6).  It  is hypothesised  for TPSs  that  the  shape of  the active  site 
already determines the product. Therefore, by making the active site larger or smaller it 
can accommodate different macrocycles.                     
  Our  collaborators  from  TU  Munich  screened  CotB2  for  mutants  that  alter  the 
product spectrum. They identified mutations F149L, W288G, F107Y and F107A to have a 
major  impact  on  product  formation  (Fig.  6)  (Gorner  et  al.,  2013;  Janke  et  al.,  2014). 
Further, Tomita et al. described mutations W186F, F185A and N103A that also produce 
other macrocycles than CotB2wt (Fig. 6) (Tomita et al., 2017). All these mutations affect 
residues within  the  active  site.  It  seems  that  especially  the  aromatic  residues  have  a 











Fig.  6  Residue  exchanges  in  CotB2  and  their  effect  on  product  formation.  Single  point  mutations 





basis  for  quantum mechanics/ molecular mechanics  (QM/MM)  simulations  that  give 
detailed insights into the catalytic mechanism. The group of Prof. Dan Major is currently 
working with  our  coordinates  to  investigate  the  cyclisation mechanism  of  the  linear 
GGDP. 
Table 1 List of obtained structures of CotB2 mutants 
Mutant  Resolution [Å]  State  Active site  PDB‐ID 
F149L  1.6  open  ‐  4OMH 
F107A  1.9  open  1 Mg‐ion  6GGL 
F149L  1.4  closed  alendronate  unpublished 
L281V  1.5  closed  alendronate  unpublished 
M189C  2.2  closed  alendronate  unpublished 
M189C  1.9  open  ‐  unpublished 
W288G  2.1  open  ‐  unpublished 






Residue  exchanges  within  the  active  site  of  CotB2  are  not  only  of  interest  for 
elucidating  the  catalytic mechanism  ‐  they  also  have  an  application  in  biotechnology. 
The new products are scaffolds for the chemical industry and some of them even show 
bioactivity. For example, 3, 7, 18‐dolabellatriene, produced by the CotB2 variant W288G, 
is  an  effective  antibiotic  against  the  multi‐resistant  Staphylococcus  aureus  (MRSA) 
(Ioannou et al., 2011).                             
  Our collaborators from TU Munich  incorporate CotB2 and CotB2 variants  into their 
bacterial  terpene  production  pipeline.  The  different  cyclic  compounds  produced  by 





By  solving  the  structures  of  CotB2  in  different  catalytic  states, we were  able  to 
propose a mechanism for substrate binding (Fig. 7). The first step is binding of an Mg2+‐
ion  (Mg2+B). Next,  the  substrate  binds  via  its  diphosphate moiety  and  the  salt‐bridge 
Asp111‐Arg294  is  formed.  Binding  of  Mg2+A  and  Mg2+C  to  the  aspartate‐rich  motif 
ensures  proper  coordination  of  the  substrate.  Only  after  the  substrate  is  correctly 







Fig.  7  Schematic  view  of  CotB2’s  reaction  mechanism.  CotB2  is  represented  by  a  grey  cup with  the 
aspartate‐rich motif highlighted in red and the NSE/DTE motif in yellow. The reaction starts with binding 
of  the  substrate,  followed  by Mg2+A  and Mg2+C  binding.  Only  then  the  C‐terminus  (shown  in  purple) 
becomes folded and closes the active site. 
3.1.6 CotB3/CotB4 
The  chemical  modifications  necessary  to  obtain  the  bioactive  compound 
cyclooctatin from cyclooctat‐9‐en‐7‐ol are catalysed by the two P450 cytochromes CotB3 
and  CotB4.  Furthermore,  CotB3  and  CotB4  are  potential  candidates  in  the 
biotechnological  terpene  production  pipeline  to  diversify  the  terpene  scaffolds. 
Cytochromes  (CYP)  hydroxylate  non‐activated  carbon  atoms  by  utilising  molecular 
oxygen. The majority of CYP enzymes  feature a haem prosthetic group  in  their active 
site, which directs regio‐specific substrate oxidation. To accomplish this redox reaction, 
the cofactor NAD(P)H and a corresponding electron  transfer  system are  required. The 
redox partner proteins vary depending on the class of the CYP.           


















be  promising  as  the  cytochromes  are  of  bacterial  origin.  However,  an  alternative 
bacterial  expression  host  such  as  Streptomyces  could  be  tried  out  to  express  soluble 








A  manuscript  that  refers  to  results  in  this  section  is  currently  in  preparation. 
Furthermore, a patent process is ongoing, so that not all findings can be discussed in full 
detail in this thesis, including origin organism and residue numbering. 
The  diterpene  synthase  IES  was  isolated  from  a marine  organism  native  to  the 
Caribbean Sea. It produces a series of pseudopterosins, which are diterpene glycosides. 
These  compounds  have  proven  anti‐inflammatory,  anti‐tumour  and  anti‐bacterial 
properties  (Mayer  et  al.,  2010).  Pseudopterosins  seems  to  be  very  effective  against 

























transition  state between open  and  closed  state,  in which  the binding  site  is not  fully 
occupied.  In  four out of the six molecules additional density within the active site was 
observed  that  could  represent  an  AHD  molecule  and  three  Mg2+‐ions  (Fig.  10d). 
However,  since  the  resolution  of  our  structure  is  only moderate  (3.0  Å),  a  definite 
assignment was not possible.  In the  four molecules with additional density, up to nine 
residues at the C‐terminus could be modelled into the electron density, compared to the 










orange  lines. b)  IES monomer  (Chain B) bound  to alendronate  (AHD). Mg2+‐ions are presented as green 
spheres.  c)  Superposition of  IES monomer  (orange) with CotB2open  (teal).  The  aspartate‐rich motifs  are 





IES  is  yet  another member  of  class  I  TPSs  and  possesses  both  the  aspartate‐rich 
motif and the NSE/DTE motif. When superimposed with the structure of CotB2, the two 
metal‐binding motifs are positioned at the same relative sites of the proteins (Fig. 10c). 
As  in  CotB2,  the  aspartate‐rich  motif  is  unusual  as  it  is  longer  (DDXXXD)  than  the 
canonical DDXXD motif. A closer look to the active site revealed that the residues of the 
















for  the cosmetic  industry, but  it only makes up 9 % of  the  total product mixture. Our 
collaborators from TU Munich were able to shift product formation towards the desired 
product  by  mutating  the  enzyme.  Interestingly,  only  this  mutation  yielded  well 
diffracting crystals. IESwt crystals failed to diffract better than 8 Å, even after numerous 
optimisations  of  the  crystallisation  conditions  and  trying  different  crystallisation 
temperatures.                                 
  It  is not possible to access the desired compound via total chemical synthesis.  It  is 
currently  isolated  from  its natural  source,  the  soft  coral. By  applying biotechnological 










 Jan  Lorenzen,  Ronja Driller, Ayk Waldow,  Farah Qoura,  Bernhard  Loll,  Thomas 
Brück (2018), Rhodococcus erythropolis Oleate Hydratase: a New Member in the 
Oleate  Hydratase  Family  Tree  ‐  Biochemical  and  Structural  Studies, 
ChemCatChem 10:407‐414 
Fatty acid hydratases catalyse hydration and dehydration reactions of fatty acids (Jin 
and  Hanefeld,  2011).  The  substrate  of  oleate  hydratases  (OHs)  is  oleic  acid which  is 
converted  into  (R)‐10‐hydroxystearic  acid  (Fig.  11a)  (Bevers  et  al.,  2009).  There  is  an 
increasing  economic  demand  for OH  products  since  they  are  used  in  surfactant  and 
lubricant formulations and could even serve as biofuels (Hou, 2009; Song et al., 2013). 
All of the identified OHs require the cofactor FAD for catalysis.        
  OhyRe  is  a  member  of  the  OH  family,  deriving  from  the  gram‐positive  marine 
bacteria Rhodococcus erythropolis (Goodfellow and Alderson, 1977). Up to now, eleven 
sub‐families have been  identified based on  their  amino  acid  sequence  (Schmid et  al., 
2016). Only two structures of OHs had been reported prior to our work, namely those of 




We  crystallised  OhyRe  in  space  group  P6522,  solved  the  structure  via molecular 
replacement and refined it at a resolution of 2.64 Å (Lorenzen et al., 2018). The structure 
represents  the open  state of  the enzyme,  since no  cofactor or  substrate  is bound. All 
attempts to co‐crystallise OhyRe with fatty acid substrates failed.          
  OhyRe  consists  of  three  core  domains  (domain  I  ‐  III,  Fig.  11b)  and  a  C‐terminal 
domain  IV.  This  last domain  is only  an  α‐helical  segment  in OhyRe but  is 48  residues 
longer in OhyA and 32 residues longer in LAH. Domain I consists of two β‐sheets and an 






likely  that  OhyRe  binds  FAD  in  this  region.  Unfortunately,  we  did  not  succeed  in 
obtaining a crystal structure with bound FAD ‐ neither by adding FAD during purification 
of OhyRe  nor  by  co‐crystallisation  or  soaking  into  the  protein  crystals. We  therefore 
presume  that  FAD  binds  rather  weakly  to  OhyRe,  as  was  also  shown  for  OhyA 
(dissociation constant Kd of 1.8∙106 M). Domain  II contains a  large antiparallel  β‐sheet 
and  an  α‐helical portion, whereas domain  III  is  completely  α‐helical.  It  is not  entirely 
clear where the substrate, oleic acid, is binding to OhyRe. 
 




OhyRe  is a monomer  in crystallo as well as  in solution, which we proved by MALS. 
This  is  in contrast to LAH and OhyA, which are both dimers. As OhyRe  is  lacking the C‐
terminal extension of domain IV and is also shorter at the N‐terminus compared to the 
other two OHs, we assume that N‐ and C‐termini play a role  in dimerisation. Indeed,  in 









recombinantly  produced  protein,  FAD  is  lost.  We  monitored  its  presence  during 
purification at 450 nm, FAD’s UV absorption maximum, and the signal is not detectable 
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Markus  Wahl,  Bernhard  Loll,  Andi  Mainz,  Roderich  D.  Süssmuth  (2018), 
Molecular  insights  into  antibiotic  resistance:  how  a  binding  protein  traps 
albicidin, Nature Communications 9:3095 
The antibiotic albicidin  (Fig. 12)  inhibits DNA gyrase and  is therefore toxic to most 
Gram‐positive and Gram‐negative bacteria, such as S. aureus and E. coli (Hashimi et al., 
2007;  Kretz  et  al.,  2015).  However,  some  bacteria  developed  resistance  strategies 
against albicidin. AlbA from Klebsiella oxytoca is an albicidin‐binding protein that belongs 
to the MerR (Mercury Resistance (Miller, 1999)) transcriptional regulator family (Walker 








AlbAS  is a purely α‐helical protein, consisting of ten helices.  It can be divided  into two 





connected  by  a  long  linker  helix  α6  (Fig.  13a).  The  structures  of  NTD  and  CTD 
superimpose well as reflected in a rather low rmsd of 1.7 Å (Fig. 13c) for 84 aligned Cα‐





Fig. 13 Overall  structure of AlbAS. a) Structure of AlbAS  in  cartoon  representation; NTD  is  coloured  in 






(Fig. 13a).  It  is bound by  residues of  the NTD, CTD and  linker helix, primarily  through 
hydrogen bonding and π‐stacking of neighbouring aromatic  residues  (Fig. 14a). Due  to 
the  large  number  of  aromatic  residues,  the  tunnel  to which  albicidin  binds,  is  rather 
hydrophobic. Residues F16, W27 and W133 directly contribute to binding via π‐stacking 
to  albicidin’s  aromatic  groups.  Additionally,  hydrogen‐bonds  are  formed  between 
























via  MALS  measurements.  As  albicidin  is  a  rather  large  ligand  compared  with  the 
molecular  size  of  AlbAS,  one might  expect  that  considerable  protein  conformational 
changes are necessary to properly bind it. However, the values of Rh for apo AlbAS (2.0 ± 





















A  future  that  does  not  rely  on  fossil  resources  requires  exploiting  the  power  of 
enzymes. Not only can enzymes be used  to obtain chemically diverse compounds and 
antibiotics as in the case of TPSs, they are also necessary for the production of fuels and 
are  essential  components  in  wastewater  treatment  plants  or  can  be  used  for  the 
degradation of biodegradable plastics  (Roohi et al., 2017). Chen and Yu et al.  recently 





demonstrate  the  importance  of  the  C‐terminus  for  active  site  closure.  These  results 






compounds  likely  possess  bioactivity  or  can  act  as  enzyme  inhibitors.  It may  thus  be 
advantageous  to  include  them  in  substance  collections  that  are  used  for  high‐
throughput  inhibitor/modulator  screening.  Furthermore,  CotB2  molecules  could  be 
coupled  to  resin  to simplify  terpene production  in an  in vitro approach. Very  recently, 
Kirschning and co‐workers evaluated the substrate flexibility of sesquiterpene synthases 
(Oberhauser et al., 2018).  Interestingly,  the  synthases were able  to  convert unnatural 









industry,  as  they  diversify  the  product  spectrum  and  create  access  to molecules  not 
available  through  total  chemical  synthesis.  There  are  most  likely  many  more  TPSs 
producing  pharmacologically  interesting  products  that  are  not  discovered  yet.  A 
cumbersome  task  for  the next years will be  to  identify them  in  the genomes of plants 
and bacteria to exploit them for the biotechnological sector. X‐ray crystal structures of 
TPSs can help to characterise them, since  it  is not always possible to assign the correct 








Intensive  studies on  enzymes  are necessary  to  improve  catalytic  activities  and  to 
discover  their  potential  for  new  applications  in  a  sustainable  way  of  life.  Crystal 
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Sesquiterpenes and diterpenes are a diverse class of secondary
metabolites that are predominantly derived from plants and
some prokaryotes. The properties of these natural products
encompass antitumor, antibiotic and even insecticidal activ-
ities. Therefore, they are interesting commercial targets for the
chemical and pharmaceutical industries. Owing to their
structural complexity, these compounds are more efﬁciently
accessed by metabolic engineering of microbial systems than
by chemical synthesis. This work presents the ﬁrst crystal
structure of a bacterial diterpene cyclase, CotB2 from the soil
bacterium Streptomyces melanosporofaciens, at 1.64 A˚ resolu-
tion. CotB2 is a diterpene cyclase that catalyzes the cyclization
of the linear geranylgeranyl diphosphate to the tricyclic
cyclooctat-9-en-7-ol. The subsequent oxidation of cyclooctat-
9-en-7-ol by two cytochrome P450 monooxygenases leads to
bioactive cyclooctatin. Plasticity residues that decorate the
active site of CotB2 have been mutated, resulting in
alternative monocyclic, dicyclic and tricyclic compounds that
show bioactivity. These new compounds shed new light on
diterpene cyclase reaction mechanisms. Furthermore, the
product of mutant CotB2W288G produced the new antibiotic
compound (1R,3E,7E,11S,12S)-3,7,18-dolabellatriene, which
acts speciﬁcally against multidrug-resistant Staphylococcus
aureus. This opens a sustainable route for the industrial-scale
production of this bioactive compound.
Received 27 January 2014
Accepted 11 March 2014
PDB references: CotB2,
4omg; F149L mutant, 4omh
1. Introduction
Terpene molecules represent one of the most diverse groups
of natural biomolecules (Christianson, 2006, 2008; Maimone &
Baran, 2007). The initial step in terpene biosynthesis is the
stepwise condensation of isopentyl diphosphate and dime-
thylallyl diphosphate (Poulter et al., 1978) to the linear terpene
cyclase substrates geranyl diphosphate (C10), farnesyl dipho-
sphate (C15), geranylgeranyl diphosphate (C20) and geranyl-
farnesyl diphosphate (C25), leading to monoterpenes,
sesquiterpenes and diterpenes (Christianson, 2006, 2008;
Maimone & Baran, 2007; Sacchettini & Poulter, 1997; Cane,
1990). This reaction is catalyzed by isoprenyl diphosphate
synthases. The subsequent cyclization reaction is performed
by various terpene cyclases, using the linear isoprene precur-
sors to build up a vast number of polycyclic hydrocarbon
scaffolds. Remarkably, this complex chemical reaction,
comprising changes in bonding, hybridization and the intro-
duction of speciﬁc stereochemistry, is performed in a single
step. The cyclization reaction can be subdivided into three
steps: (i) initial generation of a reactive carbocation, (ii)
propagation of the carbocation through the substrate, leading
to hydride and/or methyl shifts, deprotonation and reproto-
nation and ionization of intermediates as well as the creation
electronic reprint
of a terminal carbocation, and (iii) quenching of the carbo-
cation by a base. Terpene cyclases can be divided into two
distinct classes, which are distinguished by their substrate-
activation mechanism. Class I terpene cyclases generate an
allylic carbocation by the release of pyrophosphate. Members
of this class contain a DDXXD motif (Ashby & Edwards,
1990) that binds the diphosphate function of the respective
substrate with the support of Mg2+ ions. In contrast, class II
terpene cyclases generate the carbocation by protonation of
the terminal isoprene unit, involving a DXDD motif. Besides
the differences in the activation mechanism, the two classes of
terpene cyclases have an unrelated overall fold. Class I
terpene cyclases establish the fold of class I terpene synthases
(Wendt & Schulz, 1998) and are structurally related to
isoprenyl diphosphate synthases such as farnesyl diphophate
synthase. In contrast, the class II terpene cyclases have a
multi-domain architecture frequently composed of two purely
-helical domains ( and ).
Fusicoccane diterpenes feature a 5–8–5 ring motif and,
depending on the functionalization of the ring system, they
demonstrate a broad diversity of biological activities, incuding
fungicidal and tumorstatic activities, amongst others (de Boer
& de Vries-van Leeuwen, 2012; Toyomasu et al., 2007;
Subbarao et al., 2009; Rasoamiaranjanahary et al., 2003).
Cyclooctatin is a member of the fusicoccane family and shows
anti-inﬂammatory activity. In contrast to the anti-inﬂamma-
tory agents derived from either aspirin or ibuprofen, which
target cyclooxygenase type I or II, cyclooctatin inhibits a
lysophospholipase which catalyzes the hydrolysis of the fatty-
acid ester bonds of lysophospholipids (Kim et al., 2009; Aoyagi
et al., 1992). This lysophospholipase is upregulated in eosino-
philic leukocytes that occur in allergic reactions and inﬂam-
matory diseases.
The cyclooctatin gene cluster from the soil bacterium
Streptomyces melanosporofaciens MI614-43F2 was recently
characterized, comprising a GGDP synthase (CotB1), a
diterpene cyclase (CotB2) and two P450 cytochromes (Kim
et al., 2009). CotB2 catalyzes the cyclization of GGDP to
cyclooctat-9-en-7-ol, which is further functionalized by the two
P450 cytochromes, CotB3 and CotB4, to cyclooctatin.
Polycyclic terpenes are chemically difﬁcult to access owing
to their complex stereochemistry. For instance, chemical
synthesis of the structurally related compound cotylenol
involves at least 12 steps, partly resulting in racemic inter-
mediates and low product yields (Kato et al., 1996). Organic
total synthesis of novel bioactive diterpenes remains time-
intensive and costly and is accompanied by the production of
toxic waste streams. An elegant solution is the biotechnolo-
gical application of terpene cyclase-based biocatalysts that
offer a highly stereospeciﬁc, single-step route for the
biosynthesis of complex macrocycles with potentially high
yields and no toxic side streams. Plant-based engineering
efforts are laborious and therefore bacterial terpene cyclases
are of particular interest since they can be easily produced and
engineered in a bacterial standard expression system such as
Escherichia coli. Metabolic pathways consist of an upstream
isoprene pathway and a heterologous downstream element
(Bru¨ck et al., 2014). In the upstream element the linear educts
for a downstream diterpene synthase are produced. In the
second conversion step of the downstream element the
diterpene diphosphate is enzymatically cyclized by a terpene
cyclase to a macrocyclic oleﬁn scaffold. Successful examples of
this microbial production platform have been demonstrated
for taxadien-5-ol, a precursor of taxol (paclitaxel), a highly
potent anticancer drug (Ajikumar et al., 2010), and for arte-
misinic acid, a precursor of the antimalarial drug artemisinin
(Paddon et al., 2013).
Currently, structural information on diterpene cyclases is
limited to plant and fungal enzymes such as taxadiene
synthase (TXS; Ko¨ksal, Jin et al., 2011), ent-copalyldiphos-
phate synthase (Ko¨ksal, Hu et al., 2011) and abietadiene
synthase (Zhou et al., 2012), whereas structural information is
elusive for the bacterial counterparts. Here, we report the ﬁrst
high-resolution crystal structure of the bacterial diterpene
cyclase CotB2 from the soil bacterium S. melanosporofaciens
and demonstrate that novel oleﬁnic macrocycles with a broad
diversity and bioactivity can be generated by protein engi-
neering of the active site.
2. Materials and methods
2.1. Protein expression and purification
Codon-optimized wild-type CotB2 (CotB2wt) withNdeI and
XhoI restriction sites was fused to a C-terminal hexahistidine
tag in pET-24a (Go¨rner et al., 2013) vector and transformed
intoE. coliRosetta2 DE3 cells. Overexpression was performed
using auto-induction medium at 37C until an OD of 0.7 was
reached, and the medium was subsequently cooled to 18C
(Studier, 2005). The cells were grown overnight and were
harvested by centrifugation (6 min, 6000 rev min1 at 4C).
For resuspension of the cell pellets, buffer A (50 mM Tris–HCl
pH 7.5, 500 mM NaCl, 2 mM MgCl2, 1 mM DTT) was used.
The cells were lysed by homogenization at 4C and the lysate
was cleared by centrifugation (1 h, 21 000 rev min1 at 4C).
An Ni2+–NTA (1 ml column volume; GE Healthcare)
column was equilibrated with buffer A. CotB2wt was loaded
onto the column and washed with ten column volumes of
buffer A. CotB2wt was eluted in a linear gradient to 50 mM
Tris–HCl pH 7.5, 500 mM NaCl, 2 mM MgCl2, 1 mM DTT,
500 mM imidazole. Size-exclusion chromatography was
performed with a HiLoad Superdex S200 16/60 column (GE
Healthcare) equilibrated with buffer B (20 mM Tris–HCl pH
7.5, 150 mM NaCl, 2 mM MgCl2, 1 mM DTT). Pooled protein
fractions were concentrated with Amicon Ultra 30 000. Cali-
bration runs were performed with a high-molecular-weight
standard (GE Healthcare). The CotB2F149L variant was puri-
ﬁed as described for CotB2wt. For determination of experi-
mental phases, selenomethionine was incorporated into
CotB2wt. Transformed E. coli Rosetta2 DE3 cells were
cultured in minimal medium containing selenomethionine
(Van Duyne et al., 1993) and protein expression was induced at
an OD of 0.6 by the addition of 0.5 mM IPTG. Puriﬁcation
was carried out as described above for CotB2wt, except that all
buffers contained 4 mM DTT.
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2.2. Dynamic light scattering
Dynamic light-scattering experiments were performed with
a Spectroscatter 201 instrument (RiNA) at 20C. Prior to
the experiments, the protein samples were centrifuged
(13 000 rev min1, 10 min, 4C). The protein concentration
was 27.2 mg ml1. For each sample, 25 individual experiments
with a time course of 3 s were recorded. Data were analyzed
with the program Spectro supplied by the manufacturer.
2.3. Mutagenesis and product production
Saturation mutagenesis of Trp288 was performed as
described previously (Go¨rner et al., 2013). The mutagenesis
primers were 50-CTGAT TTATG GCAAT TTTGT GNNNA
CCACC TCCAA CAAAC GTTAT AAAAC-30 and 50-
GTTTT ATAAC GTTTG TTGGA GGTGG TNNNC
ACAAA ATTGC CATAA ATCAG-30. In order to produce
sufﬁcient amounts for the GC-MS characterization of
CotB2W288G, 1 mg puriﬁed enzyme was added to 10 ml 50 mM
Tris–HCl pH 7.5, 1 mM MgCl2 supplemented with 45 mM
GGDP (Sigma–Aldrich) and incubated for 12 h at 30C with
mild agitation. The product was extracted using 5 ml ethyl
acetate, dried with MgSO4 and concentrated to 100 ml for GC-
MS analysis.
2.4. Product identification
The diterpene products of CotB2 variants were analyzed by
a Trace GCUltra with a DSQ II (Thermo Scientiﬁc). A sample
volume of 1 ml was applied by TriPlus AS onto an SGE BPX5
column (30 m, internal diameter 0.25 mm, ﬁlm 0.25 mm). The
initial column temperature was 50C (maintained for 2.5 min).
A temperature gradient was applied from 50 to 320C
(10C min1) followed by 3 min maintenance at 320C. Mass-
spectrometric data were recorded at 70 eV (EI), m/z (relative
intensity in %) as TIC (total ion current). The recorded m/z
range was 50–650. Mass-spectrometric fragmentation patterns
were compared against the NIST NIST08MS spectral data-
base library containing a special natural product extension
(Adams, 2007).
All NMR spectra were recorded in CDCl3 with an Avance
500 MHz (Bruker) at 300 K. The chemical shifts are given in
p.p.m. relative to CHCl3 at  = 7.26 p.p.m. (
1H NMR) or CDCl3
at  = 77.16 p.p.m. (13C NMR); coupling constants (J) are given
in hertz. Optical rotations were measured using a PerkinElmer
241MC polarimeter.
2.5. Crystallization and crystal cooling
For crystallization experiments, CotB2wt was concentrated
to 27.2 mg ml1 and CotB2F149L to 26.4 mg ml1 as measured
by the absorbance at 280 nm. Crystals were obtained by the
sitting-drop vapor-diffusion method at 18 C with a reservoir
solution composed of 20%(v/v) polyethylene glycol 8000,
100 mM 3-(cyclohexylamino)-1-propanesulfonic acid (CAPS)
pH 10.0. CotB2F149L was crystallized using a reservoir solution
composed of 15%(v/v) polyethylene glycol 8000, 60 mM
CAPS pH 10.0, 2%(v/v) 2-methyl-2,4-pentanediol (MPD).
Crystals of both CotB2wt and CotB2F149L appeared after two
weeks. Selenomethionine-labeled CotB2wt was concentrated
to 26.1 mg ml1. Crystals were obtained by the sitting-drop
vapor-diffusion method at 18C with a reservoir solution
composed of 20%(v/v) polyethylene glycol 3350, 200 mM
NaH2PO4. All crystals were cryoprotected by increasing the
MPD concentration of the reservoir resolution to 25%(v/v)
and were subsequently ﬂash-cooled in liquid nitrogen.
2.6. X-ray data collection, structure determination and
refinement
Synchrotron diffraction data were collected on beamline
14.2 of the MX Joint Berlin laboratory at BESSY (Berlin,
Germany) or beamline P14 of PETRA III (Deutsches Elek-
tronen Synchrotron, Hamburg, Germany). X-ray data collec-
tion was performed at 100 K. Diffraction data were processed
with XDS (Kabsch, 2010; Table 1). Experimental phases were
determined by single anomalous dispersion with SHARP
(Vonrhein et al., 2007) using the selenomethionine-labeled
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Table 1
Data-collection and reﬁnement statistics.
Values in parentheses are for the highest resolution shell.
SeMet CotB2wt CotB2wt CotB2F149L
PDB entry — 4omg 4omh
Data collection
Space group P212121 P212121 P212121
Wavelength (A˚) 0.9757 0.9763 0.9763
Unit-cell parameters
a (A˚) 59.3 59.1 59.5
b (A˚) 101.9 100.7 98.4
c (A˚) 108.9 108.7 107.8







Unique reﬂections 43730 (3202) 79419 (5765) 77089 (5552)
Completeness 99.2 (98.0) 99.2 (98.8) 98.6 (97.5)
hI/(I)i 8.1 (2.9) 17.5 (2.6) 15.8 (2.8)
Rmeas† 0.191 (0.805) 0.068 (1.143) 0.082 (1.079)
CC1/2 99.6 (92.8) 99.9 (76.3) 99.8 (72.5)
Multiplicity 7.7 (7.5) 6.5 (6.7) 6.6 (6.8)
Reﬁnement
Non-H atoms 5066 5149
Rwork‡ 0.173 (0.259) 0.183 (0.227)
Rfree§ 0.200 (0.296) 0.216 (0.264)
No. of protein chains 2 2
No. of protein residues 559 562
No. of buffer molecules 2 2
No. of water molecules 268 303
Average B factor (A˚2)
Overall 24.0 23.7
Protein residues 23.5 23.0
Buffer molecules 46.7 55.10
Water molecules 30.0 30.6
R.m.s.d.}, bond lengths (A˚) 0.013 0.012
R.m.s.d.}, bond angles () 1.42 1.44
Ramachandran outliers (%) 0 0










hI(hkl)i is the mean intensity of symmetry-equivalent reﬂections and N(hkl) is the








hkl jFobsj (working set, no  cutoff
applied). § Rfree is the same as Rwork but calculated on 5% of the data that were
excluded from reﬁnement. } Root-mean-square deviation from target geometries.
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CotB2wt data set (Supplementary Table S1). The structure of
CotB2F149L was determined by isomorphous replacement. For
calculation of the free R factor, a randomly generated set of
5% of the reﬂections from the diffraction data set was used
and was excluded from the reﬁnement. An initial model of
CotB2wt was built with ARP/wARP (Langer et al., 2008). The
structure was initially reﬁned by applying a simulated-
annealing protocol and in later reﬁnement cycles by
maximum-likelihood restrained reﬁnement using PHENIX
(Adams et al., 2010; Afonine et al., 2012) including TLS
reﬁnement with each polypeptide chain as an individual TLS
group (Winn et al., 2001). In initial rounds of reﬁnement NCS
restraints were applied, which were completely released in the
ﬁnal stages of reﬁnement. Model building and water picking
was performed with Coot (Emsley et al., 2010). Model quality
was evaluated with MolProbity (Chen et al., 2010) and
PROCHECK (Laskowski et al., 1993). Secondary-structure
elements were assigned with DSSP (Kabsch & Sander, 1983),
and ALSCRIPT (Barton, 1993) was used for secondary-
structure-based sequence alignments. Figures were prepared
using PyMOL (DeLano, 2002).
3. Results
3.1. Overall structure
To unravel the architecture of CotB2 from S. melanosporo-
faciens, which catalyzes the cyclization of linear GGDP to
cyclooctat-9-en-7-ol (Fig. 1a), we overexpressed CotB2 in
E. coli and subsequently puriﬁed and crystallized the protein.
Initially, we attempted to solve the structure by molecular
replacement using the coordinates of the -domain of TXS
(Ko¨ksal, Jin et al., 2011), since primary-sequence comparison
showed that the -domain of TXS is the closest relative to
CotB2 for which coordinates are available, with a sequence
identity of 9.5%. Since we could not obtain a molecular-
replacement solution, we altered our search model by deletion
of the ﬂexible parts and truncation to a polyalanine model, but
this approach was not successful either. Next, we used
different structures of sesquiterpene synthases, such as
trichodiene synthase (Rynkiewicz et al., 2001), epi-isozizaene
synthase (Aaron et al., 2010), pentalene synthase (Lesburg et
al., 1997) and aristolochene synthase (Shishova et al., 2007),
as search models, but were unsuccessful. The failure of the
molecular-replacement approach is most likely to be owing to
modulation of the secondary-structure elements, leading to
differences in packing/tilting of the core -helices and making
molecular-replacement attempts difﬁcult. Notably, most of the
terpene synthase structures deposited in the PDB have been
solved by experimental phasing. Additional burdens for the
molecular-replacement approach are conformational changes
upon the binding of metal ions and substrate that lead to a
closure of the active site accompanied by changes in the tilting
of ﬂanking -helices. For instance, the unliganded and ligand-
bound form of fungal aristolochene synthase differ by a root-
mean-square deviation (r.m.s.d.) of 2.11 A˚ (Shishova et al.,
2007). Since all molecular-replacement attempts failed, we
prepared selenomethionine-labeled CotB2wt and solved the
high-resolution structure by single anomalous dispersion to
1.64 A˚ resolution in space group P212121 (Table 1 and
Supplementary Table S1). The asymmetric unit contains two
CotB2 polypeptide chains that are practically indistinguish-
able, with an r.m.s.d. of 0.14 A˚ for 274 C pairs. The electron
density is of excellent quality, which not only allows us to trace
the polypeptide chain but also to assign one sodium ion and
one buffer molecule per CotB2 monomer. CotB2 adopts the
classical -helical bundle fold of class I terpene synthases
(Wendt & Schulz, 1998; Fig. 1b). Our model is complete except
for the 15 N-terminal and ten C-terminal residues. CotB2
consists of ten core -helices (A–J) that are connected by
short loop segments and an additional ﬁve short -helices (1–
5; Fig. 1b). The core -helices surround a large, deep cleft:
the active site (Fig. 1b). Since we have crystallized CotB2 in
the absence of substrate or substrate analog, we describe here
the open state of the enzyme.
The two polypeptide chains in the asymmetric unit of CotB2
are arranged as homodimers (Supplementary Fig. S1), with the
dimer interface being established by residues of -helices F,
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Figure 1
Cyclooctatin biosynthesis and structure of CotB2. (a) Chemical structures
are given for the educt and product of CotB2. Cyclooctat-9-en-7-ol is
further functionalized by CotB3 and CotB4, two cytochrome P450
enzymes, to yield cyclooctatin. (b) One monomer of CotB2 is shown
colored in a gradient from green (N-terminus) to blue (C-terminus).
-Helices are drawn as cylinders. The location of the aspartate-rich motif
is indicated in red and the NSE/DTE motif is marked in yellow. The
double conformation at the C-terminal end of -helix F is indicated in
purple.
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: RR5067).
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3, G1, G2, 4, H and I. About 1477 A˚
2 of solvent-accessible
surface area is buried upon dimerization, and the PISA server
(Krissinel & Henrick, 2007) suggests the presence of a stable
dimer in solution. To further elaborate whether the dimer
exists in solution as well, we performed size-exclusion chro-
matography and dynamic light scattering. SEC revealed a
molecular weight of 72 kDa and DLS a molecular weight of
86 kDa (Supplementary Fig. S2) indicative of the presence of
dimeric CotB2 in solution. The two active sites of CotB2 are
arranged in an antiparallel fashion, resembling the arrange-
ment initially observed for the monoterpene (+)-bornyl
diphosphate synthase (Whittington et al., 2002) and the
sesquiterpene trichodiene synthase (Rynkiewicz et al., 2001),
but is in contrast to the parallel dimer described for farnesyl
diphosphate synthase (Tarshis et al., 1994). Using a DALI
search (Holm & Rosenstro¨m, 2010) with the coordinates of
CotB2, we tentatively expected to ﬁnd the known plant
structures of diterpene cyclases, but surprisingly the structu-
rally closest neighbors are monoterpene and sesquiterpene
cyclases. The structurally closest neighbors to be found were
the monoterpene synthase 4S-limonene (PDB entry 2ong;
Hyatt et al., 2007) as well as the sesquiterpene cyclases
trichodiene (PDB entry 2ps5; Vedula et al., 2008), aris-
tolochene (PDB entry 2oa6; Shishova et al., 2007) and epi-
isoziziaene (PDB entry 3lg5; Aaron et al., 2010), all with a
comparable r.m.s.d. of 3.3–3.6 A˚.
3.2. Active site
The ‘aspartate-rich’ motif is located at the C-terminal end of
-helix D and is supposed to bind the diphosphate moiety of
GGDP via Mg2+ ions (Figs. 1b and Supplementary Fig. S3).
Strikingly, instead of the classical DDXXD motif of class I
terpene synthases, CotB2 contains an altered 110DDXD113
motif characteristic of neither class I nor class II terpene
synthases. Whereas in all other class I terpene cyclases the
aspartate-rich motif resides at the C-terminal end of -helix D,
in CotB2 -helix D is shorter and a proline residue adjacent to
the third aspartate of the aspartate-rich motif introduces a
kink. Consequently, Asp113 points to the opposing side away
from the active site. The ‘NSE/DTE’ motif (Cane & Kang,
2000) 218IVNDFYSYDRE228 resides in -helix H (Supple-
mentary Fig. S4). Both motifs are considered to be important
for the ionization-dependent step in the cyclization reaction
and for the binding of Mg2+ ions. Presumably, the motifs
trigger ionic cleavage of the C—O bond in the GGDP
substrate. The ﬂoor of the active site is decorated by hydro-
phobic residues (Val80, Phe107, Trp109, Phe149, Val150,
Ile181, Phe185, Met189, Trp186, Leu281 and Trp288),
conferring the overall shape to the cavity that serves as a
template for the binding of GGDP and the cyclization reac-
tion. At the upper end of the pocket the ﬁrst two aspartate
residues of the aspartate-rich motif and residues of the NSE/
DTE motif point into the active site. Upon binding of GGDP
the active site closes to prevent the emerging reactive carbo-
cations from being quenched by the bulk solvent. GGDP is
stabilized by Mg2+ ions and by positively charged amino-acid
residues. In the structure of CotB2, the basic residues Arg177
and Arg227 protrude into the pocket, most likely providing
charge compensation for the diphosphate group of GGDP.
The ﬁnite C-terminus is unstructured and not resolved in the
electron density. Residue Arg294 is located in this unstruc-
tured C-terminal end in our modeled CotB2 structure. We
suggest that upon binding of the catalytically obligatory Mg2+
ions and the GGDP substrate, the active site closes and could
bring the guanidinium function of Arg294 into close proximity
to the diphosphate function of GGDP. In all of our structures
we observe a double conformation at the C-terminal end of
helix F (155MFRD158), reﬂected by a double conformation of
the protein backbone (Fig. 1b) as well as the amino-acid side-
chain rotamers. The two backbone conformations are distin-
guished by the resulting length of the -helix, which is longer
or shorter by one amino-acid residue. It is interesting to note
that the secondary-structure elements close to the active site
display such plasticity and this might explain the observation
that the so-called secondary layer residues in the vicinity of
the active site can inﬂuence the dynamic properties of the
active-site residues (Greenhagen et al., 2006).
3.3. Plasticity of the residues in the active site of CotB2
In previous work, we constructed a homology model of
CotB2 (Go¨rner et al., 2013) that was based on the structure of
the -domain of taxadiene synthase (TXS; Ko¨ksal, Jin et al.,
2011). This homology model enabled us to identify single
amino-acid residues that are potentially important for carbo-
cation migration during the cyclization reaction. Mutational
analysis of these residues revealed alternative products, as
summarized in Table 2. The substitution of Phe149 by leucine
led to cyclooctat-7-en-3-ol (Fig. 2a), with migration of the
double bond from C9/C10 to C7/C8 and the hydroxyl moving
from position C7 to C3 (Go¨rner et al., 2013). Interestingly, the
Phe149 position tolerates other substitutions as well, all of
which lead to the formation of cyclooctat-7-en-3-ol (Table 2).
To study the structural integrity of CotB2 variants in
comparison to CotB2wt and to analyze whether our mutations
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Table 2
Single amino-acid exchange of CotB2 altering the product of the
cyclization reaction.
Mutation to proline, arginine, aspartate, glutamate, threonine, valine or
isoleucine at position 107 yielded no detectable product formation.
Residue Variant Product Reference
CotB2wt — Cyclooctat-9-en-7-ol Kim et al. (2009)
Asp110 Glutamate Cyclooctat-9-en-7-ol This study
Asp111 Glutamate No product This study
Asp113 Glutamate Cyclooctat-9-en-7-ol This study
Phe107 Glycine R-Cembrene A This study
Alanine R-Cembrene A This study
Leucine Cyclooctat-9-en-7-ol isomers Go¨rner et al. (2013)
Tyrosine Cyclooctat-1,7-diene Go¨rner et al. (2013)
Phe149 Histidine Cyclooctat-7-en-3-ol Go¨rner et al. (2013)
Leucine Cyclooctat-7-en-3-ol Go¨rner et al. (2013)
Valine Cyclooctat-7-en-3-ol Go¨rner et al. (2013)
Glycine Cyclooctat-7-en-3-ol Go¨rner et al. (2013)
Tyrosine No product Go¨rner et al. (2013)
Trp288 Glycine Dolabellatriene This study
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would have an effect on the protein surroundings of the active
site, we crystallized the variant CotB2F149L. Phases for
CotB2F149L were obtained by Fourier synthesis with the
reﬁned structure of CotB2wt. The structure was reﬁned to
1.64 A˚ resolution (Table 1). The variant CotB2F149L super-
imposes with CotB2wt with an r.m.s.d. of 0.3 A˚ for 276 C pairs.
Major differences are observed for both termini that are
better resolved in the electron density in the case of
CotB2F149L. Residue 149 is located in -helix F (Supplemen-
tary Fig. S3). The side chains of Phe149 and Leu149 occupy
identical positions. Differences are observed at different
locations in the active-site pocket (Supplementary Fig. S5).
Whereas in CotB2wt the hydroxyl function of Ser152 occupies
different rotamers, we observe only a single rotamer confor-
mation in CotB2F149L. Consequently, the number of waters in
and the position of the surrounding water network are altered.
Asn220 of the NSE/DTE motif, which is likely to be involved
in Mg2+ coordination, adopts two side-chain conformations in
CotB2F149L but only one in CotB2wt. It is also interesting to
note that in CotB2F149L the aromatic rings of Tyr77, Phe107
and Trp288 are slightly rotated towards the active site and
hence reduce the active-site volume. This further extends to
the N-terminal portion of -helix C, which is translated by
0.5 A˚ towards -helix D. In general, the differences are more
pronounced in one of the monomers.
Mutational studies at position Phe107, located in -helix F,
revealed less tolerance to mutagenesis in contrast to position
149 (Table 1). Replacement by an aromatic tyrosine residue
retained the 5–8–5 ring structure but led to the formation of a
diene and elimination of the hydroxyl function (Table 2 and
Fig. 2a). Replacement by alanine led to the formation of a
cembrene-like diterpene (Go¨rner et al., 2013). Until now, we
could not identify it using our diterpene production system.
Using an in vitro conversion of GGDP by CotB2F107A, we were
now able to identify the structure by mass spectrometry
(Supplementary Fig. S6), 1H NMR and the speciﬁc rotation
(Vanderah et al., 1978; Schwabe et al., 1988) as R-cembrene A
(Fig. 2b). The proton chemical shifts revealed the character-
istic oleﬁnic proton signals at  = 4.74 (s, 1H) and 4.68 (s, 1H)
as singlets as well as triplet signals at  = 5.22 [t, 3J(H,H) =
7.6 Hz, 1H], 5.00 [t, 3J(H,H) = 6.2 Hz, 1H] and 5.08 [t, 3J(H,H)
= 6.2 Hz, 1H]. Comparison of the remaining proton signals
shows less than 0.02 p.p.m. divergence from the literature
values (Bai & Jain, 2008). The CotB2F107A variant results in a
change in the shape and the volume of the active-site pocket.
Consequently, the GGDP can fold along an altered pathway
leading to R-cembrene A. Cembrene molecules are natural
compounds with cytotoxic, pheromonal and antimicrobial
activities (Bonnard et al., 2010; Casanova et al., 2006; Tietze et
al., 2008). Hence, compounds with a cembrene scaffold or a
cembrene scaffold that is hydroxylated by downstream cyto-
chrome P450 monooxygenases could potentially lead to the
development of novel antibiotics.
3.4. Comparison with taxadiene cyclase
To date, structural information is only available for three
diterpine cyclases (Zhou et al., 2012; Ko¨ksal, Hu et al., 2011;
Ko¨ksal, Jin et al., 2011). TXS is the most attractive candidate
for comparison since it has only a single class I terpene
synthase activity. Furthermore, TXS and CotB2 both catalyze
the cyclization of GGDP to tricyclic products: taxa-4,11-diene
with a 6–8–6 ring motif and cyclooctat-9-en-7-ol with a 5–8–5
ring scaffold, respectively. The -domains of TXS (Ko¨ksal, Jin
et al., 2011) and CotB2 share a sequence identity of 9.5% and
superimpose with an r.m.s.d. of 2.9 A˚ for 199 pairs of C atoms
(Fig. 3a and Supplementary Fig. S3). The overall arrangement
of the core -helices of both proteins is comparable (Fig. 3a
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Figure 2
Overview of CotB2 variants and product outcome. (a) The structure of
CotB2 is shown in cartoon representation. The metal-binding motifs are
highlighted in red and yellow. Mutants of CotB2 are indicated by colored
spheres: Phe149 in pink, Phe107 in orange and Trp288 in green. The
different products generated by the respective mutants are depicted by
color-coded arrows. Chemical structures are shown for the different
products. (b) GC-MS analysis of different CotB2 products. The retention
time for CotB2wt is 21.60 min (cyclooctat-7-en-3-ol), that for CotB2F107A
is 20.47 min (R-cembrene A) and that for CotB2W288G is 20.78 min
(dolabellatriene). Mass-spectrometric analysis of the dolabellatriene
product of CotB2W288G is shown in Supplementary Fig. S6.
electronic reprint
research papers
1534 Janke et al.  CotB2 Acta Cryst. (2014). D70, 1528–1537
and Supplementary Fig. S3). Differences are restricted to the
lengths of the loop regions. Major differences are observed at
both the N-terminus and the C-terminus. In comparison to
TXS, CotB2 has an additional N-terminal -helix which is
absent in TXS (Fig. 3a). As a result, the N-terminus of CotB2
is in close proximity to the active site, and the missing 15
N-terminal residues in our crystal structure might fold upon
substrate binding and thereby close and shield the active site.
Beside these differences, a number of residues within the
active site of the -domain of TXS and CotB2 superimpose
very well. Hence, the structure of TXS is a very valuable
template to postulate catalytically important residues of
CotB2. The ﬁrst two aspartate residues of the aspartate-rich
motif of TXS (613DDXXD617) and 110DDXD113 of CotB2
superimpose. Therefore, it seems likely that Asp110 of CotB2
directly coordinates MgA
2+ as well as MgC
2+ and Asp111 of
CotB2 possibly coordinates MgC
2+ indirectly via a water
molecule. To further elaborate the function of the residues
within the aspartate-rich motif, we performed site-directed
mutagenesis. Mutation of the two ﬂanking aspartate residues
did not interfere with product formation, whereas enzymatic
activity was lost for the CotB2D111E mutation (Table 2).
Asp111 of CotB2 might not only be involved in Mg2+ coor-
dination, since it is hydrogen bonded with its carboxylate
function to the hydroxyl of Tyr77 (2.7 A˚) in -helix C and
seems to be rather important for protein stabilization.
A major difference is observed at the C-terminal end of
-helix D harboring the aspartate-rich motif, which is shorter
in CotB2; consequently, the third aspartates of the aspartate-
rich motifs do not superimpose (Fig. 3 and Supplementary Fig.
S3), with Asp113 of CotB2D113 being solvent-exposed. Hence,
it seems unlikely that Asp113 is involved in metal binding. In
the bacterial sesquiterpene synthase epi-isozizaene, the third
aspartate of the aspartate-rich motif is also not involved in
metal binding (Aaron et al., 2010). Strikingly, for epi-
isozizaene synthase it has been shown that the ﬁrst aspartate
residue is crucial for activity (Lin & Cane, 2009). Residues
Asn757, Asp758, Thr761 and Glu765 of the NSE/DTEmotif in
TXS, which are involved in the direct coordination of MgB
2+,
superimpose with Asn220, Asp221, Ser224 and Glu229 of
CotB2 (Fig. 3b). Beside the metal coordination, we can also
derive information on possible interactions with the dipho-
Figure 3
Superposition of CotB2wt and the -domain of TXS (PDB entry 3p5r). (a) CotB2wt is drawn in blue, with its aspartate-rich motif indicated in red and the
NSE/DTE motif in yellow. The -domain of TXS (residues 548–900) is depicted in grey. (b) Residues of the aspartate-rich and the NSE/DTE motif as
well as residues involved in the stabilization of the diphosphate function of the substrate are shown. Amino-acid side chains of CotB2wt are depicted in
blue and those of TXS are depicted in grey. For TXS the bound 2-ﬂuorogeranylgeranyl diphosphate is drawn in stick representation and the three bound
Mg2+ ions are shown as black spheres. (c) Surface representation of CotB2 (dark teal). The view is vertically rotated 180 compared with that in (a).
Section through the active site. The 2-ﬂuorogeranylgeranyl diphosphate is shown in stick representation and Mg2+ ions are shown as orange spheres as
observed in the crystal structure of TXS. Its position was obtained by a superposition of CotB2 and TXS.
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sphate function of GGDP. The guanidinium function of
Arg754 of TXS and Arg177 of CotB2 superimpose (Fig. 3b),
even though they reside on different core -helices. Notably,
the recognition and the mechanism of diphosphate activation
seem to be conserved between plant and bacterial diterpene
and monoterpene cyclases.
Superposition of the bound 2-ﬂuorogeranylgeranyl dipho-
sphate and Mg2+ ions, as modeled in the structure of TXS,
on the structure of CotB2 reveals sterical clashes of CotB2
amino-acid side chains with 2-ﬂuorogeranylgeranyl diphos-
phate. These clashes are observed at the bottom of the active
site (Figs. 3b and 3c) and are caused by the aromatic side chain
of Phe107 and the indole of Trp288 located at the very
C-terminal end of -helix J of CotB2. Consequently, the
volume of the active site of CotB2 is decreased compared with
TXS.
3.5. Importance of CotB2W288G for carbocation migration
Based on our structural observations, we investigated using
saturation mutagenesis whether Trp288 is essential for the
cyclization process. Interestingly, the variant CotB2W288G
showed the formation of a new, unexpected product. Our
E. coli diterpene production system was able to produce
1.7 mg of this compound per litre (Go¨rner et al., 2013).
Analysis by GC-MS (Supplementary Fig. S6) followed by
detailed NMR analysis revealed the formation of a bicyclic
dolabellane carbon skeleton (Fig. 2). The NMR data of the 1H
and 13C spectra diverged by less than 0.2 p.p.m. (13C) and
0.02 p.p.m. (1H) from the literature values (Ioannou et al.,
2011). Furthermore, NOESY NMR correlations and the
speciﬁc rotation were in very good agreement with the
literature (Ioannou et al., 2011). The data are consistent with
the biocatalytic formation of (1R,3E,7E,11S,12S)-3,7,18-dola-
bellatriene (Fig. 4). The formation of a dolabellane can be
explained by an early proton elimination within the proposed
reaction mechanism for cyclooctat-9-en-7-ol (Kim et al., 2009;
Fig. 4). After ionization of GGDP, a two-ring system with a
carbocation at C15 (1) is formed by bonding between C1/C11
and C10/C14. During the biocatalytic formation of dolabellane
the cyclization mechanism is stopped after deprotonation at
C16. In the biocatalytic formation of cyclooctat-9-en-7-ol the
carbocation migrates to C10 by two consecutive 1,2-hydride
shifts (C10 to C14 and C14 to C15), providing structure (2).
Deprotonation of (2) yields (3), which subsequently under-
goes closure of the third ring by bond formation between C6
and C2 facilitated by protonation of (3) at C3. Eventually,
water is added to (3), which results in the formation of
cyclooctat-9-en-7-ol. Since the absolute conﬁguration of the
CotB2-derived dolabellane product has been determined in
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Figure 4
Proposed reaction mechanism. The ﬁnal products are indicated in boxes. (a) The formation of cyclooctat-9-en-7-ol by CotB2wt, (b) the formation of
3,7,18-dolabellatriene by CotB2W288G and (c) the formation of R-cembrene A by CotB2F107A.
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this report, the cumulative data indicate that the formation of
(2) is facilitated by an energetically rather unfavorable tandem
cis-hydride transfer. This mechanistic feature has also been
reported in the biocatalysis of fusiccocin (Stoessl et al., 1988;
Banerji et al., 1978), and it is a likely option in the formation of
dolabellane and cyclooctat-9-en-7-ol. Therefore, a consecutive
cis-hydride transfer may be a particular feature of the
biosynthesis of fusicoccane-type macrocycles. Consequently,
CotB2W288G may play an important role in the cyclization
process by facilitating the potential cis tandem 1,2-hydride
shifts and promoting the migration of the carbocation. Based
on the experimentally determined absolute conﬁguration of
dolabellatriene, we can superimpose this information on
cyclooctat-9-en-7-ol and suggest the (2R, 3R, 6S, 7S, 11R
and 14R) conﬁguration (Fig. 4). The formation of
(1R,3E,7E,11S,12S)-3,7,18-dolabellatriene has signiﬁcant
implications as this structure has been shown to have potential
antibiotic activity against multidrug-resistant Staphylococcus
aureus (MRSA; Ioannou et al., 2011). To our knowledge, this
is the ﬁrst diterpene produced in a recombinant microbial
production system which demonstrates signiﬁcant bioactivity
in the absence of any additional functional decoration. Inter-
estingly, our recombinant E. coli system was capable of
producing milligram quantities of dolabellatriene without
toxicity effects. The reason for this may be linked to the fact
that E. coli is Gram-negative while Staphylococcus is a Gram-
positive organism. Therefore, pharmaceutical production of
the promising new antibiotic dolabellatriene in E. coli is an
efﬁcient route to secure an industrial-scale supply.
4. Conclusion
In this study, we determined the structure of CotB2 (Fig. 1b),
the ﬁrst structure of a diterpene cyclase of bacterial origin.
CotB2 catalyzes the cyclization of GGDP to cyclooctat-9-en-7-
ol, the precursor of the anti-inﬂammatory drug cyclooctatin.
The latter compound belongs to the family of fusicoccanes
that are produced in bacteria and fungi. Owing to their broad
biological activity (de Boer & de Vries-van Leeuwen, 2012),
they represent a potential lead scaffold for chemical and
pharmaceutical products. Moreover, cyclooctatin is of parti-
cular interest since it is a next-generation anti-inﬂammatory
drug that lacks severe side effects compared with existing anti-
inﬂammatory agents derived from either aspirin or ibuprofen.
It would be a new lead compound for the pharmaceutical
industry and various derivates of cyclooctatin could be created
through combinatorial biotechnology.
Bacterial CotB2 belongs to the class I terpene synthases
but contains an altered aspartate-rich (110DDXD113) motif for
Mg2+ binding compared with the classical DDXXD motif.
Hence, the Mg2+ coordination must be substantially different
compared with the classical class I terpene cyclases.
Comparison of the aspartate-rich motif of the cyclase
domains of CotB2 and PaFS (Toyomasu et al., 2007) from the
plant-pathogenic fungi Phomopsis amygdale reveals that fungi
have the classical aspartate-rich motif. Consequently, the
degenerated aspartate-rich motif of the model bacterial CotB2
seems to be an exception. In contrast to CotB2, the fungal
PaFS is a bifunctional fusion protein with prenyltransferase
and cyclase domains. This suggests convergent evolution of
fusicoccane-centred cyclases in bacteria and fungi. In further
studies, it would be of interest to determine the structurally
related catalytic differences between bacterial and fungal
derived fusicoccanes.
Structural comparison of CotB2 and pentalenene synthase
from Streptomyces UC5319 reveals a superposition of cataly-
tically important residues. Residues Phe107 and Phe149 of
CotB2 superimpose with Phe77 and Tyr146 of pentalenene
synthase. Hence, we propose that Phe107 and Phe149 of
CotB2 are optimally located to stabilize the reactive carbo-
cation intermediates through quadropole-charge (Burley &
Petsko, 1988) and dipole interactions, as suggested for the
sesquiterpene cyclase pentalenene (Lesburg et al., 1997). The
formation of R-cembrene A is not part of the mechanism for
the formation of cyclooctat-9-en-7-ol owing to the connection
of C1 and C14 (Fig. 4) to form a monomeric ring structure.
It can be assumed that Phe107 is essential for the correct
orientation of the GGDP substrate and migration of the
positive charge through the carbon skeleton. Aromatic resi-
dues such as Phe107, Phe149 and Trp288 may stabilize
carbocation cyclization intermediates through electrostatic
quadrupole-charge interactions and in addition by polar
residues that are able to participate in electrostatic stabiliza-
tion.
The identiﬁcation of residues with plasticity in the active
site of CotB2 allowed us to design single-point mutations of
aromatic residues potentially important for the migration of
the emerging carbocation. The mutation of Phe107, Phe149
and Trp288 altered the product outcome (Fig. 4 and Table 2).
We were able to identify two alternative products. For wild-
type CotB2 the natural product is cyclooctat-9-en-7-ol, which
features a tricyclic 5–8–5 ring system characteristic of fusi-
coccanes. In contrast, the single-point mutation CotB2F107A
led to the monocyclic cembrene Awith a single 14-membered
ring system. Mutation to CotB2W288G led to a bicyclic dola-
bellatriene product with a 5–11-membered ring system.
Dolabellatriene shows antibacterial activity (Ioannou et al.,
2011), but to date it is not accessible by organic synthesis and
hence its production depends on isolation from its natural
source. Once such a microbial production platform has been
successfully established for a wild-type terpene cyclase, it
could be very easily adapted to variants of terpene cyclase.
The incorporation of the CotB2W288G variant into a bacterial
downstream element of a microbial production platform offers
an attractive route to access this bioactive compound. The
efﬁcient production of dolabellatriene in recombinant E. coli
opens a new route for efﬁcient industrial-scale supply of this
new and highly promising drug candidate.
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Table S1 Phasing statistics 
 
Phasing statistics  
resolution [Å] a 29.66 - 2.50 
(2.56 - 2.50) 
Rcullis (acentric) b 0.864 (0.964) 
phasing power (acentric) c 1.042 (0.698) 
no. of selenium sites 16 
a values in parentheses refer to the highest resolution shell. 
bRcullis = 〈phase-integrated lack of closure〉/〈|FPH − FP|〉 












Figure S1 Dimeric arrangement of CotB2. In one monomer the protein is coloured in a gradient 
from green (N-terminus) to blue (C-terminus). α-helices are drawn as cylinders. The second 
monomer is drawn in gray. The location of the aspartate-rich motif is indicated in red and the 
NSE/DTE-motif is marked in orange. The double conformation at the C-terminal end of helix F 








Figure S2 Dynamic light scattering experiments with CotB2. (a) The autocorrelation function of 
experimental data (red circles). The time of the experiments is logarithmically plotted against the 
amplitude. (b) The logarithmic size distribution is plotted versus the intensity. The experimental 





Figure S3 Structure-based alignment of CotB2 and the α-domain of TXS. On top the amino acid sequence of CotB2, its 
secondary structure elements are depicted. Below the amino acid sequence of TXS as well as the secondary structure 
elements of TXS. The aspartate-rich motif is highlighted in red and the NSE/DTE-motif in yellow. Residues subjected to 






Figure S4 NSE/DTE-motif. The NSE/DTE (218IVNDFYSYDRE228) motif of CotB2 resides on 
α-helix H. Amino acids are depicted in stick representation. Final m2Fo-DFc electron density 







Figure S5 Superposition of CotB2wt and CotB2F149L. View into the active site of CotB2. CotB2wt 
is drawn in blue and CotB2F149L in green. Active site residues undergoing conformational 
changes upon mutation of phenylalanine to leucine at position 149 are shown in stick 











Figure S6 Mass spectrometry of the diterpene product dolabellatriene of CotB2W288G (retention 
time 20.71 min), recorded on a Trace GC Ultra with DSQII (Thermo Scientific), m/z was 
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Abstract: 
Diterpenes constitute a versatile class of natural biomolecules predominantly derived from plants, 
fungi and prokaryotes. Properties of these natural products include anti-tumor, anti-inflammatory, 
antibiotic, and insecticidal activities, which makes these compounds high value commercial targets for 
the chemical and pharmaceutical industry. Since chemical synthesis of terpenes can be difficult, 
production can be alternatively performed in engineered microorganisms on natural occurring routes. 
Terpene bilden die größte Gruppe von Naturstoffen mit derzeit über 60.000 bekannten Verbindungen 
[3]. Aufgrund ihrer vielfältigen biologischen Eigenschaften finden sie Einsatz in nahezu allen 
Bereichen der Industrie, beispielsweise als Duftstoffe, Arzneimittel, Insektizide oder auch als 
Biokraftstoff. So reicht die strukturelle Diversität dieser Stoffklasse von einfachen azyklischen 
Duftstoffen wie Citronellol über Monozyklen, wie zum Beispiel Menthol (Abb. 1), zu komplizierten 
polyzyklischen Verbindungen wie dem Anti-Tumor-Wirkstoff Taxol. Grundbausteine aller Terpene sind 
C5-basierte Isopreneinheiten, deren Anzahl im Terpengrundgerüst die Gruppenzugehörigkeit und 
strukturelle Komplexität bestimmen (Abb. 1). Der erste Schritt in der Terpenbiosynthese ist die 
Produktion linearer, aliphatischer Polyprenyldiphosphate. In der Natur können diese durch 
Transferasen zu strukturell einfachen Carotinoiden verlängert werden. Die strukturelle Vielfalt der 
resultierenden C10-C30 Polyprenyle entsteht durch Zyklisierungen, welche durch die Enzymfamilie 
der Terpensynthasen katalysiert wird. So können ausgehend von nur wenigen Vorläufermolekülen 
eine immense Anzahl von zyklischen Grundgerüsten generiert werden, die dann von weiteren 
Enzymen, wie z.B. P450 Monooxygenasen, zusätzlich funktionalisiert werden. 
Viele der von Pflanzen, Bakterien und Pilzen produzierten Terpene besitzen Bioaktivität. Insbesondere 
in der Gruppe der C20 basierten Diterpene, deren Grundgerüst aus vier C5-Isopreneinheiten besteht, 
existieren viele Verbindungen mit antiviralen, entzündungshemmenden, antitumorösen oder 
antimikrobiellen Eigenschaften. Diese Eigenschaften machen die Klasse der Diterpene besonders 
interessant für die pharmazeutische Industrie. Allerdings sind die hochkomplexen Polyzyklen mit 
mehreren Stereozentren nur aufwändig durch klassische organische Synthese zugänglich. Eine 
Alternative ist die Herstellung von Terpenen in genetisch modifizierten Mikroorgansimen. Dabei 
werden alle zur Synthese benötigten Gene in Mikroorganismen wie Escherichia coli oder Hefen 
exprimiert. So können z.B. mit Zucker als Ausgangsstoff komplexe Terpene hergestellt werden 
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(Abb. 2). Durch die Verwendung von modularen plasmid-basierten Produktionssystemen können 
einzelne Gene der „upstream“ und „downstream“ Syntheselinie ausgetauscht werden um das Produkt 
oder die Produktivität zu verändern [8]. Um danach stabile Produktionsorganismen zu erhalten kann 
man die Produktionskaskade in das Genom des Wirts integrieren. Diese biologischen Pipelines stellen 
eine attraktive Alternative im Vergleich zur organischen Totalsynthese dar, da strukturell 
hochkomplexe Makrozyklen innerhalb einer Zelle unter nachhaltigen Produktionsbedingungen 
generiert werden können. Die hier produzierten Makrozyklen können in Folge als Ausgangsstoffe von 
Chemikern weiter modifiziert werden. 
Um die Ausbeute und Bandbreite der Produkte bei diesem biotechnologischen Ansatz zu optimieren, 
ist es unerlässlich über genaue strukturelle Informationen der Terpensynthasen zu verfügen. Denn 
über Mutationen im aktiven Zentrum dieser Enzyme lassen sich die Zyklisierungsreaktionen gezielt 
steuern, was die Produktvielfalt erweitert. Neue Produkte bedeuten aber auch immer potenziell 
veränderte möglicherweise neue biologische Aktivitäten. 
Diterpensynthasen 
Diterpene, zu denen wichtige Wirkstoffe wie Taxol und Artimisinin gehören, sind von besonderem 
biotechnologischen Interesse [2]. Diterpensynthasen nutzen das Vorläufermolekül 
Geranylgeranyldiphosphat (GGDP) als Ausgangsstoff für ihre Zyklisierungsreaktion (Abb. 2). Anhand 
ihres Reaktionsmechanismus werden die Synthasen in zwei verschiedene Klassen unterteilt [3]. Wir 
beziehen uns in diesem Aufsatz ausschließlich auf die häufiger vorkommende Klasse I. Bei dieser 
Klasse wird die Pyrophosphatgruppe des GGDP über drei Mg
2+
 Kationen koordiniert, wobei der 
hydrophobe Schwanz/Endgruppe in eine hydrophobe Tasche im Inneren des Enzyms zeigt. Durch 
Abspaltung der Pyrophosphatgruppe wird ein hochreaktives Carbokation generiert und die 
Zyklisierungsreaktion initiiert. Die erste aufgeklärte Proteinstruktur einer pflanzlichen 
Diterpensynthase, ist die der Taxadienesynthase aus Taxus brevifolia [9], welche ein Intermediat in 
der Biosynthese von Taxol produziert. Hier sei angemerkt, dass die chemische Synthese von Taxol 
extrem komplex ist und über 51 Syntheseschritte beinhaltet mit einer Ausbeute von 0.4% [10]. Die 
erste Struktur einer bakteriellen Diterpensynthase ist die von CotB2 aus dem Bakterium Streptomyces 
melanosporofaciens (Abb. 4) [7]. 
Kombination von chemischen und biotechnologischen Methoden 
Der große klinische Erfolg von Taxol und Taxol-Derivaten in Kombination mit der geringen 
Verfügbarkeit aus pflanzlichen Quellen hat dazu geführt, dass ein reges Interesse an einem effizienten 
Zugang zu dieser Substanzklasse besteht. Pfeiffer und Stephanopoulos [1] ist es gelungen, die 
Fermentation um den Faktor 15.000 zu optimieren, dass Taxadien in einer Ausbeute von 1 g/L 
erhalten werden konnte. Auch die erste Oxidation konnte eine P450-vermittelte Oxidationsreaktion 
erreicht werden. Einen völlig anderen Ansatz verfolgten Baran und Mitarbeiter[11]. Zunächst wurde ein 
oxidiertes Taxadienon in 8 Stufen aus Tetramethylethen synthetisiert. Dieses wurde dann durch 
geschickte chemische C-H-Oxidationen[4] in 18 Stufen in das Taxabaccatin III überführt (Abb. 3). 
Auch wenn dieses Molekül in seiner Komplexität vom Taxol noch etwas entfernt ist, stellt dieses 
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Verfahren einen großen Fortschritt dar. Ein zukünftiges Forschungsgebiet wird sein, die Vorteile aus 
den biotechnologischen Cyclase-Prozessen mit der chemischen Modifikation unfunktionalisierter 
Terpene zu verbinden. 
Strukturelle Charakterisierung der Diterpensynthase CotB2 
CotB2 generiert Cyclooctat-9-en-7-ol, welches vom Bakterium weiter zu Cyclooctatin modifiziert wird 
(Abb. 2). Cyclooctatin ist ein entzündungshemmender Wirkstoff, der im Gegensatz zu Ibuprofen und 
Aspirin eine andere Enzymklasse inhibiert. Wir konnten erfolgreich das Gen von CotB2 in E. coli 
einführen (Abb. 2) [5, 7]. Die Ausbeute an hochreinem Cyclooctat-9-en-7-ol aus 400 ml E. coli Kultur 
beträgt 25 mg. Mittels Röntgenstrukturanalyse klärten wir die Kristallstruktur von CotB2 auf [7]. 
Strukturell nimmt CotB2 die klassische Klasse I Faltung an, bestehend aus einem Bündel von α-
Helices (Abb. 4). Die beiden Magnesium-bindenden Motive, das Aspartat-reiche Motiv und das 
NSE/DTE Motiv, befinden sich im aktiven Zentrum und sorgen für die stabile Koordination der 
Pyrophosphatgruppe. Basierend auf der Struktur wurden durch gezielte Mutagenese einzelne 
Aminosäuren im aktiven Zentrum von CotB2 ausgetauscht. In unserer Produktionspipeline wurde 
dann lediglich das native Enzym durch die neu erzeugten Varianten ersetzt. Anstelle des trizyklischen 
Wildtyp-Produktes konnten nun auch mono- und dizyklische Produkte erzeugt werden. Mit anderen 
Worten wurde durch den Austausch einzelner Aminosäuren die Reihenfolge und der Ort der 
Bindungsknüpfung soweit verändert, dass es zu anderen Ringschlussreaktionen kommt. Dieses 
Prinzip der Produktmodifizierung wurde exemplarisch an CotB2 studiert, lässt sich prinzipiell aber 
auch auf andere Terpensynthasen übertragen. 
Aufgrund ihrer geringen Aminosäuresequenzidentität ist es schwer Terpensynthasen in Genomen zu 
identifizieren. Wir können davon ausgehen, dass noch viele hunderte Terpensynthasen auf ihre 
Entdeckung warten. Bei den P450 Monooxygenasen, die die anschließende Terpenfunktionalisierung 
katalysieren, verhält es sich ganz ähnlich. Auch hier ist ein Aufspüren durch die niedrige 
Sequenzidentität und insbesondere die der zughörigen Redoxsysteme sehr schwer [6]. Es kann 
erwartet werden, das Organische Synthese und Biokatalyse in Zukunft erfolgreich bei der 
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Abb. 1: Übersicht der verschiedenen Terpen-Klassen. Abhängig von der Anzahl der Skelett-
Kohlenstoffatome werden Terpene in Hemiterpene (C5), Monoterpene (C10), Sesquiterpene (C15), 
Diterpene (C20), Triterpene (C30) und Carotinoide (C40) eingeteilt. Die Zyklisierung der linearen 




Abb. 2: Schematische Darstellung der Cyclooctatin Produktion in Bakterien. Ausgehend von Glukose 
werden im „upstream“-Bereich die Bausteine für das Diterpen-Vorläufermolekül GGDP geschaffen, 
welches dann im „downstream“-Bereich durch CotB2 zyklisiert und mit Hilfe der P450 




Abb. 3: Ansätze zur Herstellung von Paclitaxel (Taxol®): a) chemische Struktur; b) biotechnologische 
Herstellung und Oxidation von Taxadien; c) chemische Synthese von Taxadienon und Oxidation an 
vier weiteren Positionen im Molekül. 
 
 
Abb. 4: Kristallstruktur von CotB2. Gezeigt ist ein Monomer, dessen Farbverlauf vom grünen N-
Terminus bis zum blauen C-Terminus reicht. Die α-Helices sind als Zylinder präsentiert. Über 
Punktmutationen im aktiven Zentrum ist es gelungen, neue Produkte zu erzeugen. Die Aminosäuren, 
die durch Punktmutationen verändert worden sind, sowie die durch die Mutation resultierenden 
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Recently, the enzyme family of oleate hydratases (OHs: EC 4.2.1.53) have gained a rising 
scientific and economic interest, as these FAD-binding bacterial enzymes do not require 
cofactor recycling and feature high thermal and pH stability. Their products, hydroxy fatty acids, 
are used in specialty chemical applications including surfactant and lubricant formulations. The 
“oleate hydratase engineering database”, established by Schmid et al. (2017), divides all OHs 
into 11 families (HFam1 to 11). To date, only two crystal structures of homodimeric OHs from 
the families HFam2 and HFam11 have been reported. In this study, we biophysically 
characterized an OH belonging to the HFam3 family, originating from the marine bacterium 
Rhodococcus erythropolis, for the first time. The crystal structure revealed that this new OH 
(OhyRe) surprisingly is a monomer in its active form. This particular feature provides new 
avenues for enzyme engineering and recycling via immobilization. 
Introduction 
Unsaturated fatty acids are toxic to many bacteria due to their surfactant properties, 
destabilization of membranes and due to the unsaturated fatty acids inhibitory effect on the fatty 
acid biosynthesis.[1] Hence, mechanisms have evolved to counteract these effects when 
organisms are exposed to unsaturated fatty acids, such as linoleic acid or oleic acid. In 
consequence, unsaturated fatty acids are saturated by hydrogenation. However, an 
intermediate step in this hydration process is catalyzed by fatty acid hydratases.[2] Hydration of 
unsaturated fatty acids has so far only been identified  in Gram-negative and Gram-positive 
bacteria [3] and is mediated by hydratases. 
Hydratases are a group of lyases that catalyze hydration and dehydration of a substrate[4]. Even 
though many hydratases are known, only few OHs have been described.[2] OHs belong to the 
group of fatty acid hydratases (EC 4.2.1.53) and convert oleic acid into (R)-10-hydroxystearic 
acid (10-HSA).[5] To date all characterized OHs bind an FAD cofactor,[2] albeit the role of FAD 
has remained enigmatic. 
Merely two structures of OHs have been reported. One of the OH from Lactobacillus acidophilus 
(LAH), crystalized in the apo state as well as bound to the preferred substrate linoleic acid.[6] 
The second structure of an OH (OhyA) has been determined from Elizabethkingia 
meningoseptica, bound to its cofactor FAD.[7] Even though LAH and OhyA convert different 
Figure 1: Oleate hydratase (OH) reaction scheme. 
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substrates, both utilize FAD as a cofactor. Interestingly the bound FAD was oxidized in both 
hydratases, but reduced FAD led to significantly higher activity in OhyA.[7] 
Most recently, Schmid et al. assembled a “hydratase engineering database” including a total of 
2046 protein sequences.[8] Sequence comparison revealed 11 distinct families (HFam1 to 11) 
with a sequence identity of 62 % within the respective family. The only two structurally 
characterized OHs, LAH and OhyA fall into two different families, HFam2 and HFam11. For all 
other families structural information has remained elusive. Remarkably, in regions attributed to 
decorate the active site, amino acid sequences are not strictly conserved within these families.  
Hydratases are in particular interesting for commercial applications since their products, 
hydroxyl fatty acids, have a wide range of industrial and pharmaceutical applications. Hydroxyl 
fatty acids can be utilized in applications for the food industry as precursors of lactones,[9] as 
well as an emollient for cosmetics. Further applications are the employment as a surfactant or 
as additives in lubricant formulation and as a green material in polymer science.[10]  
In this study, we aimed at obtaining novel insights into the reaction mechanism of the OhyRe 
enzyme of R. erythropolis, using a combined structural, biophysical and biochemical approach. 
The OhyRe enzyme was biochemically characterized in terms of pH and temperature optimum 
as well as substrate specificity. The kinetic constants were determined for the conversion 
reaction of oleic acid to 10-HSA. Furthermore, we were able to solve the crystal structure of 
OhyRe at 2.64 Å resolution. The structure of OhyRe provides structural information for the OH 
HFam3 family of OHs for the first time. We have compared the overall architecture as well as 
structural features of the OhyRe active site to a set of reported OHs. As we identified two key 
residues, which differed in the OhyRe structure, these were replaced by site directed 
mutagenesis to residues conserved in the other family members. Most interestingly, these 
conservative amino acid replacements resulted in a strong decrease of hydration activity, 
indicating that OhyRe may follow a distinct reaction mechanism.  
Results & Discussion 
Isolation & characterization of OhyRe derived from R. erythropolis 
R. erythropolis is a Gram-positive, non-motile representative of the nocardiaceae family.[11] R. 
erythropolis is a wide spread soil bacterium which is mainly found in marine habitats, from 
coastal to deep sea sediments [12] and exhibits a broad range of biochemically interesting 
enzymes.[13] As the genome of R. erythropolis has recently been deciphered,[14] we have 
performed sequence specific genome mining, targeting alternative OH activities in this 
extremophile organism. 
To this end we have identified the 1.68 kB sequence related to known OHs albeit at a very low 
sequence identity level of max. 38 %. The gene for the putative OH was termed ohyRe, 
according to the nomenclature used by Bevers et al.[5a] for the Elizabethkingia meningoseptica 
OH ohyA. The corresponding OhyRe protein is composed of 559 amino acids with a calculated 
molecular weight of 66.3 kDa. The N-terminally His6-tagged protein was successfully expressed 
in Escherichia coli BL21(DE3) cells. Initial activity tests with the crude extract resulted in high 
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conversion rates (approx. 85%) from oleic acid to 10-HSA, confirming that OhyRe indeed 
displayed OH activity. To further characterize the enzyme, we have devised a Ni2+-affinity 
purification protocol. After final His-Trap HP affinity chromatography, the purified enzyme was 
colorless and lost its hydration activity (Fig. S1). This observation suggested a loss of the FAD 
cofactor, which has been uniformly reported to be essential for the hydration activity in all known 
OHs. Moreover, the only reported loss of FAD during purification was also associated with a 
strong decrease in hydration activity.[6] Therefore, the addition of various FAD concentrations (5 
µM to 100 µM) to the purified enzyme preparation has been evaluated to reconstitute the activity 
of purified OhyRe. The addition of FAD to a final concentration of 20 µM lead to the recovery of 
the enzymatic activity of OhyRe and was applied for all following experiments. After establishing 
an efficient purification protocol, OhyRe was biochemically characterized. 
Initial tests demonstrated that purified OhyRe has a temperature optimum for the hydration 
activity at 28 °C (Fig 2). Interestingly, OhyRe exhibits a relatively wide temperature tolerance 
with high activity in the low temperature region (72 % of max. at 20 °C) and still moderate 
activity in the high temperature area (21 % of max. at 45 °C). This wide temperature tolerance 
might reflect the diversity of the occurrence of R. erythropolis from costal to deep sea habitats. 





























Figure 2: Determination of the temperature optimum for the oleate hydratase (OH) OhyRe from R. erythropolis in 20 
mM Tris-HCl buffer at pH 7.2. Relative activity is given to the temperature optimum at 28 °C (100 %). All experiments 
were carried out in biological duplicates and technical triplicates. 
The determination of the pH optimum (Fig. 3) showed a high pH tolerance in a range from pH 
5.0 to 8.0 for OhyRe, the highest activity was reached at pH of 7.2.  
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Figure 3: Determination of the pH optimum for the oleate hydratase (OH) OhyRe from R. erythropolis at 28°C. 
Relative activity is given to the optimum at pH 7.2 (100 %). All experiments were carried out in biological duplicates 
and technical triplicates. 
These results correlate with the recommended cultivation conditions for R. erythropolis 
published by the German Collection of Microorganisms and Cell Culture (Leibniz Institute 
DMSZ). 
The substrate spectrum of OhyRe was experimentally determined in reactions with the purified 
enzyme and different free fatty acids (FFAs) (Table 1). All experiments were carried out in 
biological duplicates and technical triplicates. The enzyme showed neither detectable activity for 
any saturated fatty acid tested (C14:0 to C18:0), nor for myristoleic acid, vaccenic acid, 
eicosatrienoic acid and eicosatetraenoic acid, respectively. Low conversion rates could be 
observed for linoleic acid, α- and γ-linolenic acid. The highest affinity, under the given 
conditions, was detected for oleic acid, followed by palmitoleic acid. Complex lipids, like the 
tested triolein or microalgae derived oils were not converted by the enzyme. These results 
correspond to published data for other known OHs [6] and confirm the preference of OHs for the 
9-Z double bond in the fatty acid carbon chain. The kinetic parameters were experimentally 
defined for OhyRe, with oleic acid as the preferred substrate, and resulted in a KM value of 0.49 
± 0.1 mM and a kcat value of 34 ± 5 min
-1. 
 
Table 1: Tested substrates, identified products and corresponding specific activity of conversion reaction with OhyRe. 








C16:1 ω7 palmitoleic Acid 10-hydroxypalmitic acid 1205 ± 70.6 
C18:1 ω9 oleic Acid 10-hydroxystearic acid 1266 ± 30.3 






Engleder et al. [7] demonstrated by multiple sequence alignment of 10 OHs that the catalytically 
crucial residues are highly conserved within the OH family. The alignment of OhyRe with 14 
different OHs (Fig. S2) predominantly confirmed this hypothesis, but also depicted two 
exceptions. Interestingly, two amino acid residues that are highly conserved in all other OHs 
differ in the sequence of OhyRe, namely the residues M77 and V393. Further structural 
comparison of OhyRe and OhyA (Fig. S3) showed that these residues correlate with the 
residues E122 and T436 from OhyA, which are responsible for the activation of the water 
molecule or the binding of the carboxylate, [7] respectively. A conservative substitution of the two 
identified residues to the familial conserved residues (M77E, V393T) was executed by site 
directed mutagenesis and resulted in the effect depicted in Fig. 4. 
 
Figure 4: Relative conversion activity from oleic acid to 10-HSA from OhyRe wild type enzyme (OhyRe WT), set as 
100 %, and its respective mutants (M77E, V393T). All experiments were carried out in biological duplicates and 
technical triplicates. 
Fig. 4 shows the relative hydration activity of the OhyRe wild type enzyme compared to the two 
constructed mutants M77E and V393T with oleic acid as substrate. The conservative 
substitution of both residues resulted in a strong decrease in the conversion efficiency from oleic 
acid to 10-HSA of 81 % and 90 %, respectively. This strong decrease in hydration activity 
  
  
C18:3 ω3 α-linolenic Acid 10-hydroxy-12,15(Z,Z)-octadecadienoic acid 150 ± 1.7 
C18:3 ω6 γ-linolenic Acid 10-hydroxy-6,12(Z,Z)-octadecadienoic acid 615 ± 36.0 
7 
 
supports the hypothesis that OHs from the HFam3 family might follow a distinct catalytic 
mechanism. 
In comparison to the two other structurally characterized OHs LAH [6] and OhyA [7], OhyRe 
shows a sequence identity of 35 % and 34 %, respectively. Beside the low sequence identity, 
both the LAH and OhyA have large N- and C-terminal amino acid sequence extensions (Fig. S4 
and 6A,B), which are absent in OhyRe. To understand whether those extensions are common 
for all other OHs, we performed a sequence alignment (Fig. S2). Interestingly, OH sequences 
can be roughly divided in sequences with amino acid extensions at the N- and the C-termini 
present or absent. Consequently, this raised the question, whether OhyRe might be structurally 
different compared to the members of the HFam2 and HFam11 families. Hence we tried to 
crystalize the protein for structure determination by X-ray crystallography. 
 
Overall structure 
We obtained crystals of OhyRe that belong to space group P6522. The diffraction of the OhyRe 
crystals was anisotropic, resulting in complete data set to a resolution of 2.64 Å. The structure of 
OhyRe was determined by molecular replacement with two protein chains in the asymmetric 
unit corresponding to a very high solvent content of about 75%. The structure was refined with 
good stereochemistry to good R factors (Table S1, supporting information). Both polypeptide 
chains are practically identical with a root mean square deviation (rmsd) of 0.1 Å for 522 pairs of 
Cα-atoms. The structure is complete, except for the 5 N-terminal residues and a loop region 
ranging from residue 42 to 67 due to missing electron density caused by its high flexibility 
(Fig. 5A). No redox cofactor could be identified in the electron density maps. Hence our 




Figure 5: Overall structure of OhyRe in cartoon representation. (A) Domain organization of OhyRe: Domain I in 
orange, domain II in green, domain III in pink and domain IV in yellow. The bound Mg
2+
 and coordinating waters are 
shown as orange and red spheres, respectively. Magenta spheres indicate the boarders of a flexible linker, ranging 
from residue 61 to 86, which could not be modelled due to its flexibility. (B) Zoom onto domain IV with a superposition 
of OhyRe and LAH, domain IV of LAH is shown in gray. (C) Superposition of OhyRe and OhyA, domain IV of OhyA is 
shown in gray. Dashed line indicates an un-modelled loop region. 
The closest related structures, as analyzed by the DALI software,[15] are the OHs LAH (PDB-id 
4ia6) and OhyA (PDB-id 4uir). OhyRe superimposes with a rmsd of 1.8 Å for 500 pairs of Cα-
atoms and 1.6 Å for 501 pairs of Cα-atoms, respectively. In analogy to the structures of LAH 
and OhyA, OhyRe is composed of three core domains (residues 1–540; Fig. 5A and 6) that are 
related to other FAD-dependent enzymes. Domain I (residues 6–115, 223–300, 322–344, and 
478–540) is a mixed α/β domain composed of a parallel five-stranded β-sheet packed between 
two α-helices on one side and a three-stranded antiparallel β-sheet on the other side (Fig. 5A), 
resembling a variant of the Rossmann fold. Domain II (residues 116–131, 301–321, and 345–
477) consists of an antiparallel β-sheet (Fig. 5A) flanked by three α-helices defining the 
cofactor- and substrate-binding site in conjunction with domain I. Domain III (residues 132-222) 
is exclusively α-helical (Fig. 5A) and its fold is structurally related to monoamine oxidases.[16] 
Domain IV (residues 541-559) of OhyRe is composed of merely one single α-helix. In contrast to 
the structures of LAH and OhyA the C-terminal domain is truncated by 32 or 48 residues, 
respectively. As a consequence two α-helices are absent in domain IV of OhyRe (Fig. 5B and 
C). The structure of LAH has been determined in apo and product-bound state. Upon substrate 
recognition and binding the two C-terminal α-helices of domain IV undergo a large 
conformational change and thereby allow the substrate to enter a cavity that ends at a cleft 
between domain I and III.[6] 
For both the LAH and OhyA a homodimeric quaternary structure in solution as well as in 
crystallo has been reported.[6-7] For other OHs such as the one from L. fusiformis,[17] S. 
maltophilia [18] and M. caseolyticus [19] dimers in solution were reported as well. As analyzed by 
the PISA server,[20] OhyRe is a monomer in crystallo. To analyze the situation in solution and to 
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confirm our structural analysis, we performed multi-angle light scattering (MALS) experiments. 
Our experiments clearly revealed that OhyRe is monomeric in solution (Fig. S5). The latter 
finding is in agreement to our observations for OhyRe assembly in the crystal and strengthens 
our hypothesis that OHs, lacking N- and C-terminal extensions, are monomers. Additionally we 
examined whether the extensions might have functional implications. As discussed above, in 
the structure of LAH, domain IV reflects the C-terminal extension, suggested to be involved in 
substrate gating. Since the two reported and our crystal structures cover nearly the complete 
amino acid sequence of the respective protein, we superimposed the structures and inspected 
in particular the monomer-monomer interfaces of dimeric LAH and OhyA. Most of the dimer 
interface is established by residues that reside within the N- or C-terminal extension, including 
domain IV of LAH (Fig. 6A) and OhyA (Fig. 6B). In summary, we propose that the presence or 
absence of N- and C-terminal extensions within the amino acid sequence directly influences the 
oligomeric state of OHs. In case of OhyRe the extensions are absent and hence the protein is 
monomeric in solution. 
Notably, the crystal structure revealed a coordinated Mg2+ ion close to the putative active site of 
OhyRe (section S1). However, experimental data showed that the Mg2+ ion has no influence on 
the hydration activity of OhyRe. 
 
Figure 6: Oligomeric state of oleate hydratases (OHs). (B) LAH monomer I is shown in dark gray. Monomer II in 
surface and cartoon representation (light gray). The N-terminal domain (NTD) and domain IV in cyan. (C) The NTD 
OhyA of each monomer meanders into the other monomer. 
 
FAD binding 
All characterized OHs utilize FAD as cofactor.[2] Different roles of the FAD cofactor have been 
proposed either being directly involved in catalysis or indirectly having merely a structural role to 
stabilize the enzyme. In the crystal structure of LAH, no FAD could be located in its binding 
site.[6] In contrast, in the crystal structure of OhyA, FAD is bound, but only to one of the two 
polypeptide chains.[7] Furthermore a Kd of 1.8 x 10
-6 M was determined by isothermal 
calorimetry.[7] All indicate a rather low binding affinity of FAD to studied OHs. For our structural 
studies, we attempted to add FAD prior to the final purification step or to incubate OhyRe with 
FAD prior to the crystallization experiments. Moreover, we tried to soak FAD in our apo OhyRe 
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crystals. All our attempts to gain structural information of OhyRe bound to FAD remained 
unsuccessful so far. A primary sequence analysis reveals the presence of a characteristic 
recognition sequence GXGXXGX21E/D for nucleotide binding, also reflected by the Rossmann 
fold of the protein. A superposition of the structures of OhyA and OhyRe (Fig. 7A and B) clearly 
reveals that the cofactor binding site is large enough to accommodate a FAD molecule. 
Furthermore in the crystal structure of OhyA a PEG molecule was identified that might mimic a 
bound oleate molecule. For latter substrate enough space would be in the active site of our 
OhyRe structure (Fig. 7A and B). 
 
Figure 7: Superposition of OhyRe and OhyA. Same color coding as in Figure 5A. (A) OhyRe is colored as in Figure 1 
and OhyA in gray. View on the active site of OhyA. Magenta spheres indicate the boarders of a flexible linker in 
OhyRe, ranging from residue 42 to 67, which could not be modelled due its flexibility. In contrast upon FAD binding in 
OhyA this loop region is getting structured, indicated by two gray arrows. Moreover a short loop fragment rearranges 
upon cofactor/substrate binding (gray arrow-headed arc). In general, there would be enough space in OhyRe to 
accommodate the cofactor as well as the substrate. Solvent exposed on the back of the active site, the Mg
2+
 binding 
site located. (B) Same view in (A) zoomed on the FAD cofactor binding site of OhyA. 
Putative active site with catalytically important residues 
As mentioned above OHs can be, based on their amino acid sequences, sub-divided in 11 
families.[8] Based on the structure of OhyA, that belongs to the family HFam1,[8] E122 was 
proposed to be important for cofactor binding and being involved in catalysis by activating a 
water molecule for the attack on the partially charged double bond of the substrate.[7] Latter 
residue resides within a conserved loop region 118RGGREM123, almost strictly conserved within 
all OHs. In the sequence of the OhyRe, that falls into the family HFam3, the ultimate and 
penultimate amino acids are different, but characteristic for members of the largest HFam1 as 
well HFam3 family.[8] In the respective loop region OhyRe has the sequence 73RGGRML78. The 
exchange of OhyA E122 to OhyRe M77, will drastically alter the chemistry and can certainly not 
activate a water molecule. To investigate the influence of amino acid at position 77 in OhyRe, 
we generated a point mutation M77E. This single mutation led to a drastic decrease in hydration 
activity of OhyRe. OhyA Y241 was proposed to be as well important for catalysis, by protonation 
of the double bond [7] and is conserved with OhyRe Y205. Hence, it is tempting to propose that 
OhyRe might have a different catalytic mechanism as proposed for OhyA. 
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Interestingly, the fatty acid double-bond hydratase from Lactobacillus plantarum, LPH,[21] also 
exhibits the HFam3 family specific motive RGGREM. In contrast to LPH, which solely converts 
linoleic acid, OhyRe exhibits hydration activity for both, C16 and C18 unsaturated fatty acids. In 
addition, LPH was shown to be a homotrimer in its active form, whereas OhyRe is a monomer. 
The exact binding site of the substrates of OHs could not yet be resolved. In the crystal 
structure of LAH, a cavity was observed running from the surface of the protein towards the 
interface formed by domain I and III. This site is known to be a substrate binding site in other 
related enzyme families. Volkov et al. identified a linoleic acid (LA) molecule bound in this cavity 
with its carboxylate oriented towards the protein surface and the hydrophobic tail pointing to the 
protein interior (Fig. 8). In contrast, a PEG molecule has been identified close to the FAD 
cofactor in the structure of OhyA, possibly mimicking a bound substrate molecule (Fig. 8). 
Strinkly this binding site is fundamental different to the “interdomain”-binding site as described 
for LAH (Fig. 7B and Fig. 8). To date, there is no structural information on an OH with a real 
substrate bound to the enzyme. Therefore it is very speculative which amino acid residues are 
crucial for catalysis. A definitive answer could only provide a structure with bound substrate. 
This would allow the identification of key amino acids important for catalysis. These residues 
could be then targeted by structure-based mutagenesis. Moreover, the given resolution of 
2.64 Å of our OhyA structure, does not allow the identification of water molecules within the 
active site. But, One can imagine that the precise position of water molecules might be crucial 
for catalysis. Based on the structure of OhyA, the T436A mutant had been generated, showing 
a dramatic decrease in activity. Latter observation was interpreted as the hydroxyl of T436 being 
important for recognition and binding of the carboxylate function of the substrate. Taken 
together, both structures not only display distinct substrate binding sites, but also differ in the 
orientation of the carboxylate. In order to increase the enzymatic activity of OhyRe, we 
speculated that a mutation V393T (equivalent to T436 in OhyA) could potentially improve 
recognition and binding of the substrate. But unexpectedly, the activity was drastically reduced 
(Fig 4). 
 
Figure 8: View on the potential nucleotide and substrate binding site. Superposition of LAH (magenta) and OhyA 
(cyan) as ribbon. FAD and PEG bound to LAH are shown in stick representation. The linoleic acid substrate of LAH 
and 2-methyl-2,4-pentanediol (MPD) molecules bound to LAH are shown in stick representation. Notably a 2-methyl-
2,4-pentanediol (MPD) molecule in the LAH structure superimposed partially with the bound PEG molecule in the 






The enzyme family of OHs offers the sustainable conversion and valorization of biogenic fatty 
acids in high value lubricant additives. In contrast to heme dependent P450 hydroxylases, the 
conversion of oleic acid to 10-hdroxysteric acid by OHs can be accomplished without the need 
for co-factors. In this study a new OH from R. erythropolis could be identified by targeted 
genome mining. The biochemical characterization showed that the enzyme, OhyRe, exhibits a 
high pH-tolerance as well as high hydration activity over a wide temperature range. The crystal 
structure of OhyRe was solved to a resolution of 2.64 Å, surprisingly revealing a monomeric 
structure for the enzyme, which contrasts all other reported members of the OH family. These 
results were ultimately confirmed by MALS experiments of the protein in solution. To our 
knowledge, OhyRe is the first strictly monomeric OH and the first member of the HFam3 family 
of OHs that was characterized and crystallized so far. The HFam3 family of OHs exhibits high 
potential for further biocatalytical applications, as the monomeric enzyme provides a variety of 
options for immobilization strategies. The free N- and C-terminal ends are not involved in dimer 
association and could e.g. be feasible targets for the fusion of anchor-proteins. Furthermore, 
two mutants of OhyRe, M77E and V393T, were generated to clarify the importance of these two 
residues in the catalytic mechanism of OhyRe. These conservative substitutions, to residues 
being highly conserved within in the OH family, resulted in a drastic decrease of hydration 
activity of 80 to 90 %. This suggests that OhyRe might follow a distinct reaction mechanism. 
 
Materials and Methods 
Chemicals 
All chemicals utilized in this work were purchased from Sigma-Aldrich (Munich, Germany) and 
Carl Roth (Karlsruhe, Germany), at the highest purity grade available. 
Bacterial strains & plasmids 
The Escherichia coli strains XL-1 Blue and DH5α were used for cloning whereas the strains 
BL21 (DE3) and Rosetta2 were employed for protein expression. All plasmids and E. coli strains 
were obtained from Novagene/Merck Millipore. 
Cloning for characterization experiments 
The myosin-cross-reactive antigen coding gene O5Y_00450 from Rhodococcus erythropolis 
CCM2595, was taken as a template for a codon-optimized gene-synthesis (Life Technologies, 
Regensburg), for an E. coli host strain. The obtained synthetic gene was sub-cloned in a 
pET28a expression plasmid and transformed into chemically competent F cells.  
Cloning for crystallization experiments 
For protein production in E. coli, the OhyRe ORF was amplified with the forward primer 5’-
TATACCATGGGAATGAGCAGCAATCTGAGCC-3’ and reverse primer 5’-
TATAAAGCTTTTAACGAAACATGGTAACTGCTGC-3’ containing HindIII and NcoI recognition 
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sites, respectively) and cloned into the pETM11 vector, resulting in a construct with N-terminal 
hexa-histidine-tag that could be cleaved off by TEV protease. 
OhyRe mutant construction 
The mutants OhyRe-M77E and OhyRe-V393T were constructed by overlap-extension-PCR 
using primer sets listed in Table S2 (supporting information). 
Protein expression and protein purification for characterization experiments 
The expression of the native OhyRe or respective mutants thereof was carried out in E. coli 
BL21DE3 cells, grown in Laure Broth (LB) medium. Pre-cultures were inoculated from a cryo-
stock and grown over night in 100 ml LB in a 500 ml baffled flask at 120 rpm at 37°C. Main 
cultures were grown up to an optical density, measured at 600 nm (OD600), of 0.6 – 0.8, before 
the expression was induced by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to 
a final concentration of 0.1 mM. After 16 h of incubation at 16°C the cells were harvested and 
the resuspended (20 mM Tris-HCl buffer and 25 mM imidazole pH 7.2) cell pellets were 
disrupted by high pressure homogenization (EmulsiFlex-B15, AVESTIN). A subsequent 
centrifugation step at 20.000 g for 40 min at 4°C (Beckmann coulter J-20 XP) was applied for 
the separation of the cell debris from the soluble protein fraction. The soluble protein fraction 
was utilized for affinity chromatography via a Ni2+-NTA His-trap column (HisTrap FF, GE 
Healthcare; flow rate 1 ml/min). The purified protein solution was desalted using HiPrep 26/10 
desalting column (GE Healthcare). Protein amounts were quantified using 2-D quant kit (GE 
Healthcare) according to manufacturer’s instructions. 
 
Protein expression and protein purification for crystallization experiments 
OhyRe fused to an N-terminal hexa-histidine-tag in pET-M11 vector was transformed in E. coli 
Rosetta2. Protein was expressed in auto-induction media at 37 °C until an OD600 ~ 0.8 was 
reached and subsequently cooled down to 20 °C.[22] Cells grew over night and were harvested 
by centrifugation (6 min, 6’000 rpm at 4 °C). For resuspension of the cell pellet, buffer A was 
used (50 mM Tris/HCl pH 7.5, 500 mM NaCl, 30 mM imidazole and 1 mM DTT). Cells were 
lysed by homogenization at 4 °C and the lysate was cleared by centrifugation (1 h, 21’000 rpm 
at 4 °C). Ni2+-NTA beads (cv ~ 1 ml; GE Healthcare) were equilibrated with buffer A. OhyRe was 
loaded on the column and washed with 10 cv of buffer A. OhyRe was eluted in a linear gradient 
to buffer A supplemented to 500 mM imidazole. Pooled fractions were dialyzed over night 
against buffer B (20 mM Tris/HCl pH 7.5, 150 mM NaCl and 1 mM DTT) supplemented with 
TEV protease to cleave off the N-terminal His-tag. Uncleaved protein was separated from 
cleaved protein via an additional Ni2+-NTA affinity chromatography. Size exclusion 
chromatography was performed with a HighLoad Superdex S200 16/60 column (GE 
Healthcare), equilibrated with buffer B. Pooled protein fractions were concentrated with Amicon-




The determination of the enzymatic properties of the OH from Rhodococcus erythropolis 
CM2595 was (unless otherwise stated) executed under the following standard reaction 
conditions. The tests were carried out in a reaction volume of 200 µl in 20 mM Tris-HCl buffer 
(pH 7.2), containing the purified enzyme (final conc. of 5 µM), FAD (final conc. 20 µM) and 720 
µM OA as substrate at 28°C for 15 min. Thermo-stability was tested in a temperature range 
from 20 – 45°C. pH tolerance was monitored in a range from pH 5 – 8. To determine the 
substrate specificity of the myosin-cross-reactive antigen from Rhodococcus erythropolis 
CM2595, the purified enzyme was tested on myristic acid (C14:0), myristoleic acid (C14:1), 
palmitic acid (C16:0), palmitoleic acid (C16:1), stearic acid (C18:0), vaccenic acid (C18:1 trans-
11) oleic acid (C18:1, cis-9), linoleic acid (C18:2), linolenic acid (C18:3) and triolein as potential 
substrates. For the determination of the kinetic parameters of OhyRe towards oleic acid, 
different substrate concentrations (90 µM to 1.44 mM) and reaction times (1 to 15 min) were 
tested under standard conditions. The reactions were stopped by the addition of an equal 
volume of ethyl acetate (EtOAc) and instant, intensive vortexing. The resulting solvent phase 
was separated from the water phase and applied for silylation and subsequent analysis. 
Lipid analysis 
The preparation of the extracted lipid fractions for GC measurements was performed according 
to Volkov et al.[23] Hydroxylated fatty acids were identified by GC-MS by injecting 1 µl into a 
Thermo Scientific™ TRACE™ Ultra Gas Chromatograph coupled to a Thermo DSQ™ II mass 
spectrometer and the Triplus™ Autosampler injector. Column: Stabilwax ® fused silica capillary 
(30 m × 0.25 mm, film thickness 0.25 μm) Restek. (Program: initial column temperature 150 °C, 
increasing (4 °C/min) up to a final temperature of 250 °C. Carrier gas: hydrogen (flow rate 3.5 
ml/min). Peaks were identified by comparison to fatty acid standards or by specific molecular 
masses detected. Extracts resulting from kinetic experiments were analyzed with the 
Shimadzu™ GC-2025 system equipped with a flame ionization detector. Column: Zebron ZB-
WAX (30 m x 0.32 mm, film thickness 0,25 µm) Phenomenex. Carrier gas: hydrogen (3.00 
ml/min). Program: initial column temperature 150 °C for 1 min; increasing 5°C/min to 240°C, 
hold for 6 min. Peaks were identified by comparison to the respective standards. 
 
Crystallization 
Crystals were obtained by the sitting-drop vapor-diffusion method at 18 °C with a reservoir 
solution composed of 100 mM Bis-Tris/HCl pH 5.5 to pH 6.0, 255 mM to 300 mM magnesium 
formate and 5 % (v/v) glycerol. Crystals were cryo-protected with 25% (v/v) MPD supplemented 
to the reservoir resolution and subsequently flash-cooled in liquid nitrogen. 
Diffraction data collection, structure determination and refinement 
Synchrotron diffraction data were collected at the beamline 14.1 of the MX Joint Berlin 
laboratory at BESSY (Berlin, Germany) or beamline P14 of Petra III (Deutsches Elektronen 
Synchrotron, Hamburg, Germany). X-ray data collection was performed at 100 K. Diffraction 
data were processed with XDS [24] (Table S1). The structure was solved via molecular 
replacement in PHASER [25] by using the structure of the hydratase from Lactobacillus 
15 
 
acidophilus (PDB 4ia5) [6] as a search model. Crystals of OhyRe belong to the space group 
P6522, with two molecules in the asymmetric unit. For the refinement 2.8% of the reflections 
were set aside for the calculation of the Rfree. Model building and water picking was performed 
with COOT.[26] The structure was initially refined by applying a simulated annealing protocol and 
in later refinement cycles by maximum-likelihood restrained refinement using PHENIX.refine.[27] 
Model quality was evaluated with MolProbity [28] and the JCSG validation server.[29] Secondary 
structure elements were assigned with DSSP [30] and ALSCRIPT [31] was used for secondary 
structure based sequence alignments. Figures were prepared using PyMOL.[32] 
Multi-angle light scattering (MALS) 
MALS experiment was performed at 18°C. OhyRe was loaded onto a Superdex 200 increase 
10/300 column (GE Healthcare) that was coupled to a miniDAWN TREOS three-angle light 
scattering detector (Wyatt Technology) in combination with a RefractoMax520 refractive index 
detector. For calculation of the molecular mass, protein concentrations were determined from 
the differential refractive index with a specific refractive index increment (dn/dc) of 0.185 ml/g. 
Data were analyzed with the ASTRA 6.1.4.25 software (Wyatt Technology). 
 
Accession numbers 
The atomic coordinates and structure factor amplitudes have been deposited in the Protein Data 
Bank under the accession code 5ODO. 
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Figure S1: Adsorption spectra of final gel filtration chromatography of OhyRe at wave lengths of 260 nm, 280 nm and 
450 nm. 
The adsorption spectra of the gel filtration chromatography of OhyRe depicted in Fig. S1 show a 
clear peak for the enzyme at 260 nm and 280 nm. At 450 nm, the characteristic wave length for 
the detection of FAD, no corresponding peak could be detected. These data clearly show the loss 




Figure S2: Sequence alignment of 14 different OHs from Rhodococcus erythropulus (Rre; HFam3), Staphylococcus 
aureus (Sau; HFam2), Lysinibacillus fusiformis (Lfu; HFam2), Macrococcus caseolyticus (Mca; HFam2), Lactobacillus 
acidophilus (Lac; HFam2), Ochrobactrum anthropi (Oan; HFam2), Bifidobacterium breve (Bbr; HFam2), Streptococcus 
pyogenes (Spy; HFam2), Elizabethkingia meningoseptica (Eme; HFam11), Myroides odoratus (Mod; HFam11), 
Cellulophaga algicola (Cal; HFam11), Stenotrophomonas maltophilia (Sma; HFam2), Corynebacterium kroppenstedtii 




Figure S3: Superposition of putative active sites of OhyRe and OhyA. Highlighted in magenta are the residues M77 
and V393 subjected to mutagenesis. (A) Residues of OhyRe residing in domain I are shown as orange sticks and 
residues of  OhyA in gray  (B) Residues of OhyRe residing in domain II are shown as green sticks and residues of 
OhyA in gray. 
The superposition of the putative active sites of OhyRe (colored) and OhyA (gray), showed that 
the residues M77 and V393 from OhyRe are located in the exact same position in the three 





Figure S2: Structure-based sequence alignment of OhyRe and OhyA. Secondary structure assignment was performed 
with DSSP based on the respective crystal structure. Secondary structure elements of OhyRe are depicted above the 
primary sequence and below for OhyA. The sequence of OhyRe is colored according to the domain architecture. 
Slanted lines indicated sections of OhyRe and OhyA that are not included in the crystal structures. Gray triangles 
indicate residues of OhyRe that are involved in hydrogen bonding contact to Mg2+ coordinating water molecules. Black 
triangle shows F548 in π-stacking interaction with the flavine moiety of FAD. Other residues in hydrogen bonding 
distance to FAD are labeled with a black circle. Golden circles show OhyA E122 and Y241 that were proposed to be of 





Figure S3: SEC/MALS analysis of OhyRe. Refractive index signal is shown as green curve. Solid, green curve 




Section S1: Mg2+ binding site 
In each monomer, we detected one Mg2+ binding site, being solvent exposed on the backside of 
the putative active site of OhyRe (Fig. 5A and S6). The binding site is located at the intersection 
of domain I, domain II and domain III. The Mg2+-ion is octahedral coordinated by six water 
molecules (Fig. S6 and S7) that are bound to the carboxylates of Glu80, Glu81, Asp111 and the 
hydroxyl of Thr223 as well as to the backbone carbonyls of Ala220, Gly221, and Val222. Notably 
amino acid residues in the second coordination sphere of Mg2+ are not conserved within other 
OHs. For the OhyA of E. meningoseptica a bound Ca2+-ion has been detected by plasma optical 
emission spectroscopy analysis, but no influence on the activity could be associated (Bevers et 
al. 2009). Furthermore, in its crystal structure no Ca2+ could be identified (Engleder et al. 2015). 
Given the close proximity to the putative active site, we questioned whether the Mg2+ could have 
an influence on the catalytic activity of the OhyRe enzyme. Hence we tested the enzymatic activity 
under standard conditions and added EDTA to a final concentration of 5 mM to the reaction 
mixture. The addition of EDTA had no detectable effect on the conversion activity of OhyRe, 
suggesting that the Mg2+ doesn’t play a crucial role in the hydration reaction, but might have an 
effect on the protein stability. 
 
Figure S4: Octahedral Mg2+ coordination. Same color coding as in Figure 5A. The bound Mg2+ and coordinating waters 
are shown as orange and red spheres, respectively. Hydrogen bonding interactions, with a distance cut-off < 3.1 Å, to 
amino acid residues are shown as red dashed lines. 
 
Figure S5: Octahedral Mg2+ coordination to water molecules is indicated by black lines. Hydrogen bonding (< 3.1 Å) 
interactions to amino acid residues are shown as red dashed lines. 2Fo-Fc electron density contoured at 1.0 σ depicted 
as green mesh.  
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Table S1: Crystallographic data collection and model refinement statistics. 
Data Collection 
Wavelength [Å] 0.98141 
Temperature [K] 100 
Space group P6522 
Unit Cell Parameters 
a=b, c [Å] 
 
261.75, 127.30 




















Resolution range [Å ]a 49.47 - 2.64 (2.73 - 2.64) 
Reflections a 
Number 








Contents of the Asymmetric Unit 
Protein, Molecules, Residues, Atoms 
 





Formate (14), glycerin (2),Magnesium 
(2) 
417 










RMSD from Target Geometry 
Bond Lengths [Å] 




Validation Statistics c 
Ramachandran Plot 
Residues in Allowed Regions [%] 
Residues in Favored Regions [%] 






a data for the highest resolution shell in parenthesis 
b calculated with PHENIX (Adams et al, 2010) 
c calculated with MOLPROBITY (Chen et al, 2010) 




Table S2: Primers used for OhyRe mutant construction 
name sequence feature 
OhyRe-fw (for 
overlap) 
5’-GGA GAT ATA CCA TGG GCA GCA-3’ NcoI cutting site (red) 
OhyRe-rv (for overlap) 5’-GTG GTG CTC GAG TTA ACG AAA-3’ XhoI cutting site (red) 
M77E fw 
5’-TTT ATC AAT CGT GGT GGT CGT GAA 
CTG AAT GAA G-3’ 
Methionine to glutamic 
acid (red) 
M77E rv 
5’-CAC GAT TGA TAA AAC CTG CAT CAT 
TAC CCA GT-3’ 
 
V393T fw 
5’-C AAT GTG CTG CTG AGC ATT ACC 
GTT CAT CAT C-3’ 
Valine to threonine (red) 
V393T rv 
5’-CAG CAG CAC ATT GCT ATC AAC AAA 
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The increasing number of antibiotic-resistant bacteriaworldwide has become a major public health threat. Dis-covery and study of different bacterial resistance strategies
as well as the development of new antimicrobial compounds,
which are also able to overcome the protecting outer-membrane
barrier of Gram-negative bacteria, are of great urgency1. Albicidin
is a phytotoxic small molecule synthesized by the Gram-negative
plant pathogen Xanthomonas albilineans that causes leaf scald
disease in sugarcane plants2. Besides its phytotoxicity, albicidin is
bactericidal in the nanomolar range against Gram-positive and in
particular against Gram-negative bacteria with low minimal
inhibitory concentrations (MIC), e.g., against Staphylococcus
aureus (4.0 μg mL−1), Salmonella enteritidis (0.5 μg mL−1),
Pseudomonas aeruginosa DSM 117 (1.0 μg mL−1), and Escher-
ichia coli (0.063 μg mL−1)3,4. The molecular target of albicidin is
DNA gyrase (topoisomerase II), an enzyme essential for bacterial
DNA replication. Albicidin has been reported to block the ATP-
dependent DNA cleavage-religation step at the gyrase A subunit3.
The biosynthesis of albicidin is based on a hybrid polyketide
synthase/nonribosomal peptide synthetase5,6. The structure of
albicidin consists of six building blocks (Fig. 1a): methyl p-cou-
maric acid (MCA-1) at the N terminus; two p-aminobenzoic
acids (pABA-2 and pABA-4); the unusual non-proteinogenic α-
amino acid β-cyano-L-alanine (L-Cya-3) centered in the structure;
and two 4-amino-2-hydroxy-3-methoxybenzoic acids (pMBA-5
and pMBA-6) at the C-terminal end. The structure elucidation5,7
of albicidin and a total synthesis route4 enabled initial structure-
activity relationship (SAR) studies8–10.
Previously, a number of resistance mechanisms against albicidin
have been described: examples include the nucleoside transporter
Tsx, for which mutations have been reported that compromise its
abilities to import albicidin11,12, or the endopeptidase AlbD from
Pantoea dispersa13, which cleaves albicidin into two inactive
fragments14. Another strategy that counteracts the antibacterial
effect of albicidin is drug binding, as it is also known for the
tetracycline-binding protein (TetR family)15 or the thiostrepton-
binding protein (MerR family)16. Examples of such albicidin-
binding proteins are AlbA from Klebsiella oxytoca17 and AlbB
from Alcaligenes denitriﬁcans18, which exert protective effects for
survival of the host strains. Previous studies on AlbA/AlbB have
demonstrated non-covalent binding of albicidin17,18. Furthermore,
far-ultraviolet (UV) circular dichroism (CD) spectroscopy has
indicated a mostly α-helical structure for AlbA19. Speciﬁc amino-
acid residues such as His125 have been suggested to play a role in
albicidin binding19,20. Due to high similarities to the DNA-binding
domains of transcriptional regulator proteins NifA and NtrC
(nitrogen regulatory protein) a classiﬁcation of AlbA/AlbB as
transcription activator proteins has been suggested19.
Transcriptional regulator proteins are widespread in nature.
For instance, the MerR (Mercury Resistance) transcriptional
regulator family is known to activate several multi-drug resistance
(MDR) systems in response to environmental stress21. Members
of this family are characterized by a highly conserved N-terminal
winged helix-turn-helix (HTH) DNA-binding motif. The HTH
motif is connected by a long coiled-coil linker to a C-terminal
effector-binding domain that differs in structure and function
among the family members21. Activation of these regulators
occurs in response to oxidative stress and heavy metals or small
molecules, e.g., antibiotics, binding to the effector domain22.
Well-known members of the MerR family are the transcriptional
regulators BmrR from Bacillus subtilis22,23, and SoxR from
Escherichia coli24. Another prominent and well-described MerR
system is the thiopeptide-binding protein TipA (thiostrepton-
induced protein A) from Streptomyces lividans25,26. The tipA gene
encodes for two alternate in-frame translation products: the long
form TipAL consisting of the N-terminal HTH DNA-binding
domain (TipAN), and the shorter C-terminal thiopeptide drug-
binding domain (TipAS)27. Drug binding to TipAL leads to an
upregulation of its own expression and confers resistance against
several thiopeptide antibiotics, e.g., thiostrepton, nosiheptide, and
promothiocin A16. Previously, Grzesiek and co-workers have
solved the solution structure of TipAS bound to various
thiopeptides16,27, which for the ﬁrst time gave insights into
binding determinants and domain dynamics of the protein.
In this work, we characterized the MerR-like drug-binding
protein AlbA that displays a high binding afﬁnity to albicidin. We
elucidated the crystal structure of the complex between albicidin
and the drug-binding domain AlbAS, demonstrating that this
domain is structurally distinct from other drug-binding domains
of MerR family members, such as BmrR23 or TipAS27. The
unusual topology of AlbAS comprises two tandem domains that
are required to wrap around and fully enclose the drug in the core
of the protein. Nuclear magnetic resonance (NMR), CD, and
ﬂuorescence spectroscopic measurements provided detailed
insights into the binding mechanism and the structural elements
required for drug binding of AlbA. Consistent with our structural
data, binding studies on synthetic albicidin derivatives revealed
ligand promiscuity of AlbAS for aromatic acylpentapeptides as
well as further supported our model of the binding mechanism.
Our ﬁndings represent valuable knowledge about antibiotic cap-
ture as an important resistance mechanism and how to possibly
circumvent it in the case of albicidin.
Results
AlbA is a MerR-like transcriptional regulator. A sequence
similarity search using Basic Local Alignment Search Tool
(BLAST) for AlbA (accession number (AC): Q8KRS7)17 and
AlbB (AC: Q44567)18 suggests that they belong to the MerR
family of transcriptional regulators (E-values of 10−160 (AlbA)
and 10−37 (AlbB)). Moreover, AlbA shows high structural
homology to the thiopeptide-binding protein TipAS (Supple-
mentary Figure 1). Further homologous proteins were identiﬁed
in various Gram-negative bacteria belonging to the family of
Enterobacteriaceae like Raoultella ornithinolytica, Leclercia ade-
carboxylata, or Enterobacter mori (Supplementary Figure 2A and
Supplementary Figure 3). Bioinformatic comparison of AlbA and
AlbB showed that while being distantly related in primary
structure, both proteins most probably share high secondary
structure similarity (Supplementary Figure 2B). A striking dif-
ference between both proteins is the isoelectric point (AlbA: pI=
4.99, AlbB: pI= 10.15) due to the reversed content of acidic (15%
for AlbA versus 8% for AlbB) and basic amino-acid residues (10%
for AlbA versus 15% for AlbB).
Bioinformatic analysis of the K. oxytoca and A. denitriﬁcans
genomes revealed a putative HTH motif in AlbA and AlbB that
might be involved in DNA binding. This domain is conserved in
several MerR-transcription activators21. In analogy to the TipA
system27, we assumed that the albA/albB genes each encode for
two proteins: a full-length protein and a truncated protein as a
result of two in-frame translation products. Based on the TipA
nomenclature27, we termed the full-length versions AlbAL/AlbBL
(AlbAL 40 kDa, 348 amino acids, AC: WP_016808841). Hence,
AlbAL/AlbBL consist of the MerR-characteristic N-terminal
HTH DNA-binding domain and the C-terminal drug-binding
domain AlbAS/AlbBS. Sequence alignments with TipAL and
secondary structure prediction illustrated that AlbAS (25.8 kDa,
221 amino acids) may comprise an unusual tandem arrangement
of two TipAS-like drug-binding domains (Supplementary Fig-
ure 1). Interested in the capture mechanism toward albicidin, we
subsequently focused on AlbAS and validated the results by
employing AlbAL in key experiments (Supplementary Figure 4A).
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AlbA captures albicidin with low nanomolar binding afﬁnity.
Initial in vitro agar diffusion assays with E. coli and a pre-
incubated AlbA-albicidin mixture clearly demonstrated the
albicidin-neutralizing effect of both AlbAS (Fig. 2a) and AlbAL
(Supplementary Figure 5A).
MIC values for albicidin were determined against four K.
oxytoca and seven Klebsiella pneumoniae strains as well as several
ESKAPE organisms such as P. aeruginosa, R. ornithinolytica,
Acinetobacter baumanii, and Enterobacter cloacae. All strains
were resistant against albicidin with MIC values of ≥64 µg mL−1.
By bioinformatic analysis, we identiﬁed AlbA homologs in many
of these pathogens (Supplementary Figure 3) indicating that AlbA
may function as a widespread resistance mechanism.
Far-UV CD spectroscopy of AlbAS and AlbAL in the absence
and presence of albicidin showed signal minima at wavelengths of
209 and 222 nm, which are characteristic of α-helical secondary
structures (Fig. 3a and Supplementary Figure 5B). No signiﬁcant
changes in secondary structure were induced by albicidin binding
to both proteins. However, assessing the thermodynamic protein
stabilities showed that the melting temperature, Tm, of AlbAS
increased signiﬁcantly upon albicidin binding from 66 to 81 °C
(Fig. 3b). Binding of albicidin to AlbAL caused a less-pronounced
increase in Tm from 71 to 74 °C (Supplementary Figure 5C).
We further inspected the structural rearrangement of AlbAS
upon albicidin binding via two-dimensional (2D) NMR experi-
ments with 15N-labeled AlbAS. The 1H-15N heteronuclear single-
quantum coherence (HSQC) spectrum of AlbAS was character-
ized by considerable line-broadening and signal overlap (Fig. 3e).
Peak picking yielded only 95 of the expected 209 cross-peaks. By
contrast, addition of albicidin not only caused chemical shift
changes but also the appearance of new cross-peaks (approxi-
mately 175 cross-peaks in total). For example, the well-resolved
indole region of tryptophans showed three versus nine cross-
peaks in the absence and presence of the ligand, respectively. A
tentative assignment of these side-chain signals using Trp-to-Phe
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MCA-1 pABA-2 L-Cya-3 pABA-4 pMBA-5 pMBA-6
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a
Fig. 1 Structure of albicidin. a Albicidin is composed of six building blocks (denoted A–F): p-coumaric acid (MCA-1); p-aminobenzoic acid (pABA-2 and
pABA-4); non-proteinogenic α-amino acid L-Cya-3; and two 4-amino-2-hydroxy-3-methoxybenzoic acids (pMBA-5 and pMBA-6). b Overview of tested
compounds. Structural variations with respect to albicidin are highlighted in gray
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became detectable upon albicidin binding (Supplementary
Figure 6). Interestingly, the observation of doubled resonances
for the side chains of W56 and W133 indicated that these residues
adopt two different and slowly interconverting conformations in
the albicidin–AlbAS complex (Supplementary Figure 6). The
NMR data suggest that the extensive line-broadening for the
unbound AlbAS is caused by internal dynamics on a microsecond
to millisecond timescale, which are frozen in a more rigid
albicidin-bound state.
Size-exclusion chromatography with multi-angle light scatter-
ing (SEC-MALS) measurements yielded molecular masses, M, of
27.1 and 27.2 kDa for AlbAS in the absence and presence of
albicidin, respectively (Supplementary Figure 7A). In contrast to
monomeric AlbAS, the full-length protein AlbAL formed a dimer
in solution in both the unbound state (M of 82.2 kDa) and
albicidin-bound state (M of 85.5 kDa) (Supplementary Figure 7B).
Dimerization has been shown for other MerR proteins as well,
enabling DNA promoter binding28,21. In agreement with a
dimeric state, 2H,15N-labeled AlbAL yielded rather broad
resonance lines in 1H-15N transverse relaxation-optimized
spectroscopy (TROSY) experiments. More importantly, albicidin
binding to AlbAL caused many of the characteristic chemical shift
perturbations observed for AlbAS–albicidin indicating a very
similar binding mode (Supplementary Figure 5D and E).
In order to estimate the binding strength between AlbAS and
albicidin, we monitored characteristic signals in a well-resolved
reporter region of the 1H-15N HSQC spectrum during a titration
series (Supplementary Figure 8A). The simultaneous observation
of signals arising from both AlbAS and its albicidin-bound state,
as well as and the mutual change in populations of these two
states indicated a slow-exchange regime in agreement with strong
ligand binding in the nM–pM range (Supplementary Figure 8B
and Supplementary Figure 8C)29. Owing to this very strong
interaction and the high protein concentrations required in the
NMR experiments, we employed ﬂuorescence spectroscopy to
avoid ligand depletion effects and to ultimately determine the
dissociation constant, Kd, of albicidin binding to AlbAS and
AlbAL. The experimental read-out was based on quenching of
ﬂuorescence emission of AlbAS/AlbAL upon binding of albicidin
(Fig. 4a). Analysis of the observed binding response for AlbAS
yielded a Kd of 5.6 ± 0.2 nM and indicated positive cooperativity
with a Hill coefﬁcient, n, of 3.0 ± 0.5 (Fig. 4b). The full-length
protein AlbAL showed a similar binding afﬁnity (Kd of 7.4 ± 0.9
nM) and cooperativity (n of 2.0 ± 0.2) (Supplementary Figure 5F).
These results demonstrated that the drug-binding domain of
AlbA acts as a high-afﬁnity capture system for albicidin.
It has been shown previously that albicidin exhibits a half
maximal inhibitory concentration (IC50) of 40 nM for its
molecular target DNA gyrase3. To investigate whether AlbAS is
capable of protecting DNA gyrase against albicidin, we performed
an NMR-based in vitro competition experiment employing the
gyrase construct GyrBA59 from E. coli (Supplementary Fig-
ure 9A). Puriﬁed and enzymatically active GyrBA59 (Supple-
mentary Figure 9B and C) was incubated with MgCl2, ATP,
supercoiled pBR322 plasmid DNA, and equimolar amounts of
AlbAS. An equimolar amount of albicidin was then added to the
mixture to allow for direct competition. The overlay of 1H-15N
correlation spectra showed that AlbAS fully populated the
albicidin-bound state with no free AlbAS being detectable
(Supplementary Figure 9D and E). This demonstrated that AlbAS
can efﬁciently sequester albicidin before the inhibitor targets
DNA gyrase.
The structure of the AlbAS–albicidin complex. We obtained
well-diffracting crystals for the AlbAS–albicidin complex and
solved its structure by single-wavelength anomalous dispersion
with selenomethionine-labeled AlbAS (Fig. 5a). Model reﬁnement
(1.7 Å resolution) converged with excellent statistics and geo-
metry (Supplementary Table 1 and Supplementary Figure 10A
and B). The structure of AlbAS could be fully modeled except for
the C-terminal residues 215–221. An asymmetric unit contains
two copies of the protein that are virtually identical with a root
mean square deviation (rmsd) of 0.6 Å for all Cα atoms. AlbAS
adopts an all-α-helical fold in agreement with CD spectroscopy
(Fig. 3a). As postulated from our bioinformatic analysis (Sup-
plementary Figure 11A and Supplementary Figure 1), the struc-
ture of AlbAS is organized in two repeat units, i.e., the N-terminal
domain (NTD, residues M1-R112) and the C-terminal domain
(CTD, residues Y113-E221). A 24-residue α-helix (P92-R112)
connects the NTD with the CTD. To reﬂect the tandem
arrangement in AlbAS, we designated helices of the NTD as α1-
α6 and the equivalent helices of the CTD as α1′-α6′ (Supple-
mentary Figure 11A). The NTD and CTD are arranged relative to
each other via 21 screw pseudosymmetry and can be super-
imposed (using boundaries D20-L114 and D128-A215) with an
rmsd of 1.7 Å (Fig. 5b and Supplementary Figure 11A).
A DALI30 search for structurally related folds resulted in very
low Z-scores. The most related structure with a Z-score of 5.8 is
the drug-binding domain TipAS (PDB 2MBZ, in complex with
promothiocin A)27 with a sequence identity of only 13%. TipAS
(G111-P253) superimposes with both the NTD (M1-R112) and
CTD (Y113-Q214) of AlbAS with Cα rmsd values of 2.2 and 5.0
Å, respectively. The deviations mainly arise from structural
differences at the N-terminal regions, whereas helices α2-α6 of
the NTD (D20-L114) and helices α2′-α6′ of the CTD (Y128-
A215) can be well aligned to helices α9-α13 of TipAS (Y155-
P253) yielding rmsd values of 2.5 and 2.8 Å, respectively.
To test the albicidin-binding potential of the individual
domains, we prepared constructs comprising either the NTD
(AlbASNTD) or the CTD (AlbASCTD) (Supplementary Figure 4B).







AlbASNTD+ albicidin AlbASCTD+ albicidin AlbASM+ albicidin
Fig. 2 Agar diffusion assays. a–c AlbAS, AlbASNTD, AlbASCTD, and AlbASM (40 µM) with 40 μM albicidin (in triplicates I–III). The ﬁrst plate illustrates the
sample arrangement on the assay plates. Positive control with only 40 µM albicidin (+) and negative control with 40 µM protein in 5% DMSO and buffer
(−) are shown on top. Representative results are shown for three independent experiments
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05551-4
4 NATURE COMMUNICATIONS |  (2018) 9:3095 | DOI: 10.1038/s41467-018-05551-4 | www.nature.com/naturecommunications
1H-15N HSQC spectra (Supplementary Figure 12A and B).
However, in agar diffusion assays they failed to suppress the
antibacterial effects of albicidin (Fig. 2b). This observation can be
ascribed to diminished afﬁnities toward albicidin, as ﬂuorescence
spectroscopy yielded Kd values of 3.4 ± 0.2 μM (AlbASNTD) and
0.6 ± 0.1 μM (AlbASCTD), respectively (Fig. 4c).
In contrast to TipAS, which binds its macrocyclic ligands in an
N-terminal pocket (Fig. 5c)27, the elongated and rather rigid
albicidin molecule is accommodated in a central tunnel of AlbAS
thereby pervading both, its NTD and CTD. Interestingly, both
repeat units utilize an equivalent pocket to harbor the different
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Fig. 3 Impact of albicidin binding on structure and stability of AlbAS. a Far-UV CD spectra of AlbAS in the absence (black) or presence (red) of albicidin
(molar ratio 1.5:1 albicidin:AlbAS) at 21 °C. b–d CD-detected thermal unfolding of AlbAS in the absence (black) or presence (red) of albicidin, compound 5,
or compound 7. Tm values are indicated by dashed lines. For the overlay, the [Θ]MRW(215 nm) signals of AlbAS–albicidin and AlbAS–compound 5 were scaled
to that of AlbAS alone using a factor of 1.157 and 1.091, respectively. e–g Overlay of 1H-15N HSQC NMR spectra of AlbAS in the absence (black) or
presence (red) of albicidin, compound 5, or compound 7, respectively. CD experiments were performed once. NMR experiments with the AlbAS–albicidin
complex were performed ﬁve times and a representative spectrum is shown in e. NMR experiments using albicidin derivatives were conducted once
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(Supplementary Figure 11B). The binding tunnel is decorated by
residues of all helices, except for the N-terminal helix α1 (Fig. 5a),
and exhibits a predominantly hydrophobic inner surface. The
building blocks A, B, and C of albicidin are surrounded by the
NTD of AlbAS, whereas building blocks D, E, and F are enclosed
by the CTD. The high-salt crystallization conditions reﬂect the
hydrophobic character of the interaction, which is mediated by
several hydrophobic residues pointing into the tunnel, e.g., F16,
W27, W56, L60, L71, T88, I95, L130, W133, P134, W162, and
W195 (an overview of all interacting residues is given in
Supplementary Figure 13). Five out of eight Trp side chains
(W27, W56, W133, W162, and W195) line the inner surface of
the tunnel. Residues F16, W27, W133, and W162 are π-stacked to
the aromatic building blocks A, E, and F of albicidin. Besides
strong hydrophobic interactions, a salt bridge between the
carboxylate moiety of albicidin and R181 of the CTD might play
an important role for the orientation and ﬁxation of the ligand in
the tunnel (Fig. 5d). Furthermore, several hydrogen bonds
contribute to the binding of albicidin. For example, pMBA-6
(building block F) establishes two hydrogen bonds to Y169 and
Q205 of the CTD (Fig. 5d), while N24 and H78 of the NTD
hydrogen-bond to the hydroxyl and carbonyl moiety of MCA-1
(building block A), respectively (Fig. 5e). Owing to its rigid
scaffold with a single α-amino acid, albicidin adopts a V-shaped
conformation with the Cα atom of L-Cya-3 at the center and the
building blocks A-B-C and D-E-F forming the two arms that span
c
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AlbAS + compound 5
AlbAS + compound 7
AlbAS + compound 4
Fig. 4 Determination of binding afﬁnities by monitoring quenching of ﬂuorescence emission of AlbAS. a Fluorescence quenching of AlbAS (200 nM; λexc=
280 nm) with increasing albicidin concentrations. b Nonlinear regression (Eq. (2), see Methods section) of ﬂuorescence quenching data yielding a Kd of
5.6 ± 0.2 nM and a Hill coefﬁcient, n, of 3.0 ± 0.5 for the interaction of albicidin with AlbAS (20 nM). c Nonlinear regression of the quenching data yielded
Kd values of 3.4 ± 0.2 and 0.6 ± 0.1 µM for the interaction of albicidin with the dissected domains AlbASNTD (100 nM) and AlbASCTD (100 nM),
respectively. d AlbAS (20 nM) titrated with compound 4 did not lead to signiﬁcant quenching of the ﬂuorescence emission signal. e Titration of AlbAS (20
nM) with compound 5 yielded a Kd of 55.5 ± 3.6 nM (Eq. (2), see Methods section). f Titration of AlbAS (20 nM) with compound 7 yielded a Kd of 14.0
± 2.9 nM (Eq. (3), see Methods section). Representative binding curves are shown for two independent experiments each. Errors are given as s.d
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Fig. 5 Structure of the AlbAS–albicidin complex and key residues of AlbAS for albicidin binding. a AlbAS is shown in cartoon representation with the NTD
(α1-α6) in blue and the CTD (α1′-α6′) in cyan. The elongated helix α6 connecting both domains is highlighted in orange. Albicidin is shown in ball-and-stick
representation (yellow) and pervades both domains of AlbAS. b Superposition of the NTD and CTD of AlbAS. α-helical elements are labeled (a prime
indicates assignment to the CTD). The protruding helix α1 of the NTD is predicted to be part of a longer α-helical linker region of AlbAL, which connects the
HTH motif and the drug-binding region of the protein. c Superposition of the AlbAS–albicidin complex (ligand not shown) and TipAS (PDB 2MBZ)27 bound
to promothiocin A (ball-and-stick representation, carbon magenta). A region that is unfolded in isolated TipAS and forms an α-helical lid (α6-α9) after drug
binding is colored in white. Helices present in the unbound form of TipAS are drawn in dark gray. d Interactions of the AlbAS CTD with albicidin portion D-
E-F. e Interactions of the AlbAS NTD with albicidin portion A-B-C. Residues of the NTD, the CTD, and albicidin are colored in blue, cyan, and yellow,
respectively, with oxygens in red and nitrogens in blue. Hydrogen bonds and ionic interactions are indicated by dashed lines
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an angle of about 130°. Importantly, the side chain of N75 of
AlbAS forms two hydrogen bonds with the amide proton and the
carbonyl oxygen of the central L-Cya-3 (Φ and Ψ values of 66.0°
and −128.7°), thereby stabilizing this speciﬁc conformer of
albicidin. The cyanomethylene side chain of L-Cya-3 is oriented
outwards the binding tunnel approaching helices α6 and α1′.
Interestingly, the amide proton of pABA-4 is pointing at the triple
bond of the nitrile moiety with a distance of about 1.4 Å.
Besides the mainly hydrophobic character of the interaction
between AlbAS and albicidin, we propose that N75, R181, and
Q205 are important residues for recognition of albicidin. Based
on the crystal structure we generated the triple variant AlbASM
with amino-acid substitutions N75A, R181A, and Q205A
(Supplementary Figure 4A). Employing the agar diffusion assay
as a ﬁrst line of evidence, AlbASM was indeed not capable of
efﬁciently suppressing the antibacterial activity of albicidin
(Fig. 2c), albeit binding was not fully impeded (Supplementary
Figure 14).
AlbAS tolerates structural variations of albicidin. The above-
described interaction between AlbAS and albicidin raised further
questions on the tolerance of AlbAS toward structural variations
of albicidin and thus the possible design of albicidin analogs,
which could escape arrest by AlbAS. Based on previous SAR
studies, we were equipped with a number of synthetic albicidin
derivatives and substructures thereof8,9. We employed the agar
diffusion assay with E. coli and 1H-15N HSQC experiments in
order to monitor the ability of AlbAS to bind albicidin analogs
(Supplementary Figure 14 and 15).
From our library of albicidin-derived compounds we chose
seven derivatives (compounds 1–7) as well as the TipAS-speciﬁc
ligand thiostrepton A as a control substance (Fig. 1b). These
albicidin derivatives comprised variations of building blocks A
and C, which otherwise stabilize the AlbAS–albicidin complex
through hydrogen bonds to N24 and H78 (building block A),
N75 (L-Cya-3, building block C), as well as π–π stacking and
hydrophobic interactions (building block A) to W27 of AlbAS. In
compound 1, a ﬂuorine atom replaced the phenolic hydroxyl
group of the coumaric acid (building block A), thus eliminating
hydrogen bond capabilities to N24. The agar diffusion assay
showed that the presence of AlbAS abolished the antibacterial
activity of compound 1 (Supplementary Figure 15). Moreover, the
HSQC signal pattern clearly indicated strong binding by AlbAS
similar to that of albicidin (Supplementary Figure 16).
Compound 2 bore two structural modiﬁcations: (i) it was
shorter than albicidin due to a substitution of coumaric acid by a
para-hydroxy benzoic acid moiety; and (ii) L-Cya-3 was
substituted by the sterically more demanding L-Thr with H-
bond donor and acceptor capabilities. Despite the expectedly
missing hydrogen bond to residue N24 and the variation in the
side chain of L-Cya-3 (building block C), the agar diffusion assay
indeed conﬁrmed binding of the strongly antibacterial compound
2 (Supplementary Figure 15). Accordingly, we observed the
characteristic HSQC signal pattern as in the case of albicidin
binding to AlbAS (Supplementary Figure 14 and 16). Apparently,
both structural modiﬁcations (building blocks A and C) had no
signiﬁcant inﬂuence on binding by AlbAS.
In order to assess the importance of the only stereocenter in
albicidin for binding to AlbAS, we also tested the antibacterially
active enantiomer of albicidin4 bearing D-Cya-3 (compound 3).
Remarkably, AlbAS was still able to bind compound 3
(Supplementary Figure 14) and thus to prohibit its antibacterial
effects (Supplementary Figure 15).
Finally, we tested truncated albicidin derivatives (compounds
4, 5, and 6) to evaluate binding contributions from the NTD and
CTD (Fig. 1b). Compound 4 only consisted of the building blocks
A and B, and therefore addressed binding contributions from the
NTD of AlbAS. On the contrary, compound 5 comprised only the
C-terminal building blocks D, E, and F, and was thought to
potentially accommodate in the CTD of AlbAS. Ultimately,
compound 6 was devoid of building blocks A and F and was thus
hypothesized to miss essential interactions with residues N24,
W27, W162, Y169, R181, and Q205 in the NTD and CTD. The
truncated albicidin variants 4, 5, and 6 did not display
antibacterial activity (Supplementary Figure 15), however, the
change in the NMR signal pattern clearly demonstrated
interaction between AlbAS and the respective derivatives
(Supplementary Figure 14). Notably, while compounds 5 and 6
again caused spectra in the slow-exchange regime (strong
binding), compound 4 showed a gradual chemical shift change
typical for fast-exchange systems (weak binding, Fig. 4d).
Fluorescence quenching experiments with AlbAS and compound
5 resulted in a Kd of 55.5 ± 3.6 nM (Fig. 4e). Compound 4 had no
consistent effect on ﬂuorescence emission spectra of AlbAS
suggesting a very low binding afﬁnity (Fig. 4d). Taken together,
these results underline the importance of the CTD as a ﬁxation
point for albicidin.
Facing the high structural similarities between albicidin and the
anti-Gram-negative compounds cystobactamid31 and coralmy-
cin32, we tested binding capabilities of an albicidin derivative
(compound 7)33 with cystobactamid-like features (Fig. 1b). The
pattern of NMR reporter signals of AlbAS clearly pointed to a
strong binding of compound 7 in the nanomolar Kd range. Our
ﬂuorescence quenching experiments revealed a Kd of 14.0 ± 2.9
nM for compound 7 (Fig. 4f), which is similar to the binding
afﬁnity of AlbAS toward albicidin (5.6 ± 0.2 nM), however, no
cooperative behavior was observed. Analysis of the agar diffusion
assay showed that AlbAS is able to neutralize the antibacterial
effects of compound 7, albeit with decreased efﬁciency (Supple-
mentary Figure 15). Finally, thiostrepton A was devoid of any
binding afﬁnity toward AlbAS (Supplementary Figure 15 and
Supplementary Figure 14).
Discussion
AlbA has been reported as a binding protein conferring resistance
against the potent antibiotic albicidin17,19,20. Previous studies
already mentioned a single high-afﬁnity binding site for albicidin
in AlbAS20,34, and an α-helical structure19, but they lacked both
the knowledge of the chemical structure of albicidin and the high-
resolution structure of AlbAS. Our antibacterial tests using an
in vitro agar diffusion assay combined with biophysical binding
studies via CD, NMR, and ﬂuorescence spectroscopy underscore
the high binding afﬁnity of AlbAS and AlbAL toward albicidin
(Kd of 5.6 ± 0.2 and 7.4 ± 0.9 nM, respectively) and other deri-
vatives. The sensitivity of ﬂuorescence quenching experiments
was essential for the determination of such a low Kd value.
However, as we were restricted to minimum protein concentra-
tions of 20 nM, the determined Kd values could still represent
upper boundaries. Therefore, the previously reported Kd of 64
nM34 is at least one order of magnitude to high. Surprisingly,
quenching of AlbAS emission by albicidin proved to be highly
efﬁcient (100% quenching) possibly reﬂecting the network of
tryptophans in the binding tunnel, in particular in that of the
CTD (Fig. 5c).
Competition experiments with the DNA gyrase construct
GyrBA59 and albicidin (Supplementary Figure 9D and E)
demonstrated the strong binding afﬁnity of AlbAS and its ability
to protect the molecular target from inhibition. In light of pre-
viously determined IC50 values of 40 nM for DNA gyrase, we
suggest that AlbA may either be more abundant in the cell than
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DNA gyrase and/or exhibit superior association rates kon to
efﬁciently capture albicidin after cell entry.
The crystal structure of the drug-binding domain AlbAS
revealed a tandem architecture with the NTD and CTD repre-
senting structural repeats of each other that are connected by the
extended helix α6 of the NTD (Fig. 5a). Intriguingly, nature has
adapted to the elongated and fairly rigid scaffold of albicidin by
combining two TipAS-type folding units to fully enclose the
highly potent toxin. Albicidin is thus clamped between the NTD
and CTD and stabilized predominantly by hydrophobic and π–π
stacking interactions (Fig. 5d, e, Supplementary Figure 11A and
B). Based on our structural data, we can exclude the previously
suggested direct involvement of residue H125 in albicidin bind-
ing20, since this residue is located in helix α1′ and oriented
toward the protein exterior (Supplementary Figure 17). Several
hydrogen bonds, and in particular the salt bridge between the
carboxylic acid of albicidin and R181 of AlbAS, most likely confer
ligand selectivity. We assume that R181 is relevant to orient
albicidin in the binding cleft by anchoring the carboxylic acid of
pMBA-6 (building block F) in the CTD.
Attempts to crystallize AlbAS in the absence of albicidin did
not succeed. According to this, the increase in observable signals
in 1H-15N HSQC spectra of AlbAS upon albicidin binding sug-
gests that free AlbAS displays inherent protein dynamics on the
micro-to-millisecond timescale. Based on the repeat structure of
AlbAS with few direct contacts between the repeat units even in
the albicidin-bound state, we hypothesize that albicidin may ﬁx
the otherwise ﬂexible relative orientation of the NTD and CTD.
In addition, dynamics within the binding tunnel in the absence of
albicidin may also account for some of these observations, as only
three out of eight expected HSQC signals for Trp side chains were
detected with good signal-to-noise ratio (Supplementary Figure 6
and 16). Ligand-induced stabilization has also been observed for
the structurally related drug-binding protein TipAS16, for which
binding of thiopeptides induces an otherwise non-observable α-
helical lid to pack onto the ligand (Fig. 5c)27. In contrast, how-
ever, the comparison of AlbAS/AlbAL and the AlbAS/
AlbAL–albicidin complexes by CD spectroscopy showed that the
α-helical content was virtually independent of ligand binding
(Fig. 3a and Supplementary Figure 5B). The dynamic nature of
the vacant protein suggests a possible binding mechanism: AlbAS
exploits its inherent structural plasticity in order to clamp the
elongated and rather rigid albicidin molecule in a buried tunnel of
about 33 Å in length that is built from both repeat units (Sup-
plementary Figure 18). The observed positive cooperativity with
Hill coefﬁcients n of 2.0–3.0 is in agreement with a binding
process that includes recruitment of albicidin to one domain
favoring subsequent association to the neighboring domain. Such
a cooperative binding behavior has been also observed for the
MerR protein BmrR35. The strong binding of albicidin conse-
quently leads to a well-deﬁned NTD-CTD arrangement in AlbAS
causing an increase in thermal stability, ΔTm, of about 15 °C.
Our concept of ligand-mediated domain-domain bridging is
supported by binding effects caused by albicidin fragments:
despite strong binding to AlbAS (Kd of 55.5 ± 3.6 nM), the C-
terminal segment of albicidin (compound 5) did not cause the
appearance of additional resonances in the HSQC spectrum of
AlbAS, and neither did compounds 4 and 6 (Supplementary
Figure 14). This observation demonstrates that the fragments
were not capable of efﬁciently stabilizing the NTD-CTD
arrangement (Supplementary Figure 18), while all tested full-
length analogs of albicidin did (Supplementary Figure 14).
Intriguingly, the full-length cystobactamid-type analog (com-
pound 7) was not able to stabilize AlbAS to a similar extent as
albicidin (Fig. 3d, g). Despite binding with low nanomolar afﬁnity
(Kd of 14.0 ± 2.9 nM) similar to albicidin, compound 7 showed no
positive cooperativity (Fig. 4f). Moreover, compound 7 provoked
chemical shift patterns in HSQC spectra of AlbAS reminiscent of
those of the C-terminal albicidin fragment (compound 5). We
could not achieve crystallization of the AlbAS–compound 7
complex either. Taken together, these observations clearly sup-
port that cystobactamid is mainly bound to the CTD of AlbAS
without properly bridging the NTD and CTD. As AlbAS can
tolerate a shortened building block A (para-hydroxy benzoic acid
in compound 2, see Supplementary Figure 14), the steric demand
of β-methoxy-L-Asn and its anticipated effect on the backbone
conformation in building block C appears to hinder the stabili-
zation of both domains. In a previous study, we identiﬁed various
naturally occurring derivatives of albicidin, amongst them a less
active variant with a β-methoxy-L-Asn residue33. Hence, this
modiﬁcation may represent a natural mechanism against AlbA-
mediated transcriptional regulation.
Truncated AlbAS variants composed of a single domain were
not sufﬁcient to properly arrest albicidin: AlbASNTD and
AlbASCTD were not able to neutralize albicidin in the agar dif-
fusion assay (Fig. 2b) due to their much weaker binding afﬁnities.
Fluorescence quenching experiments yielded Kd values for albi-
cidin binding of 3.4 ± 0.2 µM (NTD) and 0.6 ± 0.1 µM (CTD),
respectively, indicating that recruitment of albicidin to AlbAS
may be guided by the CTD. We propose that a binding pathway
from the CTD toward the NTD of AlbAS would ensure that
albicidin is ﬁrst fully trapped in AlbAS before the binding signal is
relayed to the N-terminal HTH domain of full-length AlbAL to
induce DNA binding. The high afﬁnity of AlbAS toward the C-
terminal fragment of albicidin (compound 5) further supports the
idea of the CTD as an initial anchoring point (Supplementary
Figure 18).
Interestingly, when comparing AlbAS with AlbBS only key
residues W162, Y169, and R181 of AlbAS are conserved in AlbBS
(Supplementary Figure 2B). These residues interact with pMBA-6
(building block F) of albicidin indicating that AlbBS might
recognize this C-terminal pMBA-motif, but that its cognate
ligand might otherwise deviate from the albicidin structure. In
light of the reduced afﬁnity of AlbAS toward the cystobactamid-
type compound 7, the missing binding cooperativity and the
reduced stabilization effect we propose that AlbAS has been
evolutionarily optimized to capture albicidin rather than the
related cystobactamids or coralmycins31,32. Whether AlbBS
represents a corresponding cystobactamid- or coralmycin-
binding protein will be the subject of future investigations.
Sequence alignments and secondary structure predictions
demonstrate the widespread occurrence of AlbAS homologs with
tandem architecture among several ESKAPE pathogens (Supple-
mentary Figure 3). These homologs are sequentially different
(≤58% difference to AlbAL) but are predicted to adopt a similar
α-helical repeat structure in which key residues important for
albicidin binding are conserved. The AlbA-mediated sequestra-
tion of albicidin might thus operate in clinically relevant patho-
gens, which showed resistance against albicidin (MIC value ≥64
µg mL−1). However, at this point it is unclear to which extent
albicidin capture by AlbA homologs contributes to the overall
antibacterial resistance in vivo, as several resistance strategies will
act in concert. Likewise, it will be necessary to identify full-length
AlbAL and the truncated AlbAS species in vivo, and to quantify
their cellular abundances.
Given the ligand promiscuity of the TipAS system27,36, and
other MerR effector-binding domains (i.e., BmrR)37, we studied
whether AlbAS can accept structurally different albicidin deri-
vatives by using an in vitro agar diffusion assay and an HSQC-
based binding assay. While the former assay only provided
information on the AlbAS-mediated neutralization of anti-
bacterial derivatives, the NMR experiments gave a direct read-out
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on the binding capabilities of AlbAS. The synthetic albicidin
derivatives submitted to these assays probed steric as well as
electronic requirements for effective binding by AlbAS.
As discussed above, the albicidin fragments could not efﬁ-
ciently ﬁx the two domains of AlbAS. This observation supports
the suggested clamping mechanism, for which albicidin deriva-
tives are required that can span the entire binding tunnel, thus
connecting the NTD and CTD (Supplementary Figure 18).
Structural variations at the N terminus of albicidin (building
block A), like the withdrawal of hydrogen bond capabilities
(compound 1) or the replacement of methyl coumaric acid with
para-hydroxy benzoic acid (compound 2) had no signiﬁcant
effect on AlbAS binding. In addition, a polar L-Thr instead of L-
Cya-3 (compound 2) was similarly tolerated by AlbAS (Supple-
mentary Figure 16). Remarkably, as shown for the albicidin
enantiomer (compound 3), inversion of the only stereocenter of
the molecule was not detrimental to recognition by AlbAS. The
agar diffusion assay clearly demonstrated the neutralizing effect of
AlbAS toward compound 3 and the characteristic signal patterns
in the HSQC spectra conﬁrmed a binding mode equivalent to that
of albicidin (Supplementary Figure 16). AlbAS binding of the
enantiomeric compound 3 might be explained based on the
orientation of albicidin in the crystal structure: the side chain of L-
Cya-3 points out of the binding pocket toward the protein surface
(Fig. 5a). The surrounding helices α1′, α4, and α6 would leave
sufﬁcient space for D-Cya-3 while preserving the overall binding
mode of albicidin. These ﬁndings show that the rather ﬂexible
AlbAS tolerates structural modiﬁcations of the oligo-aromatic
scaffold of albicidin.
A connection between AlbA and transcriptional regulator
proteins has previously been suggested by Weng et al.19 and could
be corroborated by our bioinformatics analysis (Supplementary
Figure 1). The structural homology to TipAS (Fig. 5c) suggests
that AlbAS is a member of the MerR-type transcriptional reg-
ulator family. The N-terminal HTH DNA-binding domain
requires future studies on the mechanism of transcriptional reg-
ulation by AlbAL. This includes questions on how signal trans-
duction within AlbAL is triggered by albicidin binding to its drug-
binding domain. Our studies on the full-length protein AlbAL
(Supplementary Figure 5) already indicated that the binding mode
of albicidin in AlbAS is equivalent to that in AlbAL (Supple-
mentary Figure 5A and F). A major difference between the two
systems is the dimerization of AlbAL crucial for DNA binding, in
contrast to the monomeric state of AlbAS (Supplementary Fig-
ure 7). In both cases, quaternary structure is albicidin-independent
illustrating that the binding stimulus is relayed from the NTD
toward the HTH motif to trigger promoter binding and in con-
sequence the expression of, e.g., MDR transporters21.
For the TipAL system it has been suggested that the (partially)
unfolded N-terminal region in unbound TipAS becomes folded
upon thiopeptide binding. Formation of this α-helical lid (α6-α9)
stabilizes the ligand and forwards the signal to the HTH DNA-
binding domain27. Owing to the different ligand-binding sites
and the different structural organizations of the TipAS and AlbAS
N termini (Fig. 5c), the mechanisms of intramolecular signal
transduction might differ for these two systems and need to be
further investigated. Importantly, the proposed binding pathway
proceeding from the CTD toward the NTD and ﬁnally the HTH
motif may ensure a cooperative coupling between the drug-
binding stimulus and DNA binding only when the cognate ligand
is fully arrested. To avoid AlbA-mediated resistance, two cases
therefore need to be differentiated in drug development of albi-
cidin, i.e., analogs that (i) are not prone to AlbAS capture at all or
(ii) are still bound by AlbAS but do not trigger transcriptional
regulation (Supplementary Figure 18). Future studies are envi-
saged to answer these questions.
In summary, our ﬁndings contribute to a general under-
standing of resistance strategies of bacteria against antibiotics.
The knowledge on AlbA and homologous members of this
widespread class of binding proteins will be generally useful for
future antibiotic-development efforts. Depending on their phar-
macophores, potent antibiotics could be designed such that they
either completely bypass capture or that they do not trigger
regulative effects on a cellular level despite being partially arrested
by AlbA-like drug-binding proteins.
Methods
Bioinformatics. The BLAST38 was used for a protein sequence homology search
and preparation of a phylogenetic tree39. Secondary structure predictions were
performed with PSIPRED and PROMALS3D40,41.
Cloning. A codon-optimized synthetic albAS (Supplementary Table 2) coding
region (Thermo Scientiﬁc GmbH, Schwerte, Germany) was cloned into an AmpR-
pMAT vector system, using NdeI and NotI restriction enzyme sites. The plasmid
was ampliﬁed in E. coli BL21 DH5α, extracted, double digested with NdeI and NotI,
and the released fragment was cloned into expression vector pET-28a (+) for
production of AlbAS bearing an N-terminal, TEV-cleavable His6-tag. Codon-
optimized synthetic albAL (Supplementary Table 2, Thermo Scientiﬁc GmbH) was
cloned by Gibson cloning42 into an expression vector pET-28a (+) for production
of AlbAL bearing an N-terminal, TEV-cleavable His6-tag.
The amino-acid substitutions (N75A, R181A, and Q205A) in the triple variant
AlbASM as well as the substitutions for the Trp-to-Phe variants of AlbAS (W5F,
W27F, W56F, W110F, W133F, W162F, W195F, and W203F) were inserted by
Gibson assembly cloning42. To this end, one primer pair (Supplementary Table 3)
was designed to carry the point mutation in the respective base triplet and to
amplify one-half of the gene. The other primer pair ampliﬁes the remaining vector
and possesses a 16 bp overhang matching to the 3′-end of the other linear
construct. Both constructs were ligated with Taq DNA ligase (New England Biolabs
GmbH, Frankfurt am Main, Germany) after puriﬁcation with gel electrophoresis by
incubation in the Gibson mixture. The mutated plasmid was then transformed into
E. coli DH5α cells by heat shock. Transformants were selected on Luria Bertani
(LB)-agar plates supplemented with 50 μg mL−1 kanamycin and conﬁrmed later by
sequencing of the gene.
The AlbASNTD and AlbASCTD constructs were cloned using the Gibson
assembly method42 with the primer pairs listed in Supplementary Table 3. The
boundaries for the truncated AlbAS variants (AlbASNTD M1-E132 and AlbASCTD
D128-E221) were based on bioinformatic analysis before solving the AlbAS crystal
structure.
Protein synthesis and puriﬁcation of AlbAS and AlbAL. All genes including
albAS, albAL, albASM, albASNTD, albASCTD, and the Trp-to-Phe mutants were
expressed in E. coli BL21-Gold (DE3) strain (Merck Millipore, Darmstadt, Ger-
many) with the T7 promoter expression system pET-28a (+) bearing an N-
terminal TEV-cleavable His6-tag in LB medium. The expression was induced with
0.2 mM isopropyl β-D-1-thiogalactopyranoside (IPTG, Biomol, Hamburg, Ger-
many) and the cells were further incubated at 18 °C, 180 rpm for 18 h. For isotope
labeling, cells were grown in M9-minimal medium containing 15N ammonium
chloride (1 g L−1), 13C6 D-glucose (3 g L−1), and/or deuterium oxide. Cells were
harvested by centrifugation and the resuspended cell pellet (50 mM Tris-HCl, 500
mM NaCl, and 5% glycerin, pH 7.5) was lysed by one passage through a high-
pressure cell disrupter TS 0.75 KW (Constant Systems Limited, Königswinter,
Germany) at 18 000 psi and incubated with DNAse (3 U per mL lysate). Subse-
quently, cell lysates were centrifuged at 55 000 × g for 30 min to separate the cell
debris from soluble protein. The crude supernatant was ﬁltered through a 45 µm
ﬁlter membrane before loading on the puriﬁcation column. AlbAS/AlbAL pur-
iﬁcation was performed by afﬁnity chromatography on an ÄKTApuriﬁer system
(GE Healthcare, Munich, Germany) by making use of the N-terminal His6-tag
binding to a Nickel His-Trap Fast Flow Crude 1 mL column (GE Healthcare). The
washing buffer consisted of 50 mM Tris-HCl and 300 mM NaCl at pH 7.5. Then
AlbAS/AlbAL was eluted with a buffer containing 50 mM Tris-HCl, 300 mM NaCl,
and 500 mM imidazole. To remove imidazole the protein fractions were diluted
with the washing buffer and concentrated in centrifugal ﬁlter units (Merck,
Darmstadt, Germany) with a cutoff of 10 000 nominal molecular weight limit.
Cleavage of the His-tag was performed for 2 h at room temperature and 16 h at 4 °
C with the addition of 100 μM of puriﬁed TEV protease. The separation of the
protein from the cleaved His-tag was performed by a second puriﬁcation step
employing the Nickel His-Trap column as described before. Desalting and buffer
exchange was accomplished by size-exclusion chromatography on a Superdex High
Load 16/60 75 column (GE Healthcare) in the ﬁnal buffer used for NMR studies
(sodium hydrogen phosphate 50 mM and 100 mM NaCl, pH 6.8). The collected
fractions were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
and the protein concentration was determined on a nano-photometer P330
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(Implen, Munich, Germany). For long-time storage, the aliquots (0.5 mL) of pro-
tein samples were shock-frozen in liquid nitrogen and stored at −80 °C.
Selenomethionine-labeled protein was produced in 500 mL M9-minimal
medium with addition of 25 mg selenomethionine, 50 mg lysine, 50 mg threonine,
50 mg phenylalanine, 25 mg leucine, 25 mg isoleucine, and 25 mg valine shortly
bevor induction with 0.2 mM IPTG (at OD600 of 0.7–0.8). Cells were incubated at
18 °C, 180 rpm for 20 h43. Puriﬁcation was carried out as described above for wild-
type AlbAS. The ﬁnal buffer contained 50 mM Tris (pH 7.5), 100 mM NaCl, and 4
mM dithiothreitol (DTT).
Preparation of GyrBA59. The E. coli fusion protein GyrBA59, combining the full-
length GyrB and a C-terminally truncated GyrA segment (59 kDa), was cloned into
pET-28a (+) by restriction/ligation (forward and reverse primers are listed in
Supplementary Table 3) using the restriction enzyme sites NdeI and XhoI.
GyrBA59 was expressed in E. coli BL21 DE3 over 18 h at 18 °C and 250 rpm using
auto induction medium. The cells were harvested and resuspended in buffer 1A
(20 mM Tris, 150 mM NaCl, 10 mM imidazole, 10% glycerol, 2 mM DTT, EDTA-
free protease inhibitor cocktail (cOmplete, Roche), and DNase 2 U per mL lysate,
pH 8.0). After cell lysis with 14 000 psi using a high-pressure cell disrupter TS 0.75
KW (Constant Systems Limited, Königswinter, Germany) the lysate was cen-
trifuged at 50 000 × g at 4 °C for 30 min and subsequently incubated with DNAse
(2 U per mL lysate) for another 30 min at 4 °C. The protein was puriﬁed in four
steps as follows: (1) cell lysate was loaded onto a His-Trap HP column and washed
back to baseline in buffer 1B (20 mM Tris, 500 mM NaCl, 10 mM imidazole, 10%
glycerol, 2 mM DTT, and EDTA-free protease inhibitor cocktail, pH 8.0) before
being eluted with a gradient from buffer 1B into buffer 1C (20 mM Tris, 300 mM
NaCl, 300 mM imidazole, 10% glycerol, 2 mM DTT, and EDTA-free protease
inhibitor cocktail, pH 8.0) over 15 column volumes. (2) Pooled fractions were
equilibrated against buffer 1A and digested with TEV protease (1 mg per 10 mg of
protein) overnight at 4 °C to cleave the N-terminal 6x His-tag. The mixture was
loaded onto a His-Trap HP column and the tag cleavage protein was recovered
from the ﬂow through in buffer 2A (20 mM Tris, 10 mM NaCl, 5% glycerol, 2 mM
DTT, and EDTA-free protease inhibitor cocktail, pH 8.0). (3) The protein fractions
were equilibrated against buffer 2A and loaded onto a Heparin Sepharose column
to be eluted with a gradient from buffer 2A into buffer 2B (20 mM Tris, 1 M NaCl,
10% glycerol, 2 mM DTT, and EDTA-free protease inhibitor cocktail, pH 8.0) over
15 column volumes. (4) Fractions from step 3 were concentrated using a 100 kDa
cutoff ﬁlter unit, before being loaded onto a Superdex 200 HiLoad 16/60 column
(GE Healthcare) equilibrated and eluted in buffer 3A (20 mM Tris, 100 mM KCl, 1
mM DTT, and 10% glycerol, pH 8.0). The collected fractions were analyzed by
SDS-PAGE and the protein concentration was determined on a nano-photometer
P330 (Implen, Munich, Germany). Post size-exclusion fractions were pooled,
concentrated, and stored at −80 °C.
DNA cleavage assay. E. coli DNA gyrase cleavage assays were performed by
incubating 250 ng of supercoiled pBR322 plasmid DNA (Inspiralis, Norwich, UK)
with 25 nM of GyrBA59 protein in 20 µL reactions containing 35 mM Tris-HCl
(pH 8.0), 24 mM KCl, 4 mM MgCl2, 2 mM DTT, 1.8 mM spermidine, 1.4 mM
ATP, 6.5% (w/v) glycerol, and 0.1 mgmL−1 bovine serum albumin in the presence
or absence of various concentrations of albicidin (ﬁnal concentration of 5%
dimethyl sulfoxide (DMSO), incubation at 37 °C for 30 min). Linearized DNA was
released by further incubation with 0.2% (w/v) SDS and 0.1 mgmL−1 proteinase K
(Promega, Madison, USA) at 37 °C for 30 min. The reaction was stopped by
addition of 20 µL of reaction stop buffer (STEB buffer) (40% (w/v) sucrose, 100
mM Tris-HCl (pH 8.0), 10 mM EDTA, and 0.5 mgmL−1 Bromophenol Blue) and
precipitation using 30 µL of chloroform/isoamyl alcohol 24:1 (v:v). Samples were
analyzed by electrophoresis in 1% w/v agarose gel containing 0.5 mg mL−1 ethi-
dium bromide followed by photography under ultraviolet illumination.
MIC assay. The MIC assay was performed by Antiinfectives Intelligence GmbH
(Rheinbach, Germany) using internationally standardized protocols and employing
clinical isolates of K. oxytoca, K. pneumoniae, R. ornithologica, P. aeruginosa, A.
baumannii and E. cloacae.
Chemical synthesis. Synthesis protocols and analytical data have been recently
described for albicidin9, compound 18, compounds 3, 5, and 614 as well as com-
pounds 4 and 733. The coupling of the N-terminal building block and the global
deprotection of compound 2 are described in the Supplementary Methods part 1.
Thiostrepton A was purchased from Merck (Darmstadt, Germany).
Agar diffusion assay. To verify the neutralizing ability of AlbAS, AlbAL, AlbASM,
AlbASCTD, or AlbASNTD against different compounds, agar diffusion assays with
the respective compounds were performed. An overnight culture of E. coli DH5α
was diluted to an OD600 of 0.05 with 0.75% LB-agar. The protein-albicidin reaction
mixture consisted of a 1:1 mixture of 40 μM albicidin (or derivatives) with 40 μM
protein (either AlbAS or its variants AlbAL, AlbASM, AlbASNTD, and AlbASCTD).
The mixture was incubated for 20 min at room temperature in the dark. Reaction
mixtures of 30 μL were transferred in triplicates of 2 mm holes on the inoculated
agar plate. The plates were evaluated concerning growth-inhibition zone after
incubation for 18 h at 37 °C.
CD spectroscopy. For determination of the melting temperature and information
on protein-ligand stability, CD measurements were performed on a J-815 CD
spectrometer (Jasco, Groß-Umstadt, Germany). Protein samples (2.0 mM for
AlbAS and 0.2 mM for AlbAL) were saturated with 1.5-fold albicidin and diluted to
a protein concentration of 20 μM in order to ensure a ﬁnal DMSO content of only
0.05% for AlbAS and 0.5% for AlbAL. A volume of 250 μL of the reaction mixture
was transferred into a quartz cuvette with 1 mm path length. Six far-UV spectra
were accumulated in a wavelength range of 195–300 nm (203–300 nm for AlbAL)
at three different temperatures (10, 21, and 90 °C) with a scanning speed of 50 nm s
−1. For evaluation of the spectra the measured buffer blank (50 mM sodium
hydrogen phosphate and 100 mM NaCl, pH 6.8) was subtracted from the averaged
spectra. The temperature curves were recorded from 10–90 °C in 0.5 °C min−1
steps while monitoring the ellipticity at 215 nm (218 nm for ALbAL). The resulting
values were recalculated into molar ellipticity [Θ]MRW with consideration of con-
centration, path length, number of amino acids, and molecular weight of the
sample. For visualization purposes, the temperature curves of AlbAS–albicidin and
AlbAS–compound 5 in Fig. 3b, c were scaled to that of AlbAS using scaling factors
of 1.175 and 1.091, respectively. The melting temperatures of AlbAS,
AlbAS–albicidin, AlbAS–compound 5, AlbAS–compound 7, AlbAL, and
AlbAL–albicidin were determined by nonlinear regression of the measured data
using Eq. (1). In case of AlbAS–albicidin a biphasic unfolding curve was observed,
which we ascribed to the two-domain arrangement. The Tm was thus determined
by ﬁtting the second transition representing the stabilized domain/species. In all
other cases, the protein unfolding curves appeared as monophasic.














with Θ being the measured ellipticity, ΔHv:Hm denoting the van’t Hoff enthalpy at
the transition point, ΘN and mN as well as ΘU and mU deﬁning the pre-transition
and post-transition phase.
NMR spectroscopy. For binding studies with albicidin and its derivatives, each
ligand was dissolved in 100% d6-DMSO and added to 15N-labeled AlbAS or 2H,
15N-labeled AlbAL in 50 mM sodium hydrogen phosphate (pH 6.8), 150 mM NaCl
buffer (usually 0.24 mM AlbAS or AlbAL in 85% buffer, 5% d6-DMSO, and 10%
D2O) yielding a 1.5-fold excess of the ligand. After incubation for 20 min at room
temperature in the dark, the sample was centrifuged at 20 000 × g for 3 min and the
supernatant was transferred to a 5 mm NMR tube. The AlbAS blank sample
(Supplementary Figure 14) was measured in 100% buffer without addition of
ligands and DMSO. Spectra were recorded on a Bruker Avance III 700MHz NMR
spectrometer (Bruker BioSpin, Rheinstetten, Germany) with a TXI probe head.
Standard Bruker pulse sequences were used. 2D 1H-15N HSQC spectra were
recorded at 298 K with acquisition times of 90 and 22 ms for the 1H and 15N
dimension, respectively. The experiments were accumulated with ≥16 scans
depending on protein sample concentration. 2D 1H-15N TROSY spectra were
accumulated with 256 scans and acquisition times of 90 and 22 ms for the 1H and
15N dimension, respectively. Several AlbAS–albicidin samples were measured with
the same result and a representative spectrum is given for the ﬁgures in the main
manuscript and the SI. NMR experiments with AlbAS and albicidin analogs were
conducted once with accumulation of ≥16 scans depending on protein con-
centration. For alignment of HSQC and TROSY spectra, the TROSY spectrum was
corrected by 1/2 1JNH in both dimensions.
AlbAS–albicidin titration experiments were performed by means of 1H-15N
HSQC experiments. Samples were prepared similarly as in the method described
above: spectra were recorded at 303 K for AlbAS in buffer (50 mM sodium
hydrogen phosphate and 150 mM NaCl, pH 6.8) at different protein-albicidin
ratios. Albicidin was added to a 0.8 mM 15N-labeled AlbAS sample to the following
ﬁnal protein-albicidin ratios: 0.1, 0.2, 0.5, 0.8, and 1. During each titration step, the
DMSO concentration was increased and reached a ﬁnal concentration of 7.3% (v/
v). The experiment was conducted once with accumulation of 16 scans for each
titration step. The spectra were recorded with acquisition times of 90 and 20 ms in
the direct 1H and indirect 15N dimension, respectively.
For the competition experiment with the DNA gyrase construct GyrBA59, 1.7
mM ATP was incubated with 3.4 mM MgCl2 for 10 min. Subsequently, 30 µM
GyrBA59 and 3 µg supercoiled pBR322 plasmid DNA (Inspiralis) were added and
incubated for another 10 min. Finally, 30 µM 15N-labeled AlbAS were added to the
mixture followed by 30 µM albicidin (10% D2O and 5% DMSO ﬁnal
concentration). Owing to the low protein concentrations (to achieve a 1:1 ratio of
gyrase and AlbAS), a 1H-15N band-selective optimized ﬂip-angle short-transient
heteronuclear multiple quantum coherence (SOFAST HMQC)44 experiment was
performed. The 1H-15N SOFAST HMQC was recorded with 2048 scans and with
acquisition times of 45 and 38 ms for the 1H and 15N dimensions, respectively.
Measurements were performed at 303.2 K. The control experiment was performed
under the same conditions but without the addition of MgCl2, ATP, pBR322
plasmid DNA, and GyrBA59.
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For preliminary resonance assignments, three-dimensional HNCA and HNCO
experiments were performed employing 13C, 15N-AlbAS (0.8 mM) saturated with
albicidin. All NMR data were processed and analyzed with Bruker TopSpin 3.1
Software and SPARKY45.
Size-exclusion chromatography with multi-angle light scattering. SEC-MALS
experiments were performed at 18 °C in buffer containing 50 mM Tris (pH 7.5),
100 mM NaCl, and 0.02% NaN3. A sample of 225 µg of AlbAS or AlbAL (with and
without saturating amounts of albicidin) were loaded onto Superdex 75 or
Superdex 200 increase 10/300 columns (GE Healthcare) that were coupled to a
miniDAWN TREOS three-angle light-scattering detector (Wyatt Technology) in
combination with a RefractoMax520 refractive index detector. For calculation of
the molecular mass, protein concentrations were determined from the differential
refractive index with a speciﬁc refractive index increment (dn/dc) of 0.185 mL g−1.
Data were analyzed with the ASTRA 6.1.4.25 software (Wyatt Technology).
Fluorescence assay. Fluorescence quenching measurements were performed by
monitoring tryptophan ﬂuorescence of AlbAS (20 nM), AlbAL (20 nM),
AlbASNTD, and AlbASCTD (100 nM) on a FluoroMax 2 spectrometer from Horiba
(Potsdam, Germany). The excitation wavelength was set to λexc= 280 nm. Emis-
sion spectra were recorded from λem= 290–450 nm with a scanning speed of 1 nm
s−1 and an integration time of 1 s. The excitation and emission slit widths were set
to 8 and 4 nm, respectively. Proteins were solved in 50 mM sodium phosphate
buffer with 150 mM NaCl and 0.01% DMSO at pH 6.8. All measurements were
performed twice and the standard deviation is given for the Kd and the Hill factor
n. Data evaluation was performed by integration of the emission band (318–410
nm for AlbAS, 316–412 nm for AlbAL, and 319–390 nm for AlbASNTD and
AlbASCTD) for every titration step. The area under the curve (AUC) of the buffer
blank (buffer with 0.01% DMSO) was subtracted from the measured titration data.
The quenching factor was determined by subtraction of AUCs for each titration
step from the AUC of the protein in the absence of ligand. For determination of the





where [L], n, and Bmax denote the total ligand concentration, the Hill coefﬁcient,
and the maximum binding capacity of the protein, respectively. For the determi-
nation of the Kd for AlbASNTD–albicidin and AlbASCTD–albicidin as well as for
AlbAS–compound 5, the Hill coefﬁcient was constrained to n= 1 for the nonlinear
regression as the binding curve showed no cooperativity.
For the determination of the Kd for AlbAS–compound 7 the data were ﬁtted to
Eq. (3).
Y ¼
Pt½  þ L½  þ Kdð Þ 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ




where Pt is the total protein concentration.
Crystallization. Crystals of unlabeled and selenomethionine-labeled AlbAS (1.4
mM AlbAS saturated with 2.5-fold albicidin in 50 mM Tris (pH 7.5), 100 mM
NaCl, 4 mM DTT, and 5% DMSO) were obtained by the sitting-drop vapor-
diffusion method at 18 °C with a reservoir solution composed of 0.1 M Tris/HCl
(pH 8.5) and 2.0 M ammonium sulfate. For crystallization 96-well MRC plates were
used. The volume of the reservoir solution was 80 μL and the crystallization drop
contained 0.5 μL reservoir solution and 0.5 μL protein solution. Crystals had
dimensions of 200 μm× 150 μm× 50 μm and appeared within 3 days. Crystals were
cryo-protected with a solution composed of equal volumes of mother liquor and
3.4 M sodium malonate at pH 7.0 and subsequently ﬂash-cooled in liquid nitrogen.
Structure determination and reﬁnement. Synchrotron diffraction data were
collected at the beamline 14.1 and 14.2 of the MX Joint Berlin laboratory at BESSY
(Berlin, Germany) at a wavelength of 0.97949 Å and temperature of 100 K. Dif-
fraction data were processed with XDS46. Experimental phases were determined by
single anomalous dispersion with the AUTOSOL routine in PHENIX47 using
PHASER48 and SOLVE/RESOLVE49 exploiting the selenomethionine-labeled
AlbAS (Supplementary Table 1). There were 35 heavy-atom sites in the asymmetric
unit (FOM: 0.413, BAYES-CC: 60.3). An initial model of AlbAS was built with the
program AUTOSOL in PHENIX47. All dihedral angles were found in favored
(99.8%) and allowed (0.2%) regions of the Ramachandran plot. Our structure
contains no Ramachandran plot outliers. The structure was reﬁned by maximum-
likelihood restrained reﬁnement using in PHENIX, including TLS reﬁnement50.
Model adjustment and water picking was performed with COOT51. Geometrical
restraints used in the reﬁnement of albicidin were generated by using the Grade
Web Server (http://grade.globalphasing.org) that queries the Cambridge Structural
Databank with optional quantum chemical regularization. Model quality was
evaluated with MolProbity52 and the JCSG validation server53. Secondary structure
elements were assigned with DSSP54, and ALSCRIPT55 was used for secondary
structure-based sequence alignments. Figures were prepared using PyMOL56 and
channels were calculated with CAVER57.
Data availability. The atomic coordinates and structure factor amplitudes have
been deposited in the Protein Data Bank under the accession code 6ET8. Other
data are available from the corresponding author upon reasonable request.
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 Supplementary Figure 1 Sequence alignment of AlbAL with TipAL The TipAL sequence was artificially duplicated (red and orange bold 
letters) in order to match the repeat of drug-binding domains in AlbAS (black, bold letters). Regions corresponding to the N-terminal HTH 
DNA-binding domains are shown in plain letters. Start positions of AlbAS-NTD and AlbAS-CTD are indicated by arrows above and below the 
alignment, respectively. α-helices are indicated by cylinders above and below the respective amino acid sequence (black cylinders: HTH 





 Supplementary Figure 2 Phylogenetic relationship of AlbAS and sequence alignment of AlbAS and AlbBS.  A Phylogenetic relationship of 
AlbAS proteins based on a BLAST search with Klebsiella oxytoca AlbAS (red). B Sequence alignment of AlbAS and AlbBS. AlbAS secondary 
structure elements as seen in the AlbAS-albicin co-crystal structure are shown above the alignment (NTD - blue, α6 – orange, CTD – cyan, 
α6’ - red). Predicted α-helical secondary structure elements of AlbBS are shown as cylinders below the alignment. Important AlbAS-
albicidin-binding residues (triangles) are highlighted. 
 
 Supplementary Figure 3 Sequence alignments with secondary structure prediction of several AlbA homologs from selected ESKAPE 
pathogens. Predicted α-helical secondary structure elements (from PROMALS3D) are indicated by cylinders above the sequence (black 
cylinders: HTH domain, blue: AlbAS NTD, orange: α6, cyan: AlbAS CTD, red: α6’). Predicted α-helical secondary structure elements for the 
aligned MerR-family proteins are highlighted with the respective background color. Key residues are highlighted in bold letters and 
triangles. The percentage sequence identity for the aligned proteins to Klebsiella oxytoca AlbAL (100%, the protein sequence used in this 
work)  is as followed: Klebsiella oxytoca 95%, Enterobacter sp. HMSC055A11 89%, Raoultella ornithinolytica 81%, Enterobacteriaceae 80%, 
Klebsiella pneumoniae 78% and 77%, Pseudomonas aeruginosa 48%, Pseudomonas stutzeri 47% and Acinetobacter baumannii both 42%. 
 
 
 Supplementary Figure 4 Coomassie-stained SDS-PAGE of all proteins after TEV-cleavage. A AlbAS (25.9 kDa), AlbASM after TEV-cleavage 
(25.7 kDa) and AlbAL (40 kDa) after TEV-cleavage. B AlbASCTD (11.0 kDa) and AlbASNTD (15.7 kDa) after TEV cleavage. M is the protein 
standard (10 kDa to 180 kDa). 
 
 Supplementary Figure 5  Characterization of albicidin binding to AlbAL. A Agar diffusion assay with AlbAL (40 µM) and 40 μM albicidin (in 
triplicates I-III). The first plate illustrates the sample arrangement on the assay plates. Positive control with only 40 µM albicidin (+) and 
negative control with 40 µM protein in 5% DMSO and buffer (-) are shown on top. B Far-UV CD spectra of AlbAL in the absence (black) or 
presence (red) of albicidin (molar ratio 1.5: 1 albicidin:AlbAL) at 21 °C. C CD-based thermal unfolding of AlbAL in the absence (black) or 
presence (red) of albicidin. Tm values are indicated by dashed lines. D Overlay of 
2H, 15N TROSY NMR spectra of AlbAL in the absence (black) 
or presence (red) of albicidin. Dashed lines highlight the reporter region enlarged in E. F Determination of binding affinities by monitoring 
quenching of fluorescence emission of AlbAL. Non-linear regression of fluorescence quenching data yielded a Kd of 7.4  0.9 nM and a Hill 
coefficient, n, of 2.0  0.23 for the interaction of albicidin with 20 nM AlbAL. The agar diffusion assay and CD experiments were conducted 
once. The fluorescence assay was conducted twice, and the standard deviation is given for the determined Kd. For the NMR experiments, 
one purified protein sample was used and spectra accumulated with ≥ 64 scans. 
 
 Supplementary Figure 6 Assignment of Trp side-chain signals. A Sections of 1H-15N HSQC spectra showing Trp Nε-Hε resonances of AlbAS 
(black) and the eight AlbAS Trp-to-Phe mutants (red) in the presence of albicidin. Since full backbone resonance assignments were 
hampered by the molecular weight and instability of AlbAS-albicidin over several days, we attempted to assign the Trp signals by 
generating eight single Trp-to-Phe mutants (W5F, W27F, W56F, W110F, W133F, W162F, W195F, W203F), thus anticipating the loss of a 
single HSQC cross peak for each mutant. The instability of the mutants, the inherent protein dynamics and the close vicinity of Trp residues 
in the complex usually caused the loss of more than one signal for each mutant and to non-trackable chemical shift changes, which 
impeded an unambiguous assignment. However, the combined information from all spectra and the knowledge of the relative positions of 
all Trp residues in the crystal structure helped us to tentatively assign the Trp signals as shown in B. The blue spectrum shows AlbAS in the 
absence of albicidin. Dashed lines indicate ambiguity. Signals marked with an asterisk represent backbone amides identified by 3D HNCO 
and HNCA experiments, whereas Trp Hε–Nε signals were further confirmed by tryptophan-selective 2D MUSIC experiments (Standard 
Bruker pulse sequences). 
 
 Supplementary Figure 7 SEC-MALS measurements of AlbAS, AlbAS-albicidin, AlbAL and AlbAL- albicidin to determine the molecular 
mass. A AlbAS and AlbAS-albicidin form monomers in solution with molecular masses of 27.1 kDa and 27.2 kDa, respectively (theoretical 
masses of 25.8 kDa and 26.6 kDa) B Analysis of AlbAL and AlbAL-albicidin showed that the proteins form dimers in solution. The doted lines 
correspond to the average molar mass of 82.2 kDa (black) and 85.5 kDa (red) for AlbAL and AlbAL-albicidin, respectively (theoretical masses 




 Supplementary Figure 8 NMR titration experiments. A Reporter region of 1H-15N HSQC spectra of AlbAS in the absence (black) and 
presence of albicidin (red) (final DMSO concentration of 5% in both cases). B Superposition of 1D slices extracted from 1H-15N HSQC spectra 
(dashed box in A) at different albicidin/AlbAS ratios. AlbAS without compound (0.0) contains no DMSO. C Plot of the normalized peak 
integrals of the bound (red) and unbound (black) populations as a function of the molar ratio of albicidin to AlbAS. 
  
Supplementary Figure 9 Competition experiment with AlbAS and DNA gyrase construct GyrBA59. A Graphical scheme of the DNA gyrase 
with highlighted elements belonging to the artificial GyrBA59 fusion construct. B Purified GyrBA59 after TEV-cleavage (148.6 kDa) on a 
coomassie-stained SDS-PAGE. C Agarose gel-electrophoresis of the DNA-cleavage assay showing albicidin stabilizing the cleavage complex 
of E.coli GyrBA59 and pBR322 (linearized plasmid, l) over a wide range of albicidin concentrations (5 nM – 5120 nM) in presence of 1.4 mM 
ATP. Control reaction in presence of 5000 nM ciprofloxacin. rel: open nicked plasmid, l: linearized plasmid, sc: supercoiled plasmid. D 
SOFAST-HMQC of 15N-labelled AlbAS, purified GyrBA59 and albicidin with final concentrations of 30 µM each and addition of MgCl2, ATP 





Supplementary Figure 10 Electron density and B-factor representation of albicidin. A AlbAS-bound albicidin with atoms colored by B-
factors (low to high B-factors colored blue to red. B Polder electron density map of AlbAS-bound albicidin (yellow, with oxygen and 
nitrogen atoms colored red and blue, respectively) shown as a black mesh at a σ-level of 2.0. Orientation of albicidin is identical to Figure 5. 
 
 Supplementary Figure 116 Comparison of AlbAS NTD and AlbAS CTD. A Sequence alignment of the NTD (blue) and CTD (cyan). α-helical 
secondary structure elements as seen in the AlbAS-albicidin crystal structure are shown above and below the alignment as cylinders.  
Helices α6 (orange) and α6’ (red) are highlighted. Important albicidin binding residues are marked with triangles. B Structural alignment of 
AlbAS NTD (blue) and CTD (cyan) showing the binding and entrance sites of albicidin used by the two repeat units. Albicidin is shown in 
ball-and-stick representation and colored grey (for the NTD) and yellow (for the CTD). Helices α6 (orange) and α6’ (red) are highlighted. 
Different orientations are marked with arrows and rotation axis. The alignment in the left corner has the same orientation as in Figure 5B 
of the main text. 
 
 
 Supplementary Figure 12 1H-15N HSQC spectra of truncated AlbAS variants. Spectra of A AlbASNTD and B AlbASCTD are shown in black. The 




Supplementary Figure 13 Network of interactions in the albicidin binding pocket. Hydrogen bonds are illustrated as dashed lines. π-π 
stacking is highlighted with green dashed lines. Residues contributing to the hydrophobic binding tunnel are highlighted in green. 
 
 Supplementary Figure 14 Superposition of 1H-15N HSQC spectra of AlbAS with albicidin and different compounds. The first spectrum 
(same spectrum as presented in Figure 3E) shows AlbAS (black) in 95% buffer/5% DMSO, unbound- AlbAS blank in 100% buffer without 
compound (blue) and AlbAS with albicidin (red). The following spectra show AlbAS (black) with the corresponding titrated compound (red). 
AlbAS-albicidin measurements were performed on five different samples and a representative experiment is shown in the figure. The NMR 
measurements using albicidin derivatives were conducted once. 
 Supplementary Figure 15 Agar diffusion assay with different compounds. AlbAS (40 µM) with albicidin, thiostrepton A or compound 1-7 
(40 μM each) in triplicates I-III. The first plate illustrates the sample arrangement on the assay plates. Positive control with only 40 µM 
albicidin (+) and negative control with 40 µM protein in 5% DMSO and buffer (-) are shown on top. Agar diffusion assays with AlbAS-





 Supplementary Figure 16 Sections of 1H-15N HSQC downfield region of AlbAS-albicidin and derivatives. The first spectrum shows AlbAS 
(black) in 95% buffer/5% DMSO, unbound-AlbAS blank in 100% buffer without compound (blue) and AlbAS with albicidin (red). Signals 
marked with an asterisk could be assigned as backbone amides. AlbAS-albicidin measurements were conducted five times and a 
representative experiment is shown in the figure. The NMR measurements for AlbAS with derivatives were conducted once. 
 
 






Supplementary Figure 18 Model of the binding mechanism of AlbAS. In the absence of albicidin, AlbAS undergoes inherent domain-
domain motions on the micro-to-millisecond timescale. In this conformational ensemble, the N-terminal HTH domain is not competent for 
DNA binding. Upper lane: Initial anchoring of the C-terminal segment of albicidin is mediated via the CTD of AlbAS (the salt-bridge between 
R181 of AlbAS and building block F of albicidin is indicated by the charges). The subsequent binding of the NTD to the N-terminal segment 
of albicidin is highly cooperative giving an effective Kd for the entire binding process of ≤ 5.6 ± 0.2 nM. Only this mutual fixation of the NTD 
and CTD causes the HTH to adopt a DNA-binding competent state. Drug binding and transcriptional regulation of MerR-related genes are 
thus strongly coupled. Lower lane: C-terminal fragments of albicidin (here compound 5), which are still strongly captured by the CTD (Kd of 
approx. 55.5 ± 3.6 nM), do not or only inefficiently bridge the CTD and NTD. The HTH domain is thus decoupled from the drug-binding 
event and is not able to initiate transcription. Notably, in the case of AlbAL, these processes occur in a functional dimer capable of DNA 
binding after albicidin capture. 
 
 
Supplementary Table 1 Data collection, phasing and refinement statistics (SAD-SeMet). 
 SAD 
Data collection  
Space group C2221 
Cell dimensions    
    a, b, c (Å) 54.07, 123.35, 159.2 
    a, b, g  ()  90, 90, 90 
Resolution (Å) 50.00 - 1.70 (1.74 - 1.70)  
Rmeas (%) 11.9 (179.6) 
I / sI 16.53 (1.49) 
Completeness (%) 100 (100) 
Redundancy 13.50 (13.62) 
  
Refinement  
Resolution (Å) 50.00 - 1.70 (1.76 - 1.70) 
No. reflections 58928 (5818) 
Rwork / Rfree 0.177 / 0.204 
No. atoms  
    Protein 3789 
    Albicidin 124 
    Water 372 
B-factors  
    Protein 31.3 
    Albicidin 27.9 
    Water 35.4 
R.m.s deviations  
    Bond lengths (Å) 0.009 
    Bond angles () 1.02 
 
*Number of xtals for each structure should be noted in footnote. *Values in parentheses are for highest-resolution shell. 
 
[AU: Equations defining various R-values are standard and hence are no longer defined in the footnotes.]  
[AU: Phasing data should be reported in Methods section.]  
[AU: Ramachandran statistics should be in Methods section at end of Refinement subsection.] 










Supplementary Table 2 Codon optimized DNA sequences. 








































Supplementary Table 3 Oligonucleotides used for cloning. 
Oligonucleotide sequence (5’ – 3’) Name 
CTTGTATTTCCAGGGCCAATGGATCGTCTGATGGAATGGCC AlbASCTD_fw 
TCCACCAGTCATGCTAGCCATTTATTCTGCTGCCGGACCCTGTGCCT AlbASCTD_rv 













































Supplementary methods 1 Chemical synthesis and analytical data of compound 2. 
 
Synthesis of compound 2:  
To a solution of commercially available 4-(allyloxy)-benzoic acid (1.5 eq, 16 mg, 88 µmol), and 
triphosgene (0.6 eq, 11 mg, 35 µmol), dissolved in anhydrous THF (3 mL), was slowly added 2,4,6-
collidine (8 eq, 62 µL, 0.47 mmol) via syringe. After 5 minutes of stirring, a solution of the 
corresponding allyl-protected aniline pentapeptide9 (1 eq, 50 mg, 59 µmol) and DIPEA (10 eq, 100 
µL, 590 µmol), dissolved in anhydrous THF (2 mL), was added. After 16 h stirring at room 
temperature, the reaction was quenched by the addition of ice. The mixture was extracted with 
dichloromethane (3 x 20 mL). The combined organic extracts were washed with 1 N HCl (aq) 
(3 x 20 mL), sat. NaHCO3 (3 x 20 mL) and brine (1 x 20 mL), dried over Na2SO4, filtered and 
evaporated to dryness. The residue was dissolved in anhydrous THF (5 mL), and subsequently 
phenylsilane (8 eq, 58 µL, 0.47 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.4 eq, 27 mg, 
24 µmol) were added. The reaction was stirred for 16 h at room temperature under exclusion of 
light. The mixture was clarified via filtration through a 0.2 µm PTFE syringe filter and directly applied 
to a preparative RP-HPLC purification yielding compound 2 (17 mg, 21 µmol) as a white fluffy 
powder. 
Analytical data for compound 2:  
1H-NMR (500 MHz, DMSO-d6): δ (ppm) = 1.20 (d, J = 6.3 Hz, 3H), 3.78 (s, 3H), 3.91 (s, 3H), 4.15-4.24 
(m, 1H), 4.59 (dd, J = 4.8 Hz, J = 8.1 Hz, 1H), 5.08 (s, 1H), 6.88 (d, J = 8.6 Hz, 2H), 7.56-7.62 (m, 2H), 
7.80 (t, J = 8.5 Hz, 3H), 7.86-7.95 (m, 8H), 7.97 (d, J = 8.6 Hz, 2H), 8.04 (d, J = 8.9 Hz, 1H), 8.08 (d, 
J = 8.1 Hz, 1H), 9.66 (s, 1H), 10.16 (s, 1H), 10.22 (s, 1H), 10.37 (s, 1H), 11.16 (s, 1H), 11.53 (s, 1H). 
HRMS (APCI): m/z calc. for C41H37N5O13 [M-H]
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mediates, the proteins’ structural dynamics and enzyme:substrate interactions during TPS
catalysis remain elusive. Here, we present the structure of the diterpene synthase CotB2, in
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diphosphate. We captured additional snapshots of the reaction to gain an overview of
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towards tailored terpene macrocycles that are inaccessible by conventional chemical
synthesis.
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The intense structural diversity of terpenes is the molecularbasis of diverse bioactivities, which render these com-pounds as development leads in the chemical, biotechno-
logical, food and pharmaceutical industry1,2. Most terpenes
constitute a macrocyclic core skeleton3, which is generated by
cyclisation of aliphatic oligo-prenyl diphosphates3. This reaction
is catalysed by terpene synthases (TPSs). By contrast, chemically
mimicking TPS reactions to generate tailored terpene-type mac-
rocycles can be considered in its infancy, although promising
directions have been proposed4–9. During the cyclisation event,
the acyclic precursor has to be brought into a deﬁned con-
formation that positions the leaving diphosphate group and the
reactive alkene entities in proximity to initiate C–C bond forming
reactions. Moreover, the substrate environment has to stabilise
several propagating carbocations, to adjust to conformational
changes of the substrate as well as assist in intramolecular atom
transfer reactions, such as hydride or proton transfers and carbon
shifts. Such enzyme guidance is necessary to control the reaction
intermediates, although the inherent reactivity of carbocations is
also an important component in terpene biocatalysis10. In addi-
tion to the complex processes in the enzyme’s active site, global
effects such as dynamic structural changes of the protein scaffold
and inter-protein interactions during catalysis are poorly under-
stood. A detailed understanding of dynamic, biochemical and
structural effects during catalysis would ultimately enable rational
engineering of this enzyme family. This capacity would be a game
changing advantage in structure-activity-relation studies of
biologically relevant terpenes as even subtle structural modiﬁca-
tions such as the additions of methyl groups to the native sub-
strate (e.g., the “magic methyl effect”)11 or a simple H/D
exchange may have a profound inﬂuence on the biological
activity.
To elucidate the dynamic interactions of TPSs with their
substrates during catalysis, we investigated the bacterial diterpene
synthase CotB2 as a model system. This enzyme catalyses the
cyclisation of the universal diterpene precursor E,E,E-ger-
anylgeranyl diphosphate (GGDP) to cyclooctat-9-en-7-ol
(Fig. 1a), which is subsequently elaborated to the bioactive
compound cyclooctatin12. Cyclooctatin is a next-generation anti-
inﬂammatory drug targeting a lysophospholipase that is upre-
gulated in eosinophilic leucocytes rather than a cyclooxygenase
inhibited by ibuprofen or aspirin13. The CotB2 protein sequence
exhibits a modiﬁed aspartate-rich DDXD motif12 deviating from
the conventional DDXXD motif and the NSE triad NDXXSXX(R,
K)(E,D) as found in bacteria and fungi3,14, that is altered to a
DTE triad in plants. Both motifs are involved in binding a con-
served Mg2+ triad that is indispensable for precise GGDP
orientation in the active site. Upon substrate and Mg2+ binding,
TPSs undergo a discrete conformational change from an open,
catalytically inactive one to a catalytically active closed con-
formation. Even though the active site cavity is already product-
shaped in the open conformation, closure, accompanied by
translation and rotation of secondary structure elements, is



















































































Fig. 1 Enzymatic reaction and the structure of the closed state of CotB2, revealing the importance of its C-terminus. a The linear substrate geranylgeranyl
diphosphate (GGDP) is cyclised by CotB2 to a fusicoccane, with a 5-8-5 fused ring system, which is subsequently elaborated to the bioactive compound
cyclooctatin by two cytochrome P450 enzymes CotB3 and CotB4, respectively. b 2-ﬂuorogeranylgeranyl diphosphate (FGGDP) is converted to 2-ﬂuoro-
3,17,18-dolabellatriene (F-Dola). The ﬂuorinated position of the substrate-analogue FGGPP is indicated by a light blue circle. c View into the active site of
CotB2wt•Mg2+3•F-Dola. CotB2 is shown in cartoon representation coloured in light brown. The bound intermediate is shown in magenta and Mg2+-ions
are shown in green. Folding of the C-terminus (purple) leads to the formation of several hydrogen bonds (dashed lines), allowing for sensing of the
different catalytically important motives. d Structural superposition of CotB2wt (open), shown in teal, and CotB2•Mg2+3•F-Dola (closed), shown in
light brown. e GC/MS spectrum to monitor product formation by CotB2wt (black) and CotB2ΔC (red). Deletion of the C-terminus results in an inactive
enzyme
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diphosphate moiety, a reaction mechanism characteristic for class
I TPSs, generating a highly reactive, unstable carbocation15. This
initial carbocation propagates intramolecular cyclisation, which is
guided by amino acids lining the active site, where π-cation and
other electrostatic interactions drive the carbocation through an
enzyme-speciﬁc reaction cycle. The cyclisation cascade is termi-
nated by lining amino acids mediated deprotonation or addition
of a water molecule to the ﬁnal carbocation 3,16.
Delineating interactions of lining amino acids with the sub-
strate along the entire reaction trajectory is fundamental to
understand the complexity of TPS catalysis. This information can
be reliably obtained by an interdisciplinary approach combining
biochemical, structural biology, computational and biocatalytic
studies.
In 2014, we reported the ﬁrst crystal structure of CotB2 in its
open, inactive conformation without substrate. CotB2 adopts an
α-helical bundle fold that is conserved among class I TPSs (PDB-
ID 4OMG17). Single point mutations within the active site lead to
pronounced structural product diversity (Supplementary Table 1
and Figs. 1, 2)17–19.
Here, we report cumulative data that provide signiﬁcant
insights into the chemical mechanisms that constitute the cata-
lytic conversion of GGDP to cyclooctat-9-en-7-ol. Remarkably,
even though structural information of TPSs bound to a product
or different substrate analogues as well as Mg2+ have been
reported, a complete in crystallo cyclised product has not yet been
observed, demonstrating that the previously reported substrate
analogues were either not correctly positioned in the active site or
catalytically inactive due to chemical modiﬁcations.
Results
Comparison of the open and closed structure of CotB2. In this
study, we intended to probe the structural dynamics of the
CotB2 reaction using X-ray crystallography of the catalytically
relevant protein states in the presence of a substrate-analogue.
Remarkably, we could capture the closed conformation of CotB2
by co-crystallisation with the substrate-analogue 2-ﬂuoro
GGDP (FGGDP) and determined the crystal structure at 1.8 Å
(CotB2wt•Mg2+3•F-Dola (2-ﬂuoro-3,7,18-dolabellatriene); Figs. 1c,
d, 2a, Supplementary Table 2). FGGDP is functionalised with a
ﬂuorine atom at the C2 position of its hydrophobic tail (Fig. 1b)
that interferes with the propagation of the generated carbocation
(s). A direct comparison of the open and closed conformation is
possible, since our crystals are isomorphous. The overall structure
of the open and closed conformation reveals signiﬁcant differences.
Substrate binding induces a translation and rotation of α-helices B,
C, D, F and H towards the active site (Fig. 1d) to accurately
position the DDXD Mg2+ binding motif and to bring the active
site into product-shaped conformation. Upon binding of FGGDP
the 12 C-terminal residues are structured to fold over the active
site, resulting in the fully active and closed conformation (Fig. 1c,
d). Surprisingly, we did not observe the entire FGGDP molecule.
Instead, we detected clearly resolved electron density for a single
diphosphate moiety and for a ring-like structure positioned in the
active site that we interpret as the reaction intermediate 2-ﬂuoro-
3,7,18-dolabellatriene (F-Dola; Figs. 1b–d, 2a and Supplementary
Fig. 3).
With the native substrate GGDP such in crystallo snapshots
would not be feasible due to the highly unstable nature of the
carbocation intermediates. Most likely the ﬂuorinated substrate
alters propagation of the carbocation and hence we do not
observe the native product. The possibility of cyclisation reactions
of ﬂuorinated substrates has been demonstrated for 2-
ﬂuorofarnesyl diphosphate20,21. To our knowledge such a crystal
structure with a trapped intermediate has never been described
before for other TPSs crystallised in presence of isoprene
substrates. In these reported structures, the diphosphate is bound,
but not cleaved off and consequently no cyclisation reaction has
occurred (Supplementary Discussion).
The diphosphate is coordinated by three Mg2+-ions with
Mg2+B bound to the NSE motif and Mg2+A and Mg2+C being
coordinated by D110 of the non-canonical DDXD motif
(Fig. 2a and Supplementary Discussion and Supplementary
Fig. 11). Additionally, active site residues R227 and R294 make
contact with the oxygen atoms of the diphosphate moiety to
compensate its negative charge. Upon binding of Mg2+A and
Mg2+C, D110 stretches out towards the active site, causing
helix D movement thereby reducing the volume of the active
site and trapping of the substrate. Moreover, this helix D
movement positions the C-terminus for folding over the active
site to shield it from bulk solvent. The closure by the C-
terminus is initiated by formation of a salt-bridge between
D111 and R294. In our previous studies we showed that D111E
is an inactive mutant17. With our current data set, we can now
explain this observation with the exchange at position 111 that
disturbs the salt-bridge formation emphasising its catalytic
relevance. Additionally, Y295 establishes hydrogen bonds to
the diphosphate moiety derived from FGGDP as well as to
N220 of the NSE motif. The latter RY-pair (R294/Y295) has
been previously described for other TPSs22. Folding of the C-
terminus is completed by formation of a short anti-parallel β-
strand at the end of the C-terminus (Fig. 1c). Folding over of
the C-terminus does not seem to be driven by strong ionic


































Fig. 2 Structural comparison of different catalytic states of CotB2. Residues of the DDXD motif are labelled with red letters, residues of the NSE/DTE motif
with yellow letters, respectively. Water molecules are depicted as red spheres. Hydrogen bonds are indicated by dashed lines. a Catalytic centre of
CotB2wt•Mg2+3•F-Dola. Mg2+-ions are depicted as green spheres. Solid lines represent the coordination sphere of the Mg2+-ions. b Comparison of
CotB2wt•Mg2+3•F-Dola shown in magenta and CotB2wt•Mg2+B•GGSDP shown in cyan. c Comparison of CotB2F107A•Mg2+B shown in pale purple and
CotB2wt•Mg2+B•F-Dola shown in cyan
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To verify that the full closure of the active site and the folded
C-terminus is not due to crystal contacts, we crystallised CotB2
with (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate (alen-
dronate (AHD); Supplementary Table 2), a compound that
mimics the diphosphate group of GGDP. The CotB2wt•Mg2
+
3•AHD structure has the same overall structure and active site
architecture as described for CotB2wt•Mg2+3•F-Dola, but crystal-
lised in a different space group and clearly demonstrates that the
folded C-terminus is not a crystallographic artefact caused by
crystal contacts (Supplementary Fig. 4).
Importance of C-terminal region. In order to biochemically
conﬁrm the importance of the entire C-terminal region for cat-
alysis, we generated a C-terminal truncation of CotB2 terminating
at R294 (CotB2ΔC). CotB2ΔC lacks the last 12 C-terminal resi-
dues, corresponding to the lid as observed in the structure of
CotB2wt•Mg2+3•F-Dola and CotB2wt•Mg2+3•AHD. Indeed,
CotB2ΔC was an inactive mutant, not capable of catalysis as
shown by GC/MS (Fig. 1e). Co-crystallisation of CotB2ΔC with
FGGDP resulted in the open-state conformation with no sub-
strate bound (Supplementary Table 2). Additionally, this data
provides further evidence that the salt-bridge between D111 and
R294 is not sufﬁcient to fully close the active site. Interestingly,
there are two Mg2+-ions bound in the CotB2ΔC structure. One
is fully occupied Mg2+B and the other one is partially occupied
Mg2+C, which can only be fully occupied if properly coordinated
by the DDXD motif upon substrate binding and the accom-
panying conformational changes of the active site.
Closure of the active site seems to be an essential process in
TPS catalysis. The implementation, however, appears to be very
speciﬁc for each individual enzyme class. In several sesquiterpene
synthases unstructured loop regions become ordered upon ligand
binding, initiating active site closure23,24. In case of the plant-
derived bornyl diphosphate synthase, a monoterpene synthase,
the N-terminus together with a loop segment close the active site,
and the enzyme was co-crystallised with the ﬁnal product bornyl
diphosphate25. By contrast, in the structure of the sesquiterpene
aristolochene synthase from a fungus it is merely a loop segment
that closes the active site26. Interestingly, molecular dynamic
(MD) simulations of the closed state of the plant derived
taxadiene synthase indicated that the N-terminus might be
involved in closure of the active site27,28. Therefore, the
mechanism of active site closure may be very speciﬁc to the
reaction type and taxonomic origin of the respective TPS.
Given the importance of the C-terminus of CotB2 for catalysis,
we screened the PDB for other diterpene synthases for which
structural information for the open and closed conformation is
available and which are structurally most related according to a
DALI search29 (Supplementary Table 3). In the closed structure
of the labdane-related diterpene synthase (PDB-ID 5A0K) its C-
terminus is folded as well. The RY-pair (Supplementary Fig. 5) is
at the same position and engaging identical interactions with the
diphosphate. Analysing protein sequences of other bacterial
diterpene synthases for the presence of the RY-pair22 and their
ﬂanking regions, we found a conserved tryptophan six amino
acids upstream. Therefore, we suggest, that the WXXXXXRY (“X”
any amino acid) motif is relevant for other diterpene synthases
(Supplementary Fig. 5). If the tryptophan of latter motif is
exchanged in CotB2 for glycine (W288G), the product becomes
3,7,18-dolabellatriene (Supplementary Table 1 and Supplemen-
tary Fig. 2)17. In this study, we introduced the less stereochem-
cially demanding W288F mutation, which reduced CotB2’s
activity, but did not change the product proﬁle. Thus, the
aromatic character of the amino acid at position 288 in CotB2 is
important for product formation and any drastic exchange to a
non-aromatic side chain does interfere with the propagation of
the carbocation. In the bacterial sesquiterpene synthase pentale-
nene synthase the corresponding mutation W308F leds to a
product mixture30. However, in the plant-derived epi-aristolo-
chene synthase mutations of W273 resulted in total loss of
enzymatic function23. Therefore, tryptophan residues at this
strategic position within the active site are of general importance
in TPS to guide product formation.
Pre-catalytic states of CotB2. Very recently, Tomita et al. pub-
lished a co-crystal structure of CotB2 bound to the inert
substrate-analogue geranylgeranyl thiodiphosphate (GGSDP)
(CotB2wt•Mg2+B•GGSDP, PDB-ID 5GUE19), which was descri-
bed as representing the closed state of CotB2. Surprisingly, the
diphosphate moiety of GGSDP is coordinated merely by a single
magnesium-ion (Mg2+B; Fig. 2c), in contradiction to the accepted
principle of a trinuclear magnesium cluster required for catalysis.
Notably, beside the two missing Mg2+, even though the salt-
bridge between D111 of the DDXD motif and R294 is present
(Supplementary Fig. 6b), the remaining C-terminus could not be
resolved19. From our point of view this indicates that the struc-
ture of CotB2wt•Mg2+B•GGSDP represents rather a pre-catalytic
state of the enzyme reﬂecting a snapshot from the open to the
fully closed conformation (Supplementay Discussion).
To comprehend the state of the CotB2wt•Mg2+B•GGSDP
structure, we determined the structure of CotB2F107A under a
Mg2+-rich condition (CotB2F107A•Mg2+B; Supplementary
Table 2). Interestingly, a single magnesium-ion (Mg2+B) was
bound to the active site, coordinated by the residues N220, S224
and E228 of the NSE motif and two water molecules (Fig. 2c and
Supplementary Fig. 6a). It has been proposed for the sesquiter-
pene synthase aristolochene synthase, that Mg2+B only binds the
active site after the ligand has entered31. However, this does not
seem to be the case for CotB2. Therefore, we suggest the binding
of Mg2+B to be the ﬁrst step in preparing CotB2 for substrate
binding.
The position of the Mg2+B matches perfectly with that in the
CotB2wt•Mg2+B•GGSDP structure (Fig. 2c). Moreover, the
conformation of the Mg2+B coordinating amino acids are
oriented in the same manner as there are two water molecules
in our structure that mimic the oxygens of the diphosphate group
in CotB2wt•Mg2+B•GGSDP (Fig. 2b and Supplementary Fig. 6b).
In the structure of CotB2F107A•Mg2+B the salt-bridge of D111
and R294 has not yet been established (Supplementary Fig. 6a)
and the remaining C-terminus could not be resolved. This
suggests, that the accurate positioning of the diphosphate moiety
is required for the formation of the latter salt-bridge. The overall
structure of CotB2wt•Mg2+B•GGSDP is most similar to CotB2wt
and CotB2F107A•Mg2+B as indicated by a low root-mean-square
deviation (Supplementary Table 4). Hence, the structures are
likely different pre-catalytic states of CotB2.
CotB2 mechanism and structure-function dynamics. The in
crystallo capture of the reaction intermediate F-Dola provides a
static snapshot along the reaction coordinate in CotB2 (Fig. 3a).
The mechanism in CotB2 has previously been delineated
experimentally by Meguro et al. and Sato et al., and theoretically
by Hong and Tantillo32–34. To explain mechanistic details of the
entire catalytic cascade, we turned to in silico multiscale model-
ling. Modelling of the CotB2 reaction commenced with the bound
3,7,18-dolabellatriene (Figs. 3b, 4). Due to the high resolution of
the crystal structure that captured CotB2 in a fully closed, cata-
lytically competent state, QM/MM modelling yielded insight into
the possible role of the enzyme in stabilising the reaction inter-
mediates. We generated all-trans GGDP in a pre-folded
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conformation, ready for catalysis, as well as all intermediate steps
until the ﬁnal carbocation. In the initial pre-folded GGDP state,
the C1–C11 distance is 3.9 Å and the C10–C14 distance is 3.3 Å
(Fig. 4). Following initial C–O cleavage and presumably concerted
C1–C11 and C10–C14 bond formations, dolabellatrienyl cation
(A) is formed, with the cation at C15 being stabilised by π-cation
interactions with W186 (distance 4.6 Å; Fig. 4). The cation dis-
locates to C8 via a 1,5-hydride transfer reaction to yield cation B,
as shown by deuterium labelling32, with the cation being stabi-
lised by an oxygen hole formed by N103 (OD1), N103 (O) and
T106 (OG1) (Fig. 4).
The carbocation intermediate B then undergoes ring-closure
via C2–C6 bond formation to yield cation C, with the cation
located at C3 where it is stabilised by π-cation interactions, as it is
sandwiched between F107 and F149 (Fig. 4). Further stabilisation
is likely provided by additional electrostatic interactions, as the
cation migrates towards the diphosphate moiety during the B→C
transformation step. Subsequently, a proposed 1,3-hydride
transfer takes place to generate cation E. However, Hong and
Tantillo34 suggested that a series of two 1,2-hydride transfers
would be energetically favoured in the gas-phase. Based on the
modelled intermediate states in this study, there seems to be
signiﬁcant steric hindrance to a direct 1,3-hydride transfer.
Therefore, two sequential 1,2-hydride transfers to provide
intermediate E appear plausible (Fig. 3b). Identical two 1,2-
hydride shifts were also experimentally reported for tsukubadiene
synthase35. As suggested34, these different mechanistic possibi-





































































































































































































Fig. 4 Mechanistic model of initial and intermediate states of CotB2. The ﬁgure shows mechanistic steps corresponding to those in Fig. 3b. The models
were obtained from QM/MM simulations. The dashed yellow lines indicate interactions between the intermediate cation and CotB2
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et al33. In intermediate E, the cation is stabilised by F107 and the
backbone carbonyl of I181 (distance 4.2 Å; Fig. 4). The following
step involves another 1,5-hydride transfer to give carbocation G,
as shown by deuterium labelling32, with the cation located at C10,
which is partly stabilised by N285 (distance 5.4 Å) and W186
(C10–W186 distance 5.3 Å; Fig. 4). A subsequent ring-closure
generates a propyl-ring in intermediate H, while moving the
cation to C7, which is stabilised by N103 (OD1), N103 (O) and
T106 (OG1) (distances 3.9, 5.6, and 5.0 Å respectively; Fig. 4).
The subsequent step entails a 1,3-alkyl shift to yield I, as
established by 13C isotope labelling32, which moves the cation
back to C10 (C10–N285 distance 4.7 Å, C10–W186 distance 5.8
Å), and shifts the cyclopropyl moiety along the central octa-cyclic
ring (Fig. 4). Mutation of this residue to W186H results in
formation of 3,7,18-dolabellatriene19. This is conceptually very
similar to the taxadiene synthase W753H mutation, which yields
(−)-(R)-cembrene A27. The approximate energetic contribution
of the above-discussed interactions between active site moieties
and the carbocation intermediates were quantiﬁed using density-
functional theory cluster calculations (Supplementary Tables 6
and 7). Inspection of these interaction energies clearly show that
the enzyme stabilises the evolving carbocations, with values
between ca. −10 and −20 kcal/mol. The reaction concludes with
attack by a water molecule at position C7, followed by
deprotonation, to give the ﬁnal product cyclocotat-9-en-7-ol. A
potential hydroxylating water molecule was not observed in the
crystal structure. But based on the current mechanistic model, it
could be located between N103 (OD1), N103 (O) and T106
(OG1). The role of Asn in binding hydroxylating water molecules
has been stressed in the context of 1,8-cineole synthase36. The
above mechanistic model suggests that the CotB2 active site
architecture has evolved to chaperone the changing cation
along the entire reaction coordinate. Future QM/MM calculations
will address the complete free energy surface for the CotB2
catalysed reaction. We note that the role of the enzyme
environment in guiding the carbocations along the reaction
coordinate is in line with our earlier work37–39 and that of Peters
and co-workers40,41.
Discussion
Co-crystallising CotB2 with FGGDP enabled us to capture an
intermediate state of the reaction mechanism. In combination
with structural and biochemical data we could point out the
importance of the properly folded C-terminus for the enzymatic
activity. Our ﬁndings allowed us to propose a complete catalytic
mechanism of CotB2 at a structural level by combining crystal-
lography, biochemical tools and theoretical modelling (Supple-
mentary Fig. 7). The enzyme mechanistic cascade commences
with Mg2+B binding to the NSE motif, although this binding
event is not accompanied by any conformational changes of the
main structural core of CotB2. Subsequently, the substrate binds
with its diphosphate moiety to Mg2+B. This binding event
induces the formation of the salt-bridge between D111 and R294.
Binding of the ions Mg2+A and Mg2+C to the diphosphate moiety
of the substrate causes the largest conformational change in the
enzyme, including rigid helix motion, which reduces the active
site volume, and assures proper coordination of the substrate. At
this point, the complete C-terminus can fold over the active site,
thereby establishing a hydrogen network between the two cata-
lytic motifs, and shields the active site from bulk solvent. Once all
the pre-catalytic binding events and conformational changes are
established, GGDP is correctly positioned to subsequently
undergo cyclisation, which in the case of FGGDP results in
premature quenching of the cyclisation reaction, as shown by the
co-crystallisation of CotB2 with FGGDP. The closure of the C-
terminus is the ﬁnal trigger that initiates the chemical reaction
cascade in CotB2, and possibly in additional class I TPSs.
Using theoretical modelling, we modelled the reaction using
the natural substrate, GGDP. Importantly, based on in silico
multiscale modelling we conclude that the three-dimensional
active site architecture is such that the evolving carbocation is
stabilised by precisely positioned amino acids and the bound
diphosphate at each stage of the reaction cascade. Product release
is possibly facilitated by the opening/unfolding of the C-terminus,
which is entropically favourable, and might be the ﬁrst stage in
active site opening and release of the ﬁnal product.
In summary, the cumulative experimental data, in conjunction
with computational simulations, clearly demonstrate an active
role of the protein scaffold in guiding the carbocation driven
reaction towards a deﬁnitive end product. In line with our direct
crystal structure evidence, there is mounting indirect evidence
that the enzyme plays a crucial role in: binding the substrate,
folding the substrate, selectively stabilising highly reactive car-
bocations to guide the reaction cascade towards the desired
product and ﬁnally deprotonate or hydroxylate the ﬁnal product
by careful positioning of active site moieties. Therefore, the data
delineated from the abrupt product trapped in the closed
CotB2 structure provide fundamental advance in the under-
standing of TPS structural dynamics during catalysis.
Moreover, we identiﬁed universal structural features, which
can be exploited for rational engineering of other bacterial TPS
towards tailor-made terpene macrocycles. This information will
pave the way for future semi-synthetic drug development stra-
tegies. The proof of concept for this strategy has already been well
documented42. With respect to CotB2, site-directed mutagenesis
of plasticity residues in the active site altered the enzymes product
portfolio, which strongly argues for an active involvement of the
protein scaffold in guiding the catalytic transformation of car-
bocations into distinct products17. The CotB2 mutation F107A
afforded cembrene A as a product. The cembrene-type diterpenes
display diverse bioactivities, including cytotoxic, insect deterrent
and antimicrobial. Relevant work on insecticidal cembrenes has
recently been reported43. Similarly, the single mutation of W288G
alters to product to (1R,3E,7E,11S,12S)−3,7,18-dolabellatriene. Its
structure has been reported to have potential antibiotic activity
against multidrug-resistant Staphylococcus aureus. However, most
of the targeted mutagenesis strategies were designed based on the
open, non-catalytically active CotB2 structure. Therefore, the
catalytic relevance of targeted amino acids in the active site could
not be predicted, which often leads to generation of non-
productive mutants. Moreover, one could not predict the struc-
ture of the cyclisation product. On the basis of our current model
with a catalytically relevant intermediate in the active site it is
feasible to trace and predict productive mutations. Furthermore,
future expansion of our data to other TPSs may also enable
prediction of the resulting terpene cyclisation product when
targeting a speciﬁc amino acid residue(s).
Methods
Cloning. DNA manipulations and cloning procedures were performed according to
standard protocols (Supplementary Methods). Nucleotide sequences of all primers
used in this study are summarised in Supplementary Table 5.
Protein expression and puriﬁcation. CotB2wt and CotB2F107A fused to a C-
terminal hexa-histidine-tag in a pET-24a vector were expressed in Escherichia coli
Rosetta2 DE3 cells. Cells were harvested by centrifugation (6 min, 6000 rev min−1
at 4 °C) and resuspended in buffer A (50 mM Tris/HCl pH 7.5, 500 mM NaCl, 5
mM MgCl2, 1 mM DTT). The cells were lysed by homogenisation and the lysate
was cleared by centrifugation (1 h, 21,000 rev min−1 at 4 °C). Puriﬁcation included
Ni2+–NTA afﬁnity chromatography (elution in a linear gradient to buffer A
containing 500 mM imidazole) and subsequent size-exclusion chromatography in
buffer B (20 mM Tris/HCl pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT)17,18.
CotB2ΔCter in pETM-11 was puriﬁed as CotB2wt except for an additional
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proteolytic step after Ni2+-NTA afﬁnity chromatography. The amino-terminal
His6-tag of CotB2ΔCter was cleaved overnight by tobacco etch virus protease while
dialysing in buffer B.
Crystallisation. CotB2F107A was concentrated to 28 mg/ml as measured by the
absorbance at 280 nm. Crystals were obtained by the sitting-drop vapour-diffusion
method at 18 °C with a reservoir solution composed of 17.5% (v/v) polyethylene
glycol 4000, 100 mM Tris/HCl at pH 8.5 and 100 mM MgCl2. For co-crystallisation
experiments, CotB2wt was concentrated to 20 mg/ml and incubated in a ﬁvefold
molar excess of FGGDP for 30 min on ice. Crystals were obtained by the sitting-
drop vapour-diffusion method at 18 °C with a reservoir solution composed of 30%
(v/v) polyethylene glycol 400, 100 mM HEPES/NaOH at pH 7.5 and 200 mM
MgCl2. CotB2ΔCter was concentrated to 27.9 mg/ml and incubated in a 15-fold
molar excess of FGGDP for 30 min on ice. Crystals were obtained by the sitting-
drop vapour-diffusion method at 18 °C with a reservoir solution composed of 16%
(v/v) polyethylene glycol 4000, 100 mM Tris/HCl at pH 8.5 and 100 mM MgCl2.
For co-crystallisation experiments with alendronate (Alfa Aesar, Germany),
CotB2wt was incubated in a twofold molar excess for 30 min on ice. Crystals were
obtained by the sitting-drop vapour-diffusion method at 18 °C with a reservoir
solution composed of 26% (v/v) polyethylene glycol 4000, 100 mM Tris/HCl at pH
8.5 and 150 mM MgCl2. All crystals were cryo-protected with 25% (v/v) 2-methyl-
2,4-pentanediol supplemented to the reservoir resolution and subsequently ﬂash-
cooled in liquid nitrogen.
Structure determination and reﬁnement. Synchrotron diffraction data were
collected at the beamline 14.2 of the MX Joint Berlin laboratory at BESSY II (Berlin,
Germany) and beamline P14 or beamline P11 of PETRA III (Deutsches Elektronen
Synchrotron, Hamburg, Germany) at 100 K and wavelengths as followed: 0.9184 Å
(CotB2wt•Mg2+3•F-Dola and CotB2wt•Mg2+3•AHD), 1.0332 Å (CotB2ΔC•Mg2+B)
and 0.9763 Å (CotB2F107A•Mg2+B). Diffraction data were processed with XDS44
(Supplementary Table 2). The structures were determined by molecular replace-
ment with the coordinates of CotB2wt (PDB-ID: 4OMG17) as search model using
PHASER45. The structure was reﬁned by maximum-likelihood restrained reﬁne-
ment in PHENIX46,47. Model building and water picking was performed with
COOT. Geometrical restraints, used in the reﬁnement of the ﬂuorinated inter-
mediate, were generated by using the PRODRG Web Server or ELBOW48. Model
quality was evaluated with MolProbity49 and the JCSG validation server (JCSG
Quality Control Check v3.1). Secondary structure elements were assigned with
DSSP50. Figures were prepared using PyMOL51. The Ramachandran plot shows
that 98.64% (CotB2wt•Mg2+3•F-Dola), 98.43% (CotB2wt•Mg2+3•AHD), 98.73%
(CotB2ΔC•Mg2+B) and 99.64% (CotB2F107A•Mg2+B) of all residues are in favoured
regions. The MolProbity Clashcores are 5.48 (CotB2wt•Mg2+3•F-Dola), 4.57
(CotB2wt•Mg2+3•AHD), 3.03 (CotB2ΔC•Mg2+B) and 2.87 (CotB2F107A•Mg2+B).
Computational modelling. The modelling commenced with construction of cation
A based on 2-F-3,7,18-dolabellatriene trapped during crystallisation of FGGDP in
CotB2 (monomer A of PDB-ID 6GGI). The substrate GGDP was then constructed
by performing the reverse reaction in silico16. Hydrogen atoms were added using
the HBUILD facility of CHARMM. Subsequently, the enzyme was soaked in a pre-
equilibrated TIP3P water52 box of size about 80 × 80 × 80 Å3, and the effect of ionic
buffer environment and system charge neutralisation was accounted for by addi-
tion of 29 Na+ and 20 Cl− ions53. Subsequently, we relaxed the system by per-
forming step-wise energy minimisation, followed by MD simulations. The MD
simulations entailed a 25 ps heating period up to 298 K followed by 5 ns of equi-
libration. During the ﬁrst 1 ns of the equilibration simulations, weak harmonic
restraints (1 kcal/mol Å2) were imposed on the backbone Cα atoms (residues
24–290), as well as nuclear Overhauser effect (NOE) restraints on selected
hydrogen bonds in the protein and between the protein and cofactor diphosphate
and Mg2+ ions. The MD heating was performed in the NVT ensemble, while
equilibration was performed in the NPT ensemble54. Long-range electrostatics
were treated via particle-mesh Ewald summation.
Following MD equilibration, we performed hybrid QM/MM energy
minimisations on the complete system, with the QM region deﬁned as GGDP and
the three Mg2+ ions. Employing a combination of NOE restraints and general
distance restraints, we generated the following cations along the reaction
pathway34: A, B, C, E, G, H and I (Figs. 3b, 4). All MM calculations used the
CHARMM protein34 and nucleic acid force ﬁelds55, in conjunction with
parameters for GGDP56, while QM/MM calculations57 employed the SCCDFTB
method58 for the QM region. All simulations used the CHARMM simulations
programme 59.
Synthesis of isprenoid ligand. Detailed experimental procedures are provided in
the Supplementary Methods. Intermediate reactions steps and the ﬁnal product
were characterised by 1H-NMR (Supplementary Table 8A), 13C-NMR (Supple-
mentary Table 8B),19F-NMR (Supplementary Table 9A) and 31P-NMR (Supple-
mentary Table 9B). The precise molecular weight was conﬁrmed by mass
spectrometry (Supplementary Table 10).
Data availability
The atomic coordinates have been deposited in the Protein Data Bank with the accession
code 6GGI (CotB2wt•Mg2+3•F-Dola), 6GGJ (CotB2wt•Mg2+3•AHD), 6GGK
(CotB2ΔC•Mg2+B) and 6GGL (CotB2F107A•Mg2+B). Other data are available from the
corresponding author upon reasonable request.
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Towards a comprehensive understanding of the structural dynamics of a 
bacterial diterpene synthase during catalysis 






FGGDP co-crystallized with other TPSs 
FGGDP has previously been co-crystallised with taxadiene synthase (TXS; PDB-ID 3P5R ref1), where 
FGGDP is bound in the active site with its diphosphate group still attached to the aliphatic tail. The 
reported TXS construct however was N-terminally truncated, stalling the enzyme in the catalytically 
inactive open conformation. Therefore, the mere binding of the substrate to the open TXS structure 
does not promote the complete closure of the active site. Consequently, FGGPP is not correctly 
positioned and cannot undergo cyclisation. 
The non-canonical DDXD motif in comparison to other TPSs with the canonical DDXXD motif  
The amino acid sequence of CotB2 shows an unconventional aspartate-rich 110DDMD113 motif residing on 
helix D (Supplementary Fig. 11a). In the structure of CotB2wt•Mg2+3•F-Dola D110 is directly involved in 
the coordination of Mg2+A and Mg
2+
C, whereas D111 forms a salt-bridge with R294 of the RY-pair. D113 is 
surface exposed and points away from the active site (Supplementary Fig 11a and c). The difference in 
the protein sequence of the aspartate-rich motif has structural consequences (Supplementary Figure 
11c). In the structure of epi-isozizaene synthase in complex with diphosphate, 3 Mg2+ ions and N-benzyl-
N,N-diethylethanaminium,2 with a canonical aspartate-rich motif 99DDRHD103, the α-helix carrying the 
motif is extended compared to CotB2 (Supplementary Fig. 11b). The first aspartate of the aspartate–rich 
motif resides at an identical position to coordinate Mg2+A and Mg
2+
C. The second aspartate establishes as 
well a salt-bridge with the RY-pair. In contrast the third aspartate points towards the active site 
approaching water molecules in the water network around the Mg2+ ions. 
Comparison of CotB2wt•Mg2+3•F-Dola and CotB2
wt•Mg2+B•GGSDP 
Tomita and colleagues stated they crystallised the fully closed structure of CotB2, the C-terminus ending 
with K296, hypothesising that the salt-bridge is the driving force of active site closure.3 However, the 
remaining C-terminal residues have not been modelled due to their flexibility. In contrast, in 
3 
 
CotB2wt•Mg2+3•F-Dola we observe the complete C-terminus, ending with the C-terminal Q307. This 
structural feature results in a higher rmsd between the open and closed structure (Supplementary 
Table 4), manifesting the importance of the C-terminus for proper closure of the enzyme. Since in 
CotB2wt•Mg2+B•GGSDP two Mg
2+-ions are missing,3 the diphosphate moiety is not properly coordinated 
(Fig. 2b), resulting in significant substrate flexibility within the catalytically active site. Moreover, in the 
reported structure the missing Mg2+ ions prevent helix D movement towards the active site thereby 
prohibiting folding over of the C-terminus. Interestingly, the hydrophobic tail of GGSDP adopts a 
position similar to the partly cyclised intermediate in our CotB2wt•Mg2+3•F-Dola structure (Fig. 2b), as 
determined by the internal shape of the active site. In summary, our observations indicate that the 
crucial step of the initiation of the cyclisation reaction is the precise orientation and binding of the 
diphosphate moiety. The structure of CotB2wt•Mg2+B•GGSDP on the other hand represents a pre-





Cloning. DNA manipulations and cloning procedures were performed according to standard protocols. 
The C-terminal deletion variant of CotB2 (CotB2ΔCter) was designed by adding restriction sites NcoI at the 
5’-end and HindIII at the 3’-end to the sequence (Supplementary Table 5; primer 1 and 2). The digested 
NcoI/HindIII fragment was ligated into the target-vector pETM-11 with a TEV-cleavable N-terminal hexa-
histidine-tag. Single point mutations V80L, M189C, V150A, L281V and W288F of CotB2 were introduced 
by quick change site-directed mutagenesis (Supplementary Table 4; primer 3 to 12). Correctness of the 
amplified gene sequences was assessed by DNA sequencing. 
 
Synthesis of (2Z,6E,10E)-2-Fluor-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl diphosphate 
(2-fluoro-geranylgeranyl diphosphate) tetrabutylammonium salt. 
Materials were purchased from commercial suppliers and used without further purification. Synthesis 
was performed as described by Roe et al. 4 and some reactions were optimised.5,6 The products of 
intermediate reaction steps were analysed by NMR and HRMS. The NMR spectra (Supplementary Figs. 8 
and 9) and HRMS data (Supplementary Fig. 10) of the final product, 2-fluoro-geranylgeranyl diphosphate 
tetrabutylammonium salt, are presented below: 
Rf = 0.73 (n-Pentan)  
1H NMR (700 MHz, CD3OD): δ = 5.15–5.03 (m, 3H, H-6, H-10, H-14), 4.65 (dd, J = 23.5, 5.3 Hz, 2H, H-1), 
3.25–3.19 (m, 24H, 12xCH2, NBu4), 2.10–2.00 (m, 8H, H-4, H-5, H-9, H-13), 1.99–1.90 (m, 4H, H-8, H-12), 
1.72 (d, J = 2.9 Hz, 3H, H-16), 1.69–1.60 (m, 24 H, 12xCH2, NBu4), 1.60–1.55 (m, 12H, H-17, H-18, H-19, H-
20), 1.40 (tq, J = 14.8, 7.4 Hz, 24H, 12xCH2, NBu4), 1.00 (t, J = 7.4 Hz, 36H, 12xCH3, NBu4) ppm. 
13C NMR (175 MHz, CD3OD):
 δ = 151.3 (d, J = 233.0 Hz, C-2), 135.1 (C-7 or C-11), 134.5 (C-7 or C-11), 
130.7 (C-15), 124.1 (C-6 or C-10), 123.7 (C-6 or C-10), 117.2 (d, J = 15.8 Hz, C-3), 110.0 (C-14), 58.1 
(d, J = 6.8 Hz, C-1), 39.5 (C-8 or C-12), 39.4 (C-8 or C-12), 29.7 (d, J = 7.1 Hz, C-4), 26.4 (C-5), 26.3 (C-9 orr 
C-13), 24.5 (C-9 or C-13), 23.4 (C-16), 19.3 (d, J = 3.5 Hz, C-17), 14.7 (C-17 or C-18 or C-19), 14.6 (C-17 or 
C-18 or C-19), 12.6 (C-17 or C-18 or C-19) ppm. 
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19F NMR (376 MHz, CD3OD):
 δ = –118.7 (t, J = 23.9 Hz) ppm. 
31P NMR (162 MHz, CD3OD):
 δ = –6.8 (s, organic monophosphate), –8.9 (d, J = 19.6 Hz), –9.4 (d, 
J = 19.4 Hz) ppm. 
HRMS (ESI-TOF, m/z): (C20H34FO7P2
-) [M-H]- = 467.1728 (calculated: 467.1768). 
 
Bacterial strains, genes and vectors for diterpene production. Cloning, protein expression and 
production of cyclooctat-9-en-7-ol was conducted as previously described.7 In brief a pET Vector 
harbouring cotB2 (GenBank: BAI44338.1) or its mutants and a pACYC vector harbouring polycistronic 
genes of dxs-pathway8 were transformed to E. coli HMS174(DE3) (Merk Millipore). Cultivation was 
carried out in BasalR-Media with 3 % glycerol as carbon source. A pre-culture was diluted to an OD of 
0.1 and protein expression induced with 0.5 mM IPTG. After cultivation at 28° C for three days, the 
products were extracted with ethyl acetate and analysed by GC/MS. 
 
Analytics of diterpenes. Diterpenes as products of the CotB2 enzyme and its variants were analysed by a 
Trace GC Ultra with DSQII (Thermo Scientific). 1 µl sample was loaded by a TriPlus auto-sampler onto a 
SGE BPX5 column (30 m, I.D 0.25 mm, film 0.25 µm). Initial column temperature was set to 50 °C and 
maintained for 2.5 min before a temperature gradient at 10 °C*min-1 up to 320 °C was applied. The final 
temperature was kept for additional 3 min. MS data were recorded at 70 eV (EI) and m/z (rel. intensity 




Supplementary Table 1. CotB2wt and CotB2 variants as well as the altered products. The numbering of 
compounds is according to Supplementary Figure 2. 
Variant Product Compound Reference 
wild-type cyclooctat-9-en-7-ol 1 9 
V80L no product - this study 
N103A 3,7,12-dolabellatriene 2 3 
F107A R-Cembrene A 3 7 









F149L cyclooctat-7-en-3-ol 7 7 



























M189C cyclooctat-9-en-7-ol 1 this study 
L281V cyclooctat-9-en-7 ol 1 this study 
W288F cyclooctat-9-en-7-ol 1 this study 











Data collection     
Space group P212121 P1 P212121 P212121 
Cell dimensions     
    a, b, c (Å) 62.9 98.7 105.9 53.4 56.5 57.0 61.0 100.0 107.7 61.4 100.1 107.9 
 ()  90.0 90.0 90.0 91.8 101.7 115.9 90.0 90.0 90.0 90.0 90.0 90.0 
Resolution (Å) 44.74 - 1.80 (1.87 - 
1.80) 
20.00 - 2.10 (2.18 - 
2.10) 
50.00 - 2.15 (2.23 - 
2.15) 
47.50 – 1.90 (1.95 
– 1.90) 
Rmeas (%) 11.4 (114.6) 14.0 (92.2) 33.3 (208.7) 12.2 (164.6) 
I / I 14.4 (1.9) 7.6 (1.4) 6.2 (1.0) 12.2 (1.4) 
Completeness (%) 99.6 (98.8) 99.1 (99.1) 99.8 (99.0) 99.9 (99.9) 
Redundancy 6.6 (6.7) 3.1 (2.8) 6.6 (6.7) 7.3 (7.4) 
     
Refinement     
Resolution (Å) 44.74 – 1.80 19.83 – 2.10 49.86 – 2.15 47.50 – 1.90 
No. reflections 61142 33590 36480 53118 
Rwork / Rfree 0.17 / 0.20 0.18 / 0.24 0.20 / 0.24 0.28 / 0.21 
No. atoms     
    Protein 2439 (A), 2484 (B) 2320 (A), 2438 (B) 2273 (A), 2271 (B) 2309 (A), 2297 (B) 
    Ligand/ion 21 (EXW), 9 (PPV) 14 (AHD) - - 
    Water 283 223 197 246 
B-factors     
    Protein 24.4 (A), 25.8 (B) 36.3 (A), 33.7 (B) 32.9 (A), 33.4 (B) 32.2 (A), 32.7 (B) 
    Ligand/ion 28.0 (EXW), 17.8 
(PPV) 
30.90 (AHD) - - 
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    Water 31.1 33.0 34.4 37.3 
R.m.s. deviations     
    Bond lengths (Å) 0.012 0.007 0.007 0.007 
    Bond angles () 1.291 0.845 0.806 0.776 
*Values in parentheses are for highest-resolution shell. 
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Z-score protein TPS family Ligand in active site resolution 
[Å] 
Lit. 
5gue 0.8   100 46.5 cyclooctat-9-en-7-ol synthase 
(CotB2) 
diterpene  GGSDP, 1 Mg2+ 1.80 12 
2oa6 3.4 15 20.3 aristolochene synthase sesquiterpene PPi, 3 Mg
2+ 2.15 13 




4okm 3.4 15 18.4   selinadiene synthase sesquiterpene PPi, 3 Mg
2+ 2.10 14 
5a0i 3.4 11 18.0 labdane-related diterpene 
synthase (LrdC) 
diterpene PPi, 2 Mg
2+ 2.57 15 
5dz2 3.3 12 17.8   germacradienol/ geosmin 
synthase 
sesquiterpene alendronate, 3 Mg2+ 2.11 16 
5erm 3.0 17 17.2   fusicoccadiene synthase diterpene pamidronate, 3 Mg2+ 2.30 17 
1jfa 3.8 13 17.1   trichodiene synthase sesquiterpene no ligand 2.50 18 
4la6 3.6 10 16.0   2-methylisoborneol synthase monoterpene 2-fluorolinalyl diphosphate, 
2 Mg2+ 
2.00 19 





Supplementary Table 4. Root-mean-square deviation (rmsd) given in Å for superposition of different 
















0.7 - 0.4 0.7 0.5 
CotB2F107A• 
Mg2+B 
0.5 0.4 - 0.5 0.2 
CotB2wt• 
Mg2+B•GGSDP 
0.3 0.7 0.5 - 0.4 
CotB2C 
 
0.4 0.5 0.2 0.4 - 
 
 
Supplementary Table 5. Oligonucleotides used for cloning. 
number description oligonucleotide sequence (5’  3’) 
1 fw Cter deletion TATACCATGGCAGGCGCACAGGATATTG 
2 rv Cter deletion TATAAAGCTTTTAACGTTTGTTGGAGGTGGTC 
3 fw V80L GATTAGCTATGTTGGTTTAGTTCTGTGGTC 
4 rv V80L CAACATAGCTAATCCAACGTTCATCACTAAC 
5 fw V150A CAGCACGTGCATTTGCTACCAGCGATCAC 
6 rv V150A CAAATGCACGTGCTGCTTCATAGGCAACTTC 
7 fw M189C GATTTTTGGATGAAATGTAGCTATCCGATTTATC 
8 rv M189C CAAAAATCCACGCCAATATCGGTAAC 
9 fw L281V GATGTTTTTCTGGATGTGATTTATGGCAATTTTG 
10 rv L281V CAGAAAAACATCCTGTGTCAGCTGATC 
11 fw W288F CACCTCCAACAAACGTTATAAAAC 
12 rv W288F GTTGGAGGTGGTAAACACAAAATTG 
11 
 
Supplementary Table 6. Total and interaction energiesa (kcal/mol) between CotB2 active site amino acid 
moieties and carbocation intermediates. 

















































































































a The interaction energies were computed as the energy of the complex relative to the energy of the 
individual molecular fragments. The structures were taken from the QM(SCCDFTB)/MM simulations 
after energy minimization, as described in the Methods section. The interaction energies were obtained 
from M06-2X/6-31+G(d,p) single point calculations, and include counter-poise correction to remove 










atom                       x         y         z atom                       x         y         z 
 C                               5.229   -1.115   -4.849  
 C                               5.743    0.050   -5.367  
 H                               6.606    0.572   -4.968  
 N                               5.051    0.385   -6.507  
 H                               5.313    1.017   -7.223  
 C                               4.082   -0.539   -6.739  
 C                               4.147   -1.503   -5.707  
 C                               3.237   -2.558   -5.694  
 H                               3.241   -3.298   -4.908  
 C                               2.309   -2.651   -6.733  
 H                               1.612   -3.478   -6.745  
 C                               3.158   -0.628   -7.763  
 H                               3.148    0.096   -8.562  
 C                               2.274   -1.706   -7.753  
 H                               1.555   -1.813   -8.552  
 H                               5.576   -1.641   -3.960  
 C                              -1.895   -1.089   -1.862  
 H                              -1.713   -0.654   -2.840  
 H                              -2.963   -1.034   -1.666  
 H                              -1.623   -2.137   -1.906  
 C                               2.537   -4.315   -1.353  
 H                               3.072   -4.584   -2.265  
 H                               2.489   -5.203   -0.733  
 H                               3.130   -3.558   -0.833  
 C                               0.377   -3.144    2.063  
 H                               0.285   -3.677    3.010  
 H                               0.497   -2.085    2.278  
 H                               1.291   -3.506    1.586  
 C                              -1.434   -0.977    0.661  
 H                              -0.660   -0.664    1.367  
 H                              -2.377   -0.537    1.009  
 C                              -1.590   -2.469    0.628  
 H                              -2.441   -2.822    0.046  
 C                              -0.816   -3.417    1.201  
 C                              -1.103   -4.877    0.899  
 H                              -2.145   -4.976    0.582  
 H                              -0.957   -5.496    1.792  
 C                              -0.191   -5.414   -0.244  
 H                              -0.656   -6.299   -0.685  
 H                               0.766   -5.728    0.172  
 C                               0.008   -4.340   -1.272  
 H                              -0.916   -3.856   -1.591  
 C                               1.166   -3.796   -1.685  
 C                               1.134   -2.417   -2.325  
 H                               0.197   -2.259   -2.854  
 H                               1.939   -2.288   -3.058  
 C                               1.306   -1.421   -1.145  
 H                               2.341   -1.067   -1.140  
 H                               1.187   -1.983   -0.210  
 C                              -2.108   -0.451   -1.760  
 H                              -2.065    0.227   -2.606  
 H                              -3.082   -0.340   -1.291  
 H                              -2.033   -1.468   -2.139  
 C                               2.018   -3.588   -0.640  
 H                               2.784   -3.008   -1.150  
 H                               2.418   -4.578   -0.438  
 H                               1.819   -3.103    0.314  
 C                              -0.011   -3.243    2.384  
 H                              -0.562   -3.558    3.270  
 H                               0.288   -2.209    2.519  
 H                               0.889   -3.861    2.330  
 C                              -1.092   -0.964    0.546  
 H                              -0.209   -0.773    1.161  
 H                              -1.945   -0.582    1.124  
 C                              -1.301   -2.435    0.359  
 H                              -1.958   -2.724   -0.459  
 C                              -0.867   -3.431    1.169  
 C                              -1.241   -4.849    0.837  
 H                              -2.220   -4.892    0.358  
 H                              -1.267   -5.470    1.735  
 C                              -0.206   -5.563   -0.147  
 H                              -0.617   -6.540   -0.379  
 H                               0.752   -5.670    0.367  
 C                              -0.124   -4.745   -1.343  
 H                              -0.957   -4.804   -2.046  
 C                               0.763   -3.671   -1.463  
 C                               0.288   -2.590   -2.203  
 H                              -0.639   -2.748   -2.754  
 H                               0.209    0.490   -4.053  
 C                               0.923   -1.284   -2.316  
 H                               0.773   -0.988   -3.359  
 H                               2.000   -1.380   -2.140  
 C                               0.436   -0.088   -1.392  
 H                               1.131   -0.110   -0.542  
 C                              -0.998   -0.107   -0.756  
 C                              -1.152    1.388   -0.363  
 H                              -0.566    1.590    0.537  
 H                              -2.189    1.645   -0.141  
 C                              -0.596    2.163   -1.548  
 H                              -0.279    3.171   -1.270  
 H                              -1.372    2.271   -2.305  
 C                               0.594    1.331   -2.073  
 H                               1.515    1.768   -1.655  
 C                               0.774    1.335   -3.626  
 C                               2.258    1.158   -3.964  
 H                               2.831    2.009   -3.601  
 H                               2.400    1.091   -5.038  
 H                               2.679    0.265   -3.511  
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 C                               0.408   -0.210   -0.951  
 H                               0.770    0.251   -0.018  
 C                              -1.135   -0.335   -0.759  
 C                              -1.564    1.153   -0.812  
 H                              -1.276    1.656    0.116  
 H                              -2.641    1.275   -0.928  
 C                              -0.797    1.745   -1.998  
 H                              -0.682    2.827   -1.907  
 H                              -1.327    1.545   -2.932  
 C                               0.600    1.086   -1.999  
 H                               1.325    1.713   -1.458  
 C                               1.201    0.684   -3.251  
 C                               2.672    0.620   -3.337  
 H                               3.167    1.146   -2.525  
 H                               3.029    0.990   -4.299  
 H                               2.979   -0.432   -3.293  
 C                               0.447    0.292   -4.448  
 H                              -0.510   -0.168   -4.208  
 H                               1.023   -0.363   -5.099  
 H                               0.219    1.193   -5.034 
 
 C                               0.229    2.568   -4.342  
 H                              -0.849    2.643   -4.244  
 H                               0.457    2.498   -5.400  
 H                               0.677    3.483   -3.972  
 C                              -0.028   -6.523   -5.529  
 H                              -0.371   -7.334   -6.171  
 H                               0.366   -6.937   -4.601  
 C                              -1.198   -5.590   -5.215  
 O                              -1.056   -4.597   -4.504  
 N                              -2.377   -5.899   -5.802  
 H                              -3.158   -5.278   -5.688  
 H                              -2.451   -6.711   -6.371  
 H                               0.757   -5.964   -6.039  
 C                               1.137   -8.889    0.094  
 H                               0.968   -8.161    0.888  
 O                               1.171   -8.224   -1.159  
 H                               1.323   -8.908   -1.836  
 H                               2.087   -9.396    0.263  








atom                       x         y         z atom                       x         y         z 
 C                              -1.357   -0.620   -2.309  
 H                              -0.929   -0.142   -3.185  
 H                              -2.377   -0.255   -2.195  
 H                              -1.418   -1.687   -2.506  
 C                               1.578   -3.587    0.203  
 H                               2.546   -3.108    0.118  
 H                               1.730   -4.661    0.336  
 H                               1.085   -3.225    1.113  
 C                              -1.874   -2.640    2.499  
 H                              -1.841   -3.308    3.352  
 H                              -2.865   -2.160    2.476  
 H                              -1.182   -1.810    2.675  
 C                              -0.855   -1.221    0.156  
 H                               0.036   -1.293    0.788  
 H                              -1.613   -0.719    0.767  
 C                              -1.427   -2.670   -0.051  
 H                              -2.424   -2.551   -0.511  
 C                              -1.606   -3.328    1.239  
 C                              -1.435   -4.790    1.161  
 H                              -2.376   -5.279    1.447  
 H                              -0.715   -5.123    1.923  
 C                              -0.989   -5.116   -0.267  
 H                              -1.771   -5.645   -0.805  
 H                              -0.115   -5.766   -0.269  
 C                              -0.688   -3.777   -0.961  
 H                              -1.119   -3.753   -1.967  
 C                               0.739   -3.321   -1.002  
C                               -4.331   -5.963   -1.091  
 C                              -4.893   -5.116   -0.118  
 H                              -5.300   -5.538    0.792  
 C                              -4.963   -3.735   -0.329  
 H                              -5.395   -3.090    0.426  
 C                              -4.500   -3.193   -1.532  
 H                              -4.588   -2.132   -1.708  
 C                              -3.854   -5.404   -2.286  
 H                              -3.446   -6.045   -3.054  
 C                              -3.942   -4.026   -2.510  
 H                              -3.596   -3.614   -3.447  
 H                              -4.267   -7.037   -0.919  
 C                               3.224   -1.267    2.636  
 O                               2.554   -1.372    1.612  
 H                               2.798   -0.791    3.519  
 H                               4.244   -1.650    2.661  
 C                              -2.230   -0.604   -1.758  
 H                              -2.426    0.112   -2.548  
 H                              -3.007   -0.483   -1.006  
 H                              -2.326   -1.599   -2.179  
 C                               2.125   -3.077   -1.525  
 H                               2.580   -2.552   -2.359  
 H                               2.598   -4.057   -1.434  
 H                               2.339   -2.528   -0.609  
 C                              -0.610   -3.030    2.669  
 H                               0.458   -3.177    2.525  
 H                              -0.934   -3.639    3.508  
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 C                               1.045   -2.435   -1.986  
 H                               0.377   -2.406   -2.845  
 H                               1.173    0.164   -3.888  
 C                               1.924   -1.250   -1.827  
 H                               2.386   -0.974   -2.774  
 H                               2.729   -1.431   -1.111  
 C                               1.024   -0.074   -1.274  
 H                               1.400    0.114   -0.258  
 C                              -0.533   -0.279   -1.051  
 C                              -0.896    1.174   -0.630  
 H                              -0.540    1.356    0.389  
 H                              -1.975    1.349   -0.634  
 C                              -0.156    2.062   -1.623  
 H                               0.080    3.040   -1.192  
 H                              -0.796    2.247   -2.483  
 C                               1.133    1.297   -2.020  
 H                               1.987    1.831   -1.577  
 C                               1.431    1.181   -3.556  
 C                               2.935    1.385   -3.779  
 H                               3.233    2.389   -3.486  
 H                               3.190    1.255   -4.824  
 H                               3.526    0.683   -3.195  
 C                               0.641    2.136   -4.454  
 H                              -0.426    1.940   -4.414  
 H                               0.954    2.004   -5.486  
 H                               0.803    3.178   -4.189  
 C                              -4.445   -5.976   -1.221  
 C                              -4.962   -5.066   -0.279  
 H                              -5.347   -5.432    0.663  
 C                              -5.015   -3.695   -0.564  
 H                              -5.410   -3.004    0.168  
 C                              -4.569   -3.225   -1.805  
 H                              -4.603   -2.169   -2.030  
 C                              -4.009   -5.489   -2.463  
 H                              -3.635   -6.179   -3.205  
 C                              -4.067   -4.122   -2.754  
 H                              -3.729   -3.766   -3.716  
 H                              -4.384   -7.039   -0.990  
 C                               5.253   -7.383    3.291  
 C                               5.069   -6.003    3.464  
 H                               5.933   -5.356    3.509  
 C                               3.781   -5.467    3.606  
 H                               3.650   -4.406    3.762  
 C                               2.663   -6.308    3.564  
 H                               1.673   -5.893    3.689  
 C                               4.120   -8.214    3.220  
 H                               4.251   -9.276    3.078  
 C                               2.832   -7.684    3.369  
 H                               1.971   -8.336    3.339  
 H                               6.256   -7.804    3.213 
 
 H                              -0.792   -1.986    2.915  
 C                              -0.656   -1.253    0.156  
 H                               0.350   -1.055    0.542  
 H                              -1.343   -0.864    0.915  
 C                              -0.814   -2.765    0.190  
 H                              -2.445   -3.149    1.562  
 C                              -1.395   -3.441    1.420  
 C                              -1.283   -4.955    1.111  
 H                              -2.251   -5.330    0.786  
 H                              -0.990   -5.528    1.989  
 C                              -0.263   -5.107   -0.024  
 H                              -0.553   -5.852   -0.769  
 H                               0.727   -5.403    0.341  
 C                              -0.156   -3.739   -0.612  
 H                              -1.327   -3.306   -0.765  
 C                               0.643   -3.231   -1.748  
 C                              -0.085   -2.627   -2.713  
 H                              -1.136   -2.905   -2.766  
 H                               0.205    0.763   -4.626  
 C                               0.278   -1.329   -3.342  
 H                              -0.490   -1.039   -4.060  
 H                               1.236   -1.351   -3.863  
 C                               0.370   -0.332   -2.142  
 H                               1.245   -0.656   -1.561  
 C                              -0.855   -0.339   -1.125  
 C                              -0.864    1.137   -0.629  
 H                              -0.082    1.277    0.123  
 H                              -1.818    1.409   -0.173  
 C                              -0.538    1.952   -1.873  
 H                              -0.246    2.977   -1.632  
 H                              -1.409    2.009   -2.529  
 C                               0.611    1.170   -2.527  
 H                               1.531    1.472   -2.002  
 C                               0.854    1.425   -4.039  
 C                               2.309    1.102   -4.385  
 H                               2.987    1.797   -3.892  
 H                               2.472    1.175   -5.455  
 H                               2.585    0.100   -4.067  
 C                               0.511    2.849   -4.458  
 H                              -0.541    3.053   -4.288  
 H                               0.706    2.984   -5.516  









atom                       x         y         z atom                       x         y         z 
 C                              -0.048   -6.537   -5.631  
 H                              -0.391   -7.476   -6.066  
 H                               0.439   -6.736   -4.676  
 C                              -1.245   -5.609   -5.410  
 O                              -1.113   -4.486   -4.928  
 N                              -2.434   -6.060   -5.870  
 H                              -3.228   -5.446   -5.829  
 H                              -2.503   -6.967   -6.272  
 H                               0.661   -6.061   -6.309  
 C                               5.154   -1.230   -4.856  
 C                               5.638   -0.141   -5.538  
 H                               6.536    0.405   -5.269  
 N                               4.845    0.098   -6.633  
 H                               5.023    0.717   -7.388  
 C                               3.831   -0.808   -6.669  
 C                               3.980   -1.666   -5.555  
 C                               3.047   -2.678   -5.332  
 H                               3.127   -3.337   -4.480  
 C                               1.984   -2.814   -6.227  
 H                               1.241   -3.584   -6.061  
 C                               2.784   -0.949   -7.561  
 H                               2.694   -0.293   -8.411  
 C                               1.860   -1.965   -7.322  
 H                               1.030   -2.100   -7.995  
 H                               5.580   -1.677   -3.957  
 C                              -2.525   -1.196   -1.626  
 H                              -2.949   -0.542   -2.384  
 H                              -3.209   -1.235   -0.782  
 H                              -2.425   -2.194   -2.046  
 C                               2.357   -2.102   -1.528  
 H                               2.599   -1.739   -2.525  
 H                               3.208   -2.670   -1.154  
 H                               2.245   -1.238   -0.872  
 C                              -0.342   -3.169    2.696  
 H                               0.737   -3.094    2.574  
 H                              -0.538   -3.814    3.549  
 H                              -0.730   -2.178    2.924  
 C                              -0.699   -1.447    0.174  
 H                               0.267   -1.042    0.486  
 H                              -1.430   -1.124    0.921  
 C                              -0.656   -2.980    0.152  
 H                              -2.098   -3.733    1.608  
 C                              -1.010   -3.744    1.453  
 C                              -0.525   -5.184    1.128  
 H                              -1.374   -5.810    0.851  
 H                              -0.067   -5.650    2.004  
 C                               0.475   -5.088   -0.047  
 C                              -0.044   -6.373   -5.594  
 H                              -0.428   -7.259   -6.099  
 H                               0.434   -6.666   -4.659  
 C                              -1.197   -5.414   -5.299  
 O                              -1.016   -4.338   -4.732  
 N                              -2.406   -5.789   -5.776  
 H                              -3.181   -5.157   -5.688  
 H                              -2.512   -6.663   -6.238  
 H                               0.686   -5.878   -6.235  
 C                               1.161   -8.394    0.040  
 H                               0.999   -7.639    0.809  
 O                               1.131   -7.781   -1.239  
 H                               1.279   -8.491   -1.886  
 H                               2.131   -8.867    0.194  
 H                               0.376   -9.148    0.101  
 C                              -2.752   -0.326   -1.994  
 H                              -2.884    0.465   -2.724  
 H                              -3.571   -0.254   -1.284  
 H                              -2.833   -1.281   -2.507  
 C                               2.062   -2.839   -1.564  
 H                               2.437   -2.598   -2.553  
 H                               2.389   -3.845   -1.295  
 H                               2.525   -2.165   -0.838  
 C                              -1.324   -2.501    2.635  
 H                              -0.235   -2.459    2.624  
 H                              -1.632   -3.047    3.521  
 H                              -1.702   -1.486    2.724  
 C                              -1.420   -0.955    0.112  
 H                              -0.561   -0.621    0.700  
 H                              -2.312   -0.617    0.648  
 C                              -1.436   -2.493    0.071  
 H                              -2.966   -3.192    1.455  
 C                              -1.870   -3.188    1.391  
 C                              -1.333   -4.640    1.247  
 H                              -2.150   -5.344    1.101  
 H                              -0.810   -4.947    2.156  
 C                              -0.381   -4.666    0.041  
 H                              -0.871   -5.086   -0.840  
 H                               0.526   -5.248    0.224  
 C                              -0.062   -3.170   -0.198  
 H                              -2.151   -2.826   -0.694  
 C                               0.584   -2.776   -1.483  
 C                              -0.269   -2.231   -2.446  
 H                              -1.315   -2.508   -2.336  
 H                               2.530   -0.575   -2.782  
 C                              -0.063   -1.146   -3.441  
 H                              -0.899   -1.029   -4.123  
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 H                               0.039   -5.506   -0.958  
 H                               1.401   -5.631    0.150  
 C                               0.732   -3.586   -0.209  
 H                              -1.376   -3.337   -0.598  
 C                               1.127   -2.959   -1.521  
 C                               0.207   -2.938   -2.518  
 H                              -0.651   -3.604   -2.460  
 H                               0.273    0.436   -4.718  
 C                               0.033   -1.691   -3.334  
 H                              -0.817   -1.791   -4.024  
 H                               0.894   -1.435   -3.958  
 C                              -0.244   -0.604   -2.359  
 H                               1.463   -3.276    0.548  
 C                              -1.151   -0.659   -1.149  
 C                              -1.289    0.842   -0.725  
 H                              -0.643    1.042    0.134  
 H                              -2.310    1.082   -0.425  
 C                              -0.828    1.656   -1.924  
 H                              -0.441    2.637   -1.649  
 H                              -1.647    1.807   -2.629  
 C                               0.263    0.766   -2.566  
 H                               1.141    0.835   -1.887  
 C                               0.757    1.123   -4.009  
 C                               2.270    0.926   -4.105  
 H                               2.796    1.642   -3.479  
 H                               2.603    1.065   -5.128  
 H                               2.562   -0.073   -3.786  
 C                               0.368    2.539   -4.419  
 H                              -0.710    2.658   -4.438  
 H                               0.740    2.741   -5.417  
 H                               0.792    3.273   -3.740 
 
 H                               0.904   -1.056   -3.926  
 C                              -0.166   -0.557   -2.077  
 H                               0.632   -2.863    0.601  
 C                              -1.415   -0.167   -1.266  
 C                              -1.142    1.327   -0.938  
 H                              -1.591    1.603    0.019  
 H                              -1.601    1.958   -1.699  
 C                               0.379    1.511   -0.936  
 H                               0.753    1.754    0.057  
 H                               0.661    2.345   -1.581  
 C                               1.014    0.187   -1.441  
 H                               1.346   -0.369   -0.551  
 C                               2.268    0.396   -2.336  
 C                               3.446    0.811   -1.454  
 H                               3.211    1.707   -0.885  
 H                               4.325    1.014   -2.062  
 H                               3.687    0.022   -0.745  
 C                               2.058    1.381   -3.489  
 H                               1.129    1.189   -4.019  
 H                               2.878    1.292   -4.196  
 H                               2.034    2.409   -3.138 




atom                       x         y         z 
 C                               5.122   -1.122   -4.851  
 C                               5.613   -0.027   -5.518  
 H                               6.530    0.492   -5.260  
 N                               4.791    0.267   -6.578  
 H                               4.967    0.887   -7.331  
 C                               3.751   -0.610   -6.606  
 C                               3.918   -1.510   -5.529  
 C                               2.979   -2.520   -5.320  
 H                               3.084   -3.220   -4.505  
 C                               1.889   -2.605   -6.189  
 H                               1.143   -3.377   -6.041  
 C                               2.672   -0.695   -7.466  
 H                               2.566   -0.002   -8.285  
 C                               1.735   -1.703   -7.236  
 H                               0.871   -1.786   -7.873  
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 H                               5.561   -1.603   -3.977  
 C                              -1.292    5.421   -4.699  
 H                              -0.827    6.377   -4.457  
 H                              -2.122    5.584   -5.386  
 C                              -1.810    4.768   -3.419  
 O                              -2.375    3.674   -3.455  
 N                              -1.652    5.447   -2.262  
 H                              -2.044    5.046   -1.439  
 H                              -1.238    6.365   -2.273  
 H                              -0.556    4.768   -5.168  
 C                              -2.695    0.396   -0.789  
 H                              -2.861    1.163   -1.542  
 H                              -3.212    0.685    0.120  
 H                              -3.141   -0.533   -1.137  
 C                               1.867   -2.085   -1.562  
 H                               2.221   -1.581   -2.459  
 H                               2.452   -3.001   -1.454  
 H                               2.086   -1.472   -0.691  
 C                              -0.486   -2.916    2.753  
 H                               0.547   -2.969    2.413  
 H                              -0.616   -3.655    3.540  
 H                              -0.655   -1.929    3.179  
 C                              -0.943   -0.792    0.677  
 H                               0.091   -0.688    1.017  
 H                              -1.580   -0.464    1.504  
 C                              -1.240   -2.272    0.386  
 H                              -2.488   -3.025    2.007  
 C                              -1.472   -3.184    1.621  
 C                              -1.333   -4.621    1.044  
 H                              -2.307   -5.105    0.983  
 H                              -0.716   -5.243    1.697  
 C                              -0.698   -4.497   -0.354  
 H                              -1.455   -4.597   -1.136  
 H                               0.064   -5.257   -0.538  
 C                              -0.112   -3.078   -0.352  
 H                              -2.165   -2.342   -0.203  
 C                               0.417   -2.487   -1.646  
 C                              -0.788   -1.444   -2.272  
 H                              -1.750   -1.786   -1.899  
 H                               1.169   -0.251   -3.886  
 C                              -0.133   -2.563   -3.019  
 H                              -0.845   -3.349   -3.238  
 H                               0.561   -2.336   -3.821  
 C                              -0.412   -0.215   -1.726  
 H                               0.745   -3.081    0.336  
 C                              -1.188    0.243   -0.506  
 C                              -0.554    1.622   -0.149  
 H                               0.104    1.513    0.714  
 H                              -1.313    2.360    0.112  
 C                               0.253    2.038   -1.376  
 H                               1.100    2.677   -1.124  
 H                              -0.378    2.582   -2.079  
 C                               0.724    0.709   -2.004  
 H                               1.561    0.358   -1.369  
 C                               1.250    0.765   -3.471  
 C                               2.728    1.160   -3.479  
 H                               2.859    2.164   -3.086  
 H                               3.116    1.144   -4.492  
 H                               3.322    0.476   -2.875  
 C                               0.432    1.704   -4.358  
 H                              -0.633    1.551   -4.217  
 H                               0.673    1.537   -5.403  










Supplementary Figure 1. Secondary structure elements and variants of CotB2. a, On top of the primary 
sequence of CotB2 the secondary structure elements are drawn. Slashed lines at the C-terminus indicate 
the terminal residue of the open state of CotB2. Missing residues have not been built due to their 
flexibility. The aspartate-rich motif (110DDXD113) is highlighted in red and the 218NSE228 motif in yellow. 
CotB2 variants, as listed in Supplementary Table 1 are indicated by circles. For colour-coding see inlet. 
The structured C-terminus of CotB2 in the closed conformation is shown in purple. b, The open structure 
of CotB2wt (PDB-ID 4OMG) is shown in gray cartoon representation. The 110DDXD113 motif is shown in red 
and the 218NSE228 motif in yellow. CotB2 variants are indicated by colored spheres. Color-coding of 







Supplementary Figure 2. Overview of products of CotB2wt and its variants. Some colour coding of 
variants and their products as in Supplementary Table 1 and Supplementary Figure 1. a, cyclooctat-9-en-
7-ol (1) produced by wild-type CotB2. b, Variant N103A producing 3,7,12-dolabellatriene (2) c, Variant 
F107A producing R-Cembrene A (3), F107Y producing cyclooctat-1,7,-diene (4), and F107L producing a 
product mixture composed of cyclooctat-9-en-7-ol (1), 3,7-dolabelladiene-9-ol (5), and cyclooctat-6-en-
8-ol (6). d, Variant F149L producing cyclooctat-6-en-8-ol (7). e, Variant W186L producing cyclooctat-9-










Supplementary Figure 3. Polder electron density maps21 shown as mesh at a σ-level of 2.0. Molecules 
are presented as ball-stick-models with carbon atoms colored in magenta, oxygen in red, phosphorous 
in orange and fluorine in light blue. a, Structure of CotB2wt•Mg2+3•F-Dola with a polder electron density 
map around the F-Dola and diphosphate molecule. b, view in a, rotated by 90°. The polder electron 












Supplementary Figure 4. a, In the structure of CotB2wt•Mg2+3•AHD, the bisphosphonate moiety of 
alendronate (AHD) is coordinated by three Mg2+-ions. The strong binding of AHD to the active site is 
reflected in low B-factors of 24 Å2. The entire C-terminus is observed and folds over the active site. 
Residues of the DDXD motif are labelled with red letters, residues of the NSE motif with yellow letters 
respectively. b, Superposition of CotB2wt•Mg2+3•AHD and CotB2
wt•Mg2+3•F-Dola. The coordination of 
the Mg2+ ions is identical in both structures. c, Structure of CotB2wt•Mg2+3•AHD with a polder electron 
density map around AHD molecule shown as mesh at a σ-level of 2.0. The AHD molecule is presented as 






> cyclooctat-9-en-7-ol synthase (WP_093468823), Streptomyces 
















































































Supplementary Figure 5. Protein sequences of diterpene TPS from different bacteria with accession 
numbers in parenthesis. Highlighted are the Mg2+ binding motifs in red and yellow as well as the 
WXXXXXRY motif in light blue. Underlined sequences refer to crystal structures of the respective 









Supplementary Figure 6. CotB2 in different catalytic states. Residues of the DDXD motif are labelled 
with red letters, residues of the NSE motif with yellow letters, respectively. Mg2+-ions are depicted as 
green spheres and water molecules as red spheres. Hydrogen bonds are indicated by dashed lines. Solid 
lines represent the coordination sphere of the Mg2+-ions. a, Catalytic centre of CotB2F107A•Mg2+B.
 b, 









Supplementary Figure 7. Schematic drawing of the different structural snapshots of CotB2. CotB2 is 
schematically drawn as a gray cup. The Mg2+ binding motifs are indicated in red (110DDXD113 motif) and 
yellow (218NSE228 motif). The unfolded C-terminus of the open state of CotB2 is indicated by a dashed 
line and in the folded, closed state as a solid purple line. a, CotB2C is still capable of binding to Mg2+B 
(dark green circle) by the NSE motif (relevant structure CotB2C•Mg2+B; PDB-ID 6GGK). But the missing C-
terminus does not allow neither to bind nor to cyclize the educt. b, In the open structure of CotB2 the C-
terminus is not folded (relevant structure CotB2wt; PDB-ID 4OMG ref10). As the first binding event, Mg2+B 
is bound by the NSE motif (relevant structure CotB2F107A•Mg2+B; PDB-ID 6GGL). Subsequently the 
substrate GGDP and the C-terminus starts to fold over the active site. A salt-bridge between R294 and 
D111 of the DDXD motif is at this stage already established (relevant structure CotB2wt•Mg2+B•GGSDP; 
PDB-ID 5GUE ref3), but most of the C-terminus remains unfolded. Binding of Mg2+A,C (light green circles) 
to the DDXD motif finally leads to a fully structured C-terminus that now completely closes the active 
site. Now, CotB2 is ready to initiate the cyclisation reaction and to cleave the diphosphate moiety 
(relevant structure CotB2wt•Mg2+3•F-Dola; PDB-ID 6GGI). Finally the cyclised product is released. c, 
Alendronate (AHD) is recognised by CotB2 like the substrate-analogue FGGDP, but the diphosphate 
28 
 
moiety cannot be cleaved (relevant structure CotB2wt•Mg2+3•AHD; PDB-ID 6GGJ). The diphosphate 
moiety of FGGDP and AHD occupies an identical position in both structures. The C-terminus is folded as 
in the closed structure of CotB2wt•Mg2+3•F-Dola. Since no cyclisation occurs, the AHD remains captured 






Supplementary Figure 8. NMR analysis of the tetrabutylammonium salt of 2-fluoro-geranylgeranyl 









Supplementary Figure 9. NMR analysis of the tetrabutylammonium salt of 2-fluoro-geranylgeranyl 








Supplementary Figure 10. HRMS analysis of tetrabutylammonium salt of 2-fluoro-geranylgeranyl 
diphosphate. (ESI-TOF, m/z): (C20H34FO7P2









Supplementary Figure 11. The non-canonical DDXD motif in comparison to other TPSs with the 
canonical DDXXD motif. a. The overall structure of CotB2wt•Mg2+3•F-Dola with α-helices drawn as 
cylinders. The 110DDMD113 motif residing on helix D is highlighted in red and the NSE motif in yellow b. 
The overall structure of epi-isozizaene synthase (PDB ID 3KB9 ref2) with α-helices drawn as cylinders. 
The 99DDRHD103 motif is highlighted in red and the DTE motif in yellow. c. Superposition of the catalytic 
motifs in CotB2wt•Mg2+3•F-Dola and epi-isozizaene synthase. Zoom into the active site. Same view as in a 
and b. The Mg2+ in the CotB2wt•Mg2+3•F-Dola structure are drawn as green spheres and of epi-isozizaene 
synthase as gray spheres. The bound F-Dola is shown in magenta and the bound N-benzyl-N,N-
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